var title_f30_42_31392="Ivermectin: Pediatric drug information";
var content_f30_42_31392=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"23\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ivermectin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F13855938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F13856362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/49/33557?source=see_link\">",
"       Ivermectin (systemic): Pediatric drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13060 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-BAD001EFC9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31392=[""].join("\n");
var outline_f30_42_31392=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/49/33557?source=related_link\">",
"      Ivermectin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_42_31393="Self-retaining retractor";
var content_f30_42_31393=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F82534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F82534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Self-retaining retractor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 486px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31393=[""].join("\n");
var outline_f30_42_31393=null;
var title_f30_42_31394="Inflammatory bowel disease colonic mucosa";
var content_f30_42_31394=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F64110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F64110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inflammatory bowel disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Crohn's disease. A prolific bacterial biofilm covers the colonic mucosa, multicolor FISH: Bacteroides is orange, Eubacterium rectale and Faecalibacterium prausnitzii are both red, all other groups are green. Despite close attachment to the mucosa, no bacteria can be found intracellularly in the columnar epithelium or submucosa. Panel (a) DAPI stain, only a few leukocytes are seen in the biofilm. A prolific biofilm without a leukocyte response is typical for inflammatory bowel disease patients treated with azathioprine. (B) Ulcerative colitis, cytopathogenic effects of bacterial adhesion, with defects (ulcerations) of the epithelial layer and migration of bacteria into the submucosa. Despite the severe inflammation, the number of bacteria is reduced compared to regions without marked inflammation as shown in figures A/a (x1000).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31394=[""].join("\n");
var outline_f30_42_31394=null;
var title_f30_42_31395="Calculation valve area AS";
var content_f30_42_31395=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Calculation of aortic valve area in aortic stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 278px; height: 462px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHOARYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwD4skj4p+Mv8AsM3n/o965ZFeR1RAzOxACgZJPoK6n4tf8lU8Zf8AYZvP/Rz1neC9YtvD/ivStXvtP/tKCxnW4NqZfLEjLyoLbW43AE8HOMd6ptpgbvxM+HGr/D19LGq3FrcJfxuyyWrllSRG2yRMSB8ykjP1riMn1Nej+M/inc+MfCEuka3pFkLwag2oQXtriHyy4PmKyYO7cTknI5A615vS5mAuT60ZPrSUUczAXJ9TRk+ppKKOZ9wFyfU0bj6mkoo5n3AXcfU0bj6mkoo5n3AXJ9TRk+ppKKOZ9wFyfU0ZPqaSijmfcCe0urizuobmznlguYXEkUsTlXjYHIZSOQQeQRX21+2Bcm1+GulsM4bV40PPbyJ/8K+Hq+1v20zj4W6V/wBhmL/0RPTUndMTV0fFrna5wcgdKmEVwYPP8qYw/wB/advp1qsetfVXwy8UaJa/B/wppuoa/p9nbix1aDUc6rGslr5krmMmzOTOx/hBHAJI+9T5mgsfLG/3NKX9zio6Sn7RhYlD9OW/OjcT0Y1HR3oU2FiQSYHU1GST1pKKlyb3HYWug8IeE9V8W3UttosUcssSl2V5kj49csQK58da9E+Hnh6SWzh1e6eWLT2uTCDC4V5CoBZc5yByOcGtKMOeViJuyucf4i0DU/Dt/wDY9YtWtrgqHCkhgy+oIyDWYqljhQST2FeiX/hbUr++u7zQILi/gt4ftVw5AXy0B68nkfT8q9Pn+Nvgy61XTdTez8V2F3aqgkgsJIEglZeu8ZBbP4UqtP2bs/6/McJKR82MpUkMCCOxptdL8RNeg8S+MNR1a0a9a3uZN6C8YGRR/d44wK5qokknZDWq1CnDGKbS0kMXcaKbRRdhY7v45xxxfF/xcsQAU6hIxx6k5P6k1wldb8Wsn4qeMc8/8Tm8/wDRz1yhBFOV22xLRWG0UoBJwKUowHINKzYxtFLinKrMQADknGKLMBlFaEOkX01u88UG6NDhiGXg/TOageyuUBLQuAO+OPzp8kuwuZFairNvZXNyjvBCzogyzDoKgZSpwwwfek4tboLobRTgDijBosxjaKdg0YNHKwG0UuDShSe1HKwG19q/tq/8ks0r/sMxf+iJ6+ONJ0y71fVLPTdPi869vJkggj3qu93YKoySAMkjqa+x/wBtb/klmlf9hqL/ANET0NNbgfFdJRRSAKWiimAlFFFABRS0UASW8MlxPHBAjPLIwRFHVmJwBV2WG80XV3tb4XNjdW7mOULxJGe/cc/jTNP0zULy3urqxs554bNRJPJHGWWJexb0HHeqyP8Avt7uydfmQZP8xVrRXEOku7iVQjzSMvTaW4/KptX0q/0e7+y6raTWlxtD+XMpVtpGQcVRq7b2F9e21zd29tcTwWwBnlRCyxg9Nx7dO9Sry9Q2KVFFFSMWikpaYCUUUUgOw+Ku0/FXxfvYqn9tXm4gZIHnv2rknxuO0kr2yMV1fxc2/wDC1PGOwsV/ti7+8Mc+c+f1rku9XJ9BIcu4HcueO4qUkyZ8yRge245z/hToo1Voy5yrddp6Vq3N/pRO610t412gHfJu+buenH0rSEUlqyZPsZaRFkACjcxG055Ndn4Z8Kahd3kpmkRpYdpaJ5sE5/h571h6TrAtTKLeC2iLEEmXDbQOy571HqOpeZdPNbzzrICGDocZYd+ua2hyRVzOXM3Y9gtdLj8K6hG2oadb2zPG0kbsplEfbJPftx3xWHrGoWNzIn2h4pUgTd8+IvMB/wBlc/ka81vddvb8RtqN7e3ckYwDPO0gx6cmqE11LMVLt90YwOKt4pLZCVJ9T0iw8OaPrumv/ZN++n6gHzKsz4iC9gO5PtiuR17w5Npl+1stxDdyJku0ZOFHvmsmCaRULCZwc9Nx5rvdCE8/hyeTUtQVIc7Y7JcI7jGdxx1H1oi41NGgd4dTzk8E8/lUs4hWVhbyPJF2Z02k/hk/zq1qsKRTARhcEZIVcYqpaLG11Ctw7RwM4Duq7iq55IHc47VzSXK7Gqd1cZihhVzVorODUp49MnmubNWxHLNEInYepXJx+dU+cU9nYEIKO/BpeMUhyM0IZ1/wpBHxR8HAH/mMWf0P79K+ov21f+SWaV/2GYv/AERPXy98JCT8T/CHHXWLP/0ctfUP7a3/ACSzSv8AsNRf+iJ6ipuET4qooorIoKKKKACiilpgFFJU1tbz3Uyw2sMk0rdEjUsx/AUAbFtomqfYnQWs0LyRfaFVyUMsIBywB4ZeOtZ+lRu90xjuLe2ZI3ffORtOFPyjg8noPemG8upJI/NnmkKr5a7nJIX+6M9B7V7No/iS58KeHra2g8KPN5ge5eR794ZGwASxjXoAOM+1bqPMrxWxF7OzZ4dUsUsqo8ccjhJMBlUkBvqO9dF448SSeL9XS8jsXtgkYQRCZpsck5yee9UovDGvNaC8TSNQFtniYwMF/PFZKDl8KuVdLcyriCW3lMVxE8Ui9UdSpH4Goq0dUt9SM0txqAuJmD7HnclwWx039z+NZ1KSs7AncKWiipGJRRRQB1nxY/5Kn4y/7DN5/wCj3rl8Y6g5rp/ix/yVPxl/2Gbz/wBHvXMow3DzMlR1AOOKqLXUGOiZRKvmrle/0rrb628MnSW/sjWL5Jcgy2tzEuGPcqRSaN4Z03XFRbXVba2nYBVjmcAls4Gc4rN8ReGNY8M6m9ve2z7ojlZowWRgOhB9K6YxlFc26Mm09NjNulto2LWkrOM4IkXB+tQQwyXB2wozN6KM1r3HiKS7RBc2NnJKDzJswzfU1dbwrq09kNSjhtvJxkhJVIA98dKSjz/DqHNy7nLMCrEHqKbmrskADAzr5CkHGwbv61WSGRwzxxu6r1YLkD61jKLT0NE7mloGny3d9ARIlvGHBMsh2qBnnmuq17xG63z2ek3xaB3zJKUByemBgdK4ea5uXUJJK5Ucbc8flSW8nlSK4Yrjrj+Vaxq8q5UZyhd3Z1cHmTyK8i+fK2Y8mP7pPf2o1CxtPDMyGQ297qOC+RKGji9PlHU/U9qo3viSSWJYoYEggUY2qcbj6n3rnWYEnr9TWk6qWi1JjBvcmlnE04aTOC2XYDLHnk/Wkl8syv5JdosnbvADY7ZxUFPiKCRPNDFMjcF6474965ud31NrAenFGe3FK20k7c7e2etJ0PFaJiOy+E2f+Fm+DywGDrFn/wCj1r6f/bW/5JZpX/Yai/8ARE9fLfwnb/i6Xg/GR/xObPj/ALbJX1J+2t/ySzSv+w1F/wCiJ6zqbhFWPiqiiisygpaKKACiiimAVbtre8SL7XbiWNVOBIpK59cHv749aqqpZgqglicADua3tVttb0vTorG9N2lmp83yHDBEc45weAcAVcI3u2tES3YzLK2ZxJI0kUaxqT+8YAk46AetdXe+OptZ8NR6Pq+k6fLHbR7YbyG3AuU5yMyHPy+o4rlNQvzelC0UUZUc+WMA+596dZnZY3eZLob1A2wn5Dz/AMtParT1tDYVrrU6Dwz411bwVNL/AMItfJGJlHmuYQ272+YdKTxB8QfEGv7RqV2ZEUAeWCVTg56A461yNFR7SV9NCuVdS297eXEX2Y3E7wtJv8neSpc99vTNVSCCQRgjtUtpczWd1Fc2srw3ETB45EOGVhyCDTJZHlkaSVmd2OWZjkk+pNRuMZS0lFIAooooA6z4sY/4Wn4y/wCwzef+j3rlK7v4o6ek/wAR/GkwuY0ddZvDsYHn98/f1rh1jZlJRGYLySBnFW4NaiUkNBqeG8nhDiKWRVfhgGODUBIJ44ptTdrYZYmlWcriMI44+Xofwp8K+Uwy+HztKHp9DVWpIJfKfO1WHcEZq1LW7Ja00Ox1LwRfWOiW+szX+hLFKNy20d2GlGOxUZx+da/w/wDEOiWsNza6tp8IScYxECWJ7nB4GBXMRaxo0dpIp0p5Zyu1RI67B78AGsA3BFwssaJGVYMAo4GK3dVQs4sz5HLRo7bxjeeD4bdIfC7aldTE5kluVVE+gGMmuVNlFJoX22Et5sUuyZSeAD90j+VVb2JEkV4STDIu9Mjp6j8CCPwrR8MyqbyWymOIbxDEfZv4T+f8648VUm1zdvy/4Y9PK6dKrW9jNfGmk30k/hf32T8rmNSVLNC8M7wyLiRGKke4prxvGQHVlPXBGKpaq6OOScXyvcbRS49qljt5JFZlU7RyT2FNRb2JbsMhZVkVpFZ0B+ZVbaSPr2o4PI6UhHp07VJD5Syj7QrtH3CMFJ/Eg1cboDqfhKR/wtHwgD1Os2f/AKPSvqX9tb/klmlf9hqL/wBET18s/CcA/FLwdyeNZs//AEelfU37a3/JLNK/7DUX/oielU6Aj4rpKKWoGFJRS0AFFFFAG7dRXGmWOn3DypbX8Eu6GNMeYBncHOBwQemTk8ccc7svxA13xG1vZeI9TkurZUaMGbDfe6sc9T6VyVvql7babdafBcOlndMrTRDo5XO3P0yapVp7SzTiTbSzNfX9HXTLopa3aX9uFB8+JCF+nNTaTeW8PhzVbee9uY3laPbaxNhZiM8tweB9e9YYJAIycGp03Cwk/cxFGkUeYfvqQDwOeh78dhQppSvFA1pZlailFa+navDZadc2raVp9zLKMC4mRmeP3XnGahJPcbMerl1qN3dWdpaXE7yW9qGWCM9EBOTj8aqVe0jVLrSLl57Jo1keJ4SXjVxtYYOAwPOO9C3GUaSilpAJRS0UAen/ABJ0LUbj4oeKxBbSATapdsrdN+ZnIweh6iuesLDVdFmaQwyKUJZ1wc/XjqPfpXqXxFuNOTxt4hW3lms501G6MqyEkSt5rZIHoa5TTZfOuY5L77SsbH928T4Ce3IIOeuK9KNONlbc5XJ3OM1OG11Cb7TAro5z5sOxY9pz2IGD+QqK30W1nsJpTfPBcRjIhlgY7vow/qBXQarZ2+m3TTaVM8rjJYNCQD79SDXLJd3lpcTGN3G4/OCMg/UVjOKT95XLi21oZ0kUkZ+dGX6jFR1sR61ceckssaTbDkBwSPypL3V0vZzLNYWgJGMRqUH6Gudxh3NLy7GSBVi3s7m5dVggkkZjgBVJpsaiWb5Y22k52qecVamaC2fAspo5AOksmfxwAKIwW7G32O88PfDeS7toF17ULbS90uVEkq52sOScnA6V6Rp3wi+HVhdC71Px/Zy28I3GKGVN7Ec9cn9BXzlPO88rPISzH1pYSUkDBVwP7/StHUT0gv1FFOOrZ7B4w8beCtOuRF4S8PtO6g+ZdXjDc79M8ZyMc9q8nmuzNO7zQq8jnsc9ewqKfa5BUF2wSxX+vFQq5iYMhZWHcGjmcUo9EOTdSTnJ3k9W+7LTwBGAMcgbsj/LxSPJJJIFkZUQ9uyirOmWbapMUZtpBHmTytwg/wA9qk1+3sIJAmn3L3e3hpmXZk/7K+nuaq2nMRfWxD9nt4LcTXbyNK5+SIccerVnzSea+cAD0HamNnPIAptYynfQtRtqeh/AfVbPTPid4fW80m21E3V/bW8TTMQbZ2mUCVcfxL1FfSP7av8AySzSv+wzF/6Inr5V+E3/ACVPwb/2GrL/ANHpX1z+12NMPw200a0b0W39rR7fsgUvu8mbGd3GMZ/Ss2+5SR8N0V6t4r8HeHvDXhvQrzVbTXIF1NXuIJ1eJndOPldOikde/WuU2eCcf63xGP8AtnD/APFUStF2b/B/5DSbOVors7A+AIbqKS6PiOeFTlojHCN49MhsioxF4FbJN34kX0/0aA/+z0uaPf8AB/5Bys5CiuuEPgQ9b3xKP+3SD/45VqVPh29rbxx3HiaOaPd5kv2WE+Zk8cebgYH50KUe/wCD/wAg5WcNSmux+y+Atw/4mniXH/XhD/8AHauabD8N4ZWe+v8AxJcRlCojFlEmGI4bIl7HnHehOL6/g/8AIfK/6scFRXaiy+H5/wCY34jH10yL/wCPVIun/D7BB8QeIx/3Coj/AO1qLx7/AIP/ACDlZxc1vNBs86KSPzF3JuUjcPUZ6ioq9Z8Uaj4B8QppCvrmvwHT7NbMFdLjbeFJOcedx16Uvhj4c+HPFNtfzeH9W8Q3cdhH51yw0uFdi4Jz81wM9DwMmrtFu0fyf+RNnbX8zyXFFei2WnfDOEzC91/xBPujIjK6Wsex+zf605HtxVQaR8Piw/4qzWx9dFX/AOP1Pu9/z/yHys4Wjp3ruxovw+/6HDWB9dEH/wAeq5qOkfDOWZTp/irWrePYAyyaSJMt3IPmjg+lPTv+f+QcrPOAKK71dC8AE/8AI66mProZ/wDj1FCsFj2P9obT9Tt9Su3fT7CaGaaV47lVIwpc/Kx/vYxyK+e5rm/sLjCCS1DHJXJKmvun4h6GdUtL97aCebG/dAykbnGcFQce/INfKHi7wxHY28zHTrvzyeFlc4GfcE/rXfy+1gpJ6o5b8kmjmH1HTZNKZGhK3APL7mbd79ePpUtnrFvJLb/a7PT7kIuDFdJ5aOP95CCD71lvpckLNFfW9zHcoPlDJgYPTOelU7/T5YZMJDtTGfvA1m5TRVompeataQai8cGnJb2rcGG2vGdfqGJOawt1uJpN0MoX+FQ3I+ppbeWa3lwhRGbruwRXZeCvAkXjC6Nta6xp9hck/wDL3KQufqAc1GsitInM2/koGkj024n28hmZgB9dtZc8hkkJbjnpkn+dej+NvhtrPhCSO3m1zTbqCSPe0ltcHYo9DkDn2rzidVWQhWDgdwMA/nUVE+Vf8AcGrjKBjPIzSUViaDi3HFN60UUASxTyRqVjcqp5IFLNO8rZkO4gYqGgY7003sFkOz6ChsnkjFPwgGd2CO1MZs8dqbVlqK51Hwn/AOSp+Df+w1Zf+j0r7A/av0HUvEHw80y30mymvHh1eGaZYlyUj8qVSx9sso/Gvj/4T/8AJU/Bv/YZsv8A0elfaH7SvjbV/AfgOy1PQGt1up9RjtmM0fmAIY5WOB65QfrUppO4z52+NrXOsadoljawXMstnfXFhDAoLt8qx4UADrXCav8ACvxppGqWenXvh+8+13f+oWICUP0zypIGMjOcY716B8O/j1rtnqktvq8VrdHU9Rika4KLH5G5gshAA9MfTFaPjf8AaD8TaT4r1+x0BrFtP85kt5JYt7xjjlSDg9O+a2qTjP3uUhJrS55rafCPxzcvbCPw3fETsyq2BhSpwdx/h59cZ7V7Rb/sw6c1zBHJ4nn+VAbpFhTcshwQo56HJ59hXmr/ALQnxAeC5ibUbU+dnDC1QNHkfwEdK4W78aeJLvXDrFxrV++pF1kM/mkHK/d4HHHYVn7T+VW/E0SXVnTfHH4cf8K48TRWcN0biwvIzPbF/wDWKgYrh+AM8dRxzXnIBJAAyTXsfgD4yGC1fRviLZ/8JLoUgABuFV5oeezNyw9s596dq/xqtJ7omw8B+GI7ZFCRCW3LOApzGSQR0/Wi8Xq/w/4dEu62PKrLQ9VvjILPTL6cxuI38qBm2MegOBwfrWgfBniUalJYf2BqhvI38t4RauWVsZweOuOa9Ltv2jvFlvMZo7DRFlk3NcMluy+e5GA7YbqOKnn/AGmPGRKfZrTR4BtUSfuGYyMByx+bv+lLmjuov70Fn3OIt/hJ46m060vofDd41vdMqxEMm456ErnKj3IAq/pHwY8aXmoaZDd6LeWVteyBPtEiAiIZ5LgHK/jjPauqk/aX8V+bdvbWGlRCZEWNCsjLDtByQN3JOefoKt6p+0x4hkud2m2NrHA9oImjmGSJsHMqkHPpwc9KpTXb8RWfc5m5+Afj2GW3X+zImWaXy8/aY/k5wGYA9Dntmur+EtheeENNvrLVJI7S61U3MaQMTvZYoiCemMbjxSfBz4w+KdS8Zw2niHUo76y+yy/JPGqnKKXU7gM7s96ofE34u6frfiTwrqWj2kCixib7bG0Z2Fnb50HQkY7j1rWFRR1cRSj0TPNPFHgTxN4asbW+1zSLiztbv/UyOysG4BxwSQcEcGp774b+KrRYGTRby7SaBLgNawvKFV87QxA4PB4r1TV/2iLmTXZ47fRdJv8ARInUWCXcJ3wYwA2fbHpn3rW+Jv7Q+vaV4nurHwv/AGPLpyIojnOZySRyQwYL+GKi6Sbtf5hrpqeW6f8ABXx7dvbF/D11bQTuq+ZM6LsBOMlSwYY64xn2q/8AEf4J654SjjutMaTxBpxjZ5bqytziAqTkMASQABnPSrXiH9obxpqpjFs9np6xypMvkR5YMox1J5B5OCKxfDPxf8TaTbf2feXA1LRZBIk9jMSgkSQ5cb1wwJycHtnpUpxe6K1POeccA0V7pb+L/gvdbU1DwLf20cUarGYJyWY9W3fOM8ngnJ47UVDQ1dn0fD8Q7aHV9TsbmNXuIbyaBQny5CuQBz16DJqzq2i6B4nhMurWhsryXCZLY57dPlb/AD0r5d8d61FY+O/FywurS/2tdhoyA3PnOP8AI61L4V+Lk/h2y2W947M7gGN4t+weoJ5x7Zrq5IxtKDszK/M7NHsXi34N37WLf2XqH9pDGSkwVJT6YYgg/jivFfGXwz1fS7xBcQnfKp2i4jwxPcDacGvU/Dvx8BKRXK2jR55LOsTf8BXNer23jDw7rMcEd4YWbgj7Uq4BPPBPH5VaqztaceZeRPs1vFnw3deCtdhh8+60u6t7Rclpmi2rj1BOMirvh7wtZXaMzX4EingpwV9+9fds0trrMcsNtcw3JQ4VLmBXiB7DBANcPqvhSfTkllOlwGCQFpV02CMbPf5wf0opOm37ys/P+kKXMj4s8S6c+nz7PtKXUZ6Sqpwf8awiDX0hNoXgq9vZ/wC1dXhjj53bosFfrs4/EivK/HXh7QrO7/4pvUvt1vjOdnl/zNKtQW8WVCbW6OCoqeW3eNtrow7+vFRbRn0HvXI00a3TG05UZzhQSfalYAHoetKG2fwL+PNCS6hfsIgG4b/ujsOuKkleMkeWhRfQnNRHdjkEAU2ne2iC1w6mngMwOAOBz7CmA46VagsriRAyRMVJ496IpydkDdjovhQAPin4Nx/0GbP/ANHpX1R+2t/ySzSv+w1F/wCiJ6+bfhNplxH8R/CUrRDC6vabncgAfvk4Hqa+oP2vdI1DWfhpp0GlWc93MmrRyskK7iFEMwJ+mSPzqp02mkluJSR8OUU+SN4pGjlUo6nDKwwQaQqQSCCCOtZ2ZQlJRRSAcilnVV6k4FfU/wAHPgz4b1zwFBd+IdPknvrpgyzrK6GNSOwBxx7juK8A+Gvha+8X+LbTTNNEZm5lPmHC4XnB+vSvuHwRpF74ftdG0kMZIILd2uZFxtL9FUDrxmt4K0HLqTu7HxF498KSaBqV41rFM2lJcPBFO3IbB4ye2Rg1zTWc4gE2zMeN24c4Gcc+lfQ3xis71NI8QwlIo7O3vSi7nUblJLBhnkkk4/Cux8AfDzSdV+BE8LafGup3VpK/mBtzF8EofboOK2q0qalfZP8AMzjKVrHx/RUs0EsJ/exunJHzDHIqKuNq25sOV2Q5ViDjGQcUlOjRpHVEUs7HAA6k1tal4T1/S7FbzUNJu7e2YAiSRMDB6GmoyaukJtLcw8mtvXIYo9F0F444lllgkaRkXBbEjAZ9TgVi7WwDg4PSul8Q2dwvh3w0zQuAbSVwcdV85uauCbjL0/VCk9UcxS96VlIxkEZ5GafBBJO4SJGdicAAVmkyjovBHhi98T3VxDZ2r3HkoHYqT8vOO3+eKK+jvgr8OfEPgWOW9mSzeTULaMlXc4TknHHfGKK74RjGKUld+qMW23dP8GfP3xbmf/haHi7EYXGsXgBA6/v35rljcPKw3qHPvXT/ABTldPij4zVCQDrN7nvn9+9cgxya5Oa2tzS3Q0YpmH3l/ej7vfArd03xNqsZ8qK+KocfIOAT6etcmrmM5ViD6ipluSesaE+vOauNQlxPoHwJrk2m+RJqOpX1lGpDCSHMgb6sTxXt2jfFPTZmMai8mTIxLIgUgeuO9fD8WpSOEikPJPBGev0zzXUW+qxJAsOs6hcwgfcwjkEfrW8uSqveRCcon2Lfaz8PdXeRLybS0mmG0tKiRufoSM1zMHwj+Gdzd+bBePJcSNuTN6rcn0BHNeSeCdY8B3NsH8S65qAaEjyoowoyPckZFat948+G+nalFNo8M84jO8zXu6V1YHjaN3AqdE+VTf5gl1sei6z8BdFvXZo7l5UK/Ks5wB+Crz+deRfEj4IWnhqxjv7fU4JoxnzYYo5AePRskD8a2dW/aAuLu6MPh6yE4cffuXdUX6IMc49TXFa14r1rVZQmo6pdR27LhrcOIoiPQAAk1UHKXx2fyFK0dtDzvWrTS7YI1q+W/ii88P8AqBWCzc5CgAV7t4Y8FaH4rkkSwVkhQDcFYMw47sxAA/ziuQ+IXw7fw9O7Ru0qnkLCPMCj3bAGfpRUoSlrGw4zS3PNSxOMnpSorOwVQWYnAAGcmus8J+DptXuFa9aW1tj90+USz/Tt+Zr1nwxofh/wPfC4NlHf6oMGFrpw4iPZtq/KOe5rKGFnJXloW6iWiOQ8G/B/Wbqy/tXxEkWh6WBvE+oHYSvUlUPJ4rE8Wa3pNldva+GWa6hjypu5+sp9VUdBXRfE/wAWapq1wz6pqUc8zLhVV9yRr7V5Wk0ESt+5Ezk8FzgD8BWjl7Jcq0IS53dnXfDDVbq6+KXg4TvvA1izVRjAUGdOgFfZn7Qd3qFp4Jtm0rVoNKme+RHnmgklBTy5CVARWIOQDnGODXxN8KWLfFXwcTgZ1qz6DH/LdK+0P2jvGF14H8I6Pq9nDHOf7VjheOToyGGYn+Qrl5veTbNbWWh8eXHhbSru5kmm8d6G80rFnJiuslj1/wCWVX9P8P8Ah20gkjuvEHhm7mc/LNKbxNg/3RFg1H8J9e8OW3xIOr+Nowtg/mSDZEXVJCcr8oHTrXpP7Qul6Taa3pV3pdpC9hc2QnjaKMKOW4I74rWnZ3s9fR/5ky0Wu3r/AMA80HhvQhdCT/hJvDIjIIMe67Gfx8ripU8OeFw+X13QGXLcfa7kfT/lj25rkNVg+06pFDb+a7vgYYAYPpx2r1vwd8BrnWbBbq9uprfzHxGoiJDLx82QDx1qlCo27Wsu6FePmYPh+OHwxrT6j4a8YeGrKQrtAke4lKjnuYh1rvdH+Jvia0mbyPGHg65aRCojeO4JB9RhOvetn40eAPAHgX4bGFLVYdVmZI7eZnLTSsv3j6Y55/Cvmfw9qb6Lr+n6lbMyvbTJL+R5H4ispS9Gvn/mUl6/18j2bX9L8R+Ir6e/1S+0KeeeRZZCLW7CttA4x5eB36U/WvE+uwQPp9h4k8NaFAYvLkgiadSRjH8ScV9E+Evijo3ivTWn0y6dpwdki4IAfGSFz1HSvMvEvh618c+KYk17ULUpK3zt5Gx1UHaU3dN3oTW8Oeomnol6/wCYnFRaseB6ho731rBbz+LvDTxQZ2ASyA8+v7us7/hD4P8AoafDn/gS/wD8RX04/wAHvhl4cQS6zcqIZXIje5nwNw6j3ArhvHOh/B7StFa/t7lp5biYfZo7OYk7UxuBXsD6msnyyeslf5/5jSa2/T/I8jsfDAsrqK5g8TeGmljYFQ1y+M/98V1+va5r2u6M2lal4o8JyWjBV4nYMAOmDtrg9S8UO91nTYhFbJIHjWYB2GOnNe+/B3xf4C8V6PZeG/FOm2cetTMYQz2+FmZhwQ4+6e31pqcYKyf4f8EXK5f8P/wDxnRfDVna30D6lrfh68s0JLQrqBQnPodvFd942tNB1Hwx4Wht5tHijhtJIvn1QDOJD91scgc9a911H4Z+DdM8D6zZ6bpMMyxwvcZ3iSQOqkj5zyOntXy38RFhuvDHgryANwspE2RrgAmQ/wAqqErwbj+X/BFJJPUupong37D5dw0LzqhVHXXItoJ6HG2st9C0+2ufP0jUdJgdcbPtGrRuB65wKr+BvANzr+qWsLTvbLJysnl5G4HoPU4zX0do/wCz74XsrS6uvEl1c3s7xO0srkIE6nzOOhA/lQ+aKvOy+Q1Z7XPPdQ+J/i660mxsLfU/BlstqAodL8EuMYGctRXh/imLS7XXLuPQLiWewWQiJ5V2sVzxmisvayhpf+vvGlc0/ix/yVPxjg/8xm9/9HvXKV1fxY/5Kn4y/wCwzef+j3rlKxLCgHHI60UlAFt76eVAkspZR0BAOKhMjtjcxOPU1HQST1q+d9RWRfgbzFO5Yjn+84/xpGmEJ/0aVQSOdq4/WqIJFHeq9oLlLqebcSAyOOMckYqdLwQsTFPMuMjOB+lZ4nlAwJGA9MmmsxbliSTT9oltuLl7nQ+HfEtzoVyZrOWSNjgkhVYn8TVvxB4vvdcnSW8uJyEPCmU/oOgrkSaKFWlawOCOifxFM8ZLSXAYcBVmbbn3/Osia/upWLSXMzMe+81UBI6UUpVHIaikOZ2b7zE/U0yiisijq/hP/wAlT8G/9hmy/wDR6V9Vftrf8ks0r/sNRf8AoievlX4T/wDJU/Bv/YZsv/R6V9Vftrf8ks0r/sNRf+iJ6APiqvsWw8P23xR+BHh+88lTrGnQ+XE+SnKnDLn0IAIr46r66/Yz1p7nwxrekS+awtLhZkY/dVXXG381z+NXCTi7oTSlozN8NfAeebWLqe/kELRx7kQElgSOBnoeAa9206xsvCui3N1cyFYraEyzSl2IVFGThc47dhXSPgHqR2GO/H/1q+Vf2q/iRI14nhLQNQP2dVJ1Lyj9584EW7uAOo9aqeIlV0tZBGmoankXxh8e3Hj/AMXTagxdNPhzFZwt/wAs48+nYnqa4SlpKyGek/B/xVa6NfizvYfNM8gEWQSAWGCBjueOfavWde1p/DWkzSappQjusSyqZJDzkDaSM+v8q+aNKkMOqWcobaUmRt3phhzXsP7RN2RBodmuowXhBmeURuXMZ+XahPsD+tdtGs403foZSjdnmnijxhrXidLdNXu2ljty5jQDAXccnj8BXPUUVxtt7moU+KR4ZUlidkkQhlZTgqR0IPrTKKQH0n+yFqcl9qXiXSdSMlzbXdurMZZjyckFeTzkE1v+NvhJrl7puhWukRw/ZrNJUlR2BK5fKgHrgDrivDvgPqTad8U9AO4iOa4ETLjO7PA69/evv1GYM4K45HWto1XTWguTmPKPhr8O9R0J7T+25Ld0tV2xLC5P0/XPvXmX7T/xTnM7eEvD90Uh2EakyoQxbPEeSOmBk465r3r4k+KrfwX4QvtYmVXeNSsMRkCF3I4xnrzjpzX576tqN3q2oT3uoXEtxczMWeSVyzE+5PNTOq6msh8qhoipRRRWYHV/Fj/kqfjL/sM3n/o965TvXWfFgZ+KfjL/ALDN5/6PeubtbZp7mKID77qn5nFVysLlekre8b6PFoXirUtNtjIYLaUohk+8R71hYonBxk4sSd1cSitjwnpces+I7DTp3ZI7iTazL1HBP9KyWXaxHXFHK7XC+thtFLit3w14dfXINWdJhEbC0a627dxkwRx7fWiMXJ2QNpK7MKkpxGOvWkpDCitfTdAvdQ0bUtStwhtrAxiXJOTvJAxx7GsooQcHiqcJKzsK6G0lSKma6KDwtNL4KuPEQmURQXq2hiK8nK7t2f0xTVNsTkkc0BTgpp3TNKoLEAdzimoIdzqPhRx8UvBwx/zGbP8A9HpX1P8Atrf8ks0r/sNRf+iJ6+fPAPh+Kw8TfDHVFklM1/rMJdWA2gJcxgbfzr6D/bW/5JZpX/Yai/8ARE9KpHldhRdz4qr1r9nr4hR+BNdvxf3HladeRASLs3ZdT8p9sZNeS0VCdmUfTPxP+PhfQns/CV9cx6lNK2+bywoij7bD7180yyPNK8krs8jHczMckn1Jpuc0lEmm7oNeoU4YwfX1zTa2tOeyGg36XCE3TsPLcIDgD37VVOPMxN2MZTtYEdjmuv8AiPex6hd6ddx+ahnthI8b4IVicErj1xXH093ZyCxJwMDPYURnaLj3Bq7TGUUUVAwooooAt6Vey6dqVreW7FZYJFkUg45BzX3dpXxFs4fCljqN+LmSJ4BM86L5h2rgMzY6DPGa+D9OuRZ3sNw1vBcrG2TDOCUf2IBBx+NdYfEdxYabFK+laVJb36OEiYTbUCsR03469OtaQceVqSuK7T0NL42/ES48eeKJXt7q4bQ4G/0SCQbQvq231NecUUVmMKKkjTeSMgUVSg2K59ieN/2f7Hxj46vtcsdYitbC6nZrmCGIFxKCwkIPTJYZOe5NSeGf2dfDOkJOmv6s95debHJBIjiBogvO0rkggnHbtXvlnpen2T3D2dja27XEjTTGKFUMsh6u2Byx7k81m3ng7wzfXD3F74c0a4nc5aSWxidmPuSuabrVLaW+4Xs431bPNPFXwx+Gq3Wo+JPE7o0c8nmSNJeFY1O37qhSMnvjrXOWv7NPg7UJ3v7XVNRfTLlVltUhZTtUjOdxB3DpXtL+BfCMkHkP4W0Fod2/yzp8JXdjGcbcZ962NP0yw061W20+ytbS3QBVigiWNAB0AAGKFWqdWn8kHJHpc8z8D/Bfwl4Ss4ENjFqOoRTGZb25jHmDPG0Y6D/GuTs/2b/C1vrN7qGqXUj200rfZ7QYSOMMMBSTyxBPHIr3v7Fa+Zv+zQ7+u7yxnrnrUeoaXp+pW/kajY2t3BuDeXPCsi5HQ4IxmhVZrr/XkHJE8B8L/sy+G7NLgeIbubUnaYPCYSYQseOVOCc545rudN+D3gzRtM1S00fTFgmvrV7SSeSVpXUMD6ng5wePQV6Zb28Ntbx29tDHDBGu1I41Cqo9ABwBVfTtK0/TBINNsLS0Erb3FvCse5umTgDJ4HNDqz6OwciPBJP2cPDsfhy90qDU5TfXMvnW9zOqb0KrwgGMleSTj2riYP2V9WZpftHiTT4wG+Qpbs29fU8jH05r6wfR9MfU49SfTrNtRjBCXRgUyqCMEB8ZHHvVvy0wRsXBGCMdRT9rJ72/r0DkXRniHhX4E6PofhHVtHv9WuZ31RENxOoWMJ5eTlAc4Hzc5zWVpnwv+GmsaHf+D9B1O2vNZjAun1CPbJMgzgDcBtI7FR617tcaHpNxcm4uNLsJZyhi817dGbYRgrkjOCOoqtovhTw7oVy1xomg6Tp1wy7GltLOOFivXBKgHHA4o9tPv+CDkjY8Gt/2YdJiltnk1Wa4t0Z2mMi7WdCBtAIIAwcknvmugsvgd4YPgqTQrfXL640+e7F8Z0aNySBtwMDGP1r2W50fTLpZludOs5hNzIJIFbf2+bI5/Gk0vRtM0i3MGladZWMBz+7toFiXnrwoAp+2n5fcg5EfPvxF+Aeiato9pZeAvs1tqFhNtuBJOGO1yOZDy2QASBx3rB0P9mKG11C3/tvxPbvskLyQQxYMka4P8R475/CvpefwxoE95Pdz6Hpcl1OQ0sz2kZeQjoWYjJI96kg8PaLAP3GkadH+7aL5LZF+RvvLwOh7jvQqsr6/1+gcqPPrf4Y+E9RXw1Nos6iLQb5bq1kspVkQkSK5RuoxkD3rlf21v+SWaV/2Gov/AERPXtVh4c0TT7aO3sNH021t45fPSKC1RFWTj5wAMBuBz14qXW9E0rXrVLXXNMsdStkcSLFeQJMiuAQGCsCM4JGfc1m5OW40ktj8u6K/Sr/hXHgf/oTfDf8A4K4P/iaP+FceB/8AoTfDf/grg/8AiaQz81aK/Sr/AIVx4H/6E3w3/wCCuD/4mj/hXHgf/oTfDf8A4K4P/iaAPzVrd0TSb7UrKf8As8F2O4OvH3QNxPNfob/wrjwP/wBCb4b/APBXB/8AE1bsvBfhaxWRbHw1olssgIcQ2ESBgRg5wvNXTkou8iZJtaH5mEYxTa/Sr/hXPgj/AKE7w3/4K4P/AImj/hXHgf8A6E3w3/4K4P8A4moKPzVor9Kv+FceB/8AoTfDf/grg/8AiaP+FceB/wDoTfDf/grg/wDiaAPzVor9Kv8AhXHgf/oTfDf/AIK4P/iaP+FceB/+hN8N/wDgrg/+JoA/NWtvV+fDug8fwTDP/bQ1+h//AArjwP8A9Cb4b/8ABXB/8TT3+H3gx40jfwj4daOPOxTpkJC55OBt4qlKya7iaPzSor9Kv+FceB/+hN8N/wDgrg/+Jo/4Vx4H/wChN8N/+CuD/wCJqRn5zaNYzX08iQQiUquSDnjn2or9H7XwJ4RtGZrTwroMBYYJj06Fc/ktFbwqQSs0Q029D4C0/wAdfEHUb2Gz0/xV4qurudgkUMOo3Du7HoAA2Sa0/FGt/FXwpPBD4j1zxfp0k6lohPqM67wOuDuwcZGfTNU/gv4n0/wj49tdS1fzks2hmtnuIF3SW/mRlRIo7kZ7c4Jx6Vl+M7LSbA2sGi+KW8QxlpHdhaywJESRjAk5LNjJwOw5NYFkv/Cx/HH/AEOXiT/waT//ABVH/Cx/HH/Q5eJP/BpP/wDFVylFAHV/8LH8cf8AQ5eJP/BpP/8AFV7H8H/Dfjr4h+HbjV2+JviKwijuDAI/tlxISQASc+YPWvnIda+xv2SJYo/hndB5UDHUJOCeR8q1UerF1Q9fg940xz8XvEpP/Xef/wCO04fB7xn/ANFe8S/9/wCf/wCO17SJohwXXHpuFL5seOHGB15o5n2LsjxX/hT3jLr/AMLf8TH/ALbz/wDx2gfB7xl0Pxe8TZ/67z//AB2vahLGBlnXb3OaFliIz5ikduetLnfYLI8WHwd8Yn/mr3ifP/Xac/8AtWl/4U94vH/NX/E+f+u8/wD8dr2rcOuc+/NDSRjIZlBxnHQ/WlzvsHKjxYfB3xf/ANFe8Uf9/wCf/wCO0H4SeK5ifK+K/iuEKACHupn3HA5BEgwD6dvU17RJIu0bHBOCAB65/wD109VAkAGcEDnNP2j7IXKeKj4OeLiM/wDC3fFJH/Xef/47Sn4PeLR/zV3xT/3/AJ//AI7XtRKopLYAHPJ600SDcCsbnnnGDR7R9l9wWPFx8HvFeOfi54q/8CJv/jlA+D3izHPxc8VfX7RN/wDHK9nXzCSBGn13f/WpGEmCQyc+39aPaPsvwDlR41/wp/xX/wBFc8Vf+BM3/wAcpR8IPFII3fFvxYQDyBczAn/yJXspYnO5SD69R+dBKnIB5NHtJeX3IdkeaXvwrupLORLP4iePILkj5JZNWkdQfdcjP51h/wDCn/Ff/RXPFf8A4Ezf/HK9oxtUtkADnNM3LnG5c+lJVZeX3IOVHjR+EHiof81c8Vf+BM3/AMco/wCFP+Kv+iueK/8AwJm/+OV7KWX+8M0qkckdu+Min7WS6L7kHKjxn/hUHirI/wCLt+Kzn/p5m4/8iUv/AAp/xV/0VzxX/wCBM3/xyvZSV2g7gPc00yIv3mAFHtZdl9yDlR8c/GHUfG3wz8UW2jW3xA8Q6gstql4ZZbuQFWLSJtwWPGFz6c9OBXAJ8TfHSBgPGPiA7l2HOoSnj2y3B9+teg/teBv+FmaezAjdpUZweuPOmrw6m5Mmx1v/AAsjxx/0OPiP/wAGc3/xVJ/wsjxx/wBDl4k/8Gc//wAVXJ0VIHWj4k+OB/zOPiP/AMGc3/xVJ/wsjxxx/wAVl4k4/wConP8A/FVydFAHWf8ACyPHGMf8Jl4j/wDBnN/8VS/8LI8cD/mcvEf/AIM5v/iq5Kii4H0/+yT4s8Ra78RdQttb17VtRtl0mSVYru8kmQOJoQGAYkA4YjPuaKxv2LiP+Fm6kP8AqDS/+j4KKqW4keV+FPCFvrGkw311e3kfn3UlpFDZ2X2hyyRq5JG9cDDfoa6q0+FmlXvh+fVrXWtWdIb0WDWw0oeeZTgYCeb7isnwtq5tfAMdrYzaX/aA1Gd2ivXiACNHCAxWT5WGUYY/GvTPDetXM3gS8jspNLn8ST61Fdx2dpdwnrsUNlDhRkfhitYxg7InmaPMX8FaGrzRtqPiFZYYhPIraKAVjP8AER5vT3qqvhzws0Mko1nXTHGAXYaQMKCu7n976c/Su2l1Tx4t5d3Gp6JHc3qNbfa3uBEzAmOQR8EfJkHqMYxgnmuItNXvPsdktxooeztU3ch0E0Hl4kUnoxYHO7kqBgcAAPkj1HzvoN/sXwYkmyfxDrScA/8AIJXOCMg/630IP417n8IvHfhXwBoQ0KNtfv3ubgzJv04Rs2QBhRuOen61826o8susSO8Xku7BkiU5CKQNqg+w2j8K9Cj1rxsnirRZjAltqYieG0F1KXWRWOGA892AJ6cYqOW9w5j6a/4W3oxtpbgaT4gaGKQxSuLLhHDBSp567iB9TVXWvjRoOg3McOs6frtm8qlkWay2F1BxkZbkV8z+INa1aG91LGmWljqEOpE6k0UiuZJDJuSPaOQgK4+TgkAnnFU/iVqmpXup28evaVNp7R2YFtbs/wDqwzA55HI6/KeeeSTQ6Ste7Gps+ntK+OfhbVLpLTT7bW7q5YHEcdqGZgBknAb0rSuPizo9tBPNLo/iJYbcssr/AGH5UKgFgTuwMAjr618b+DXlOrFUiWeNoJVmVp1t/wB0V+Y+Y3CnHc13ltdeKLbwXq0eiafEPDCicXZhvEnQ8DkvnnHHK43dunCVJNat/wBfIOd3sfQmnfGTw7qbILDT9duDIGZPLtAdwBAJHzdMkD8abH8bfCr6ktg8erR3JlEJR7cDDltvPzdia+afCt1ra65aXdxY29yjWZ8i0mkjijWEMAMLIGUDdjqCTknrzWdpjvL45gaeKG2kbUYy0UONiHzhkLt4wD6UnRS1uw9oz72wCuf4ccH1pGyCCozzyB/SmrkKOmeOwqTOOgGegyOCKyZfQa4MjjcD8vPP+frTgCHHBGT1/H/PNGSDz8oz+B/zikYFidvBU5J68UrgIuSACM/N2PelclEBQOc9lP68kU1QfLIOeDn73T/CngY5zx9TzzSGRlV8zfkhumG7/wBPelbpkg5Jz1p0g3BweMgc46e/tTWU7iMc57UeoIjn3GF/pgGn/h+NV76ZLezlmkOEQZb6Zp1vcpMWCdBgg+uRVJPcfUlNLxxtNB980pYHb1Ix3NS9wDj2pCeetKW54Jz0+lIDx1NAHx5+2EQfiZpm0g/8SiLp/wBdp68Kr3b9sT/kpmmf9giL/wBHTV4TVoh7hRRRTEFFFFABRRRQB9Sfss6jpmo/EqE6ZbeTLb+Fhb3TCMIJJlmhBbAJzxjnjOCcUVgfsXc/E3Ujz/yBZf8A0fBRVSbb1Ej56rqvBd9NYWOtTW7iORYocMwyFzKq5x9GNcrW/wCFNS0+xa8h1dbs2tyiDdahC6srq4OG4I46URdncHqjutEg8UTXupw6frNvLLp9yLaRpQxacbXUt8wywAySDyODjisyzN5bnR2XxaZ4raL7bHb3CTvDCigrgoRgg4KYHb2qre+I9KE013pmq+IYb6SU3DM0EIBlIKlsq4xwzDp3qDRtX8OwxwTahNriXsIMSi1ihMXldgVcnOcnIPFbc8bbkWZj+JLW5tfEt7Fdv5tyJiWcKVyT82QD0HNdUv8AbWn+KdFa4utNN1N8kEiw4RMnA3eWqtnOORyKoXF34IuLhp5ZPE7SscltluP5H/OK63StT8JX6jVbnxL4t+2afkQi6WGZ1XGcruYjsePXFKPK3v8An/kDTI7fRdZ1fw9qF9Pe6YJ726EsjPG/nGQTbAUfpwcn1xWD8TbLVtLvbKPW9XTV5JLUxxyv5haFQ+SDvwQ2evsa2pvE3g6aFLaXW/Fz27ymdlFtbr5bkhiQc5GSASBgVHquqeCNRlN1qOqeKp5Z0KszwW/I3ZP8XXcAc8E9+9W3C2j/AD/yCzOP8HhjqjsstvDHHbyvM1xG0kbRhfmUqvJB9q7Q6bq954WvdRsda0xdMhWc/Y1jaDzF4yRGRyOTjPTBz1qXw7a/D5IrzU4NW8R2f2IgMZIbdiwfgfLkhh6giuxi8J+DdZtTcDxZrk6qxi/1MSgCQfNjHAHGOKcYprR/mDPFNG8TanpOtNqtvNvvWTYZHJORxjlSCMYHQ9BjpxWloF9NfeLbK8vJPMuLi/ilkYnO5jKpJ9+a9W0/4TeCbqFZ49X1pInbajGOE544I54Bra8KfB/wrcXiXVhqutE2k4kDSJEA5RgePxWh03u3+f8AkFz6NjcbUb17fjUnm9CTx2JNcXLr8cAc3bSJFLIxiRuoAJwMj2B/Oqv/AAsLTYsfa4z5YUlZI1LCQ56jv261i8PLexpzLqdpb3St9o3gqVmMWD3PY0k17HFdRQl1BlI2D35/X5TXjGnfFnQbuDXI/tZtVg1lVSZ1OHjMnLcZ7bvyrk/G/wAX4bTxDbraSNdT290zKV+6qhpBgn8R+VHslu2Fz6Wtrhbi381QAN7D8mI/pVkMpbGM45xjoP8AINfMvh342CysoIIgsvzXMxed8fKrMwX6kcD3Irt/DHxs0fVfLiHmcMxMki7TtC7s4/IVDpNv3RqS6nsgJJyAevXpzUTOBJsP8eQOPQZrmNB8baJq7pDBeIbnaSUJ5O0KSfxDA1Ys9es7jVoYLeVZGnkKnB+6QCDz+Hap9k9dB3RS+K93JY/DbxHcxFlkjs3II4P4Vyfwu8cRa/pVukc5N0gS0AbJ5SNQWP1ORn610HxtTzPhR4nUFgTZkDH1FfKvgvxra+DJtcin837U0qrEbc/3Q4xn+7lgffFbUrcvvEybvofZ8erwPcGDOTt3ZB6gmn3t+tuIVLBTK4RSQTzgn+leIaR4/wBEv1eSx1HzLg7RNPJldhaTcF98BWx9avX3iSyjlXTr7ULh5ESRFDMSCxGEGR3GM/nVrDxeqYud9T2W3uldQRIjgnav581aZ1XOSBg4rxCPxjPaWHnaeiXUrOWjDfdT5fX2Irp9O8c2X9ixu8rPdIFMxI+6xlYEZ9M8fhUSw7Ww1UPBf2wWDfEvSyOn9jxf+jpq8Lr1H9ofVxrXje1nDq3l2Kw4U5C4ll4/WvLqyceV2C9wooopAFFFFABRRRQB9BfsVkf8LQ1QHlv7Gl5/7bQUUv7FgH/C0NTIzn+xpf8A0fBRTYj58ooopDCiiigAroNB8M3ms2MtxbXVjDEjYZZ7gRk4xzjuORXP17V8IPhtYeMPAmp3c42XouvKjmDEbFCgkY75JrSlHmlYUmeb6j4Xl07yzdanpID9Nlxv/wDQQfWo10a0Ns7HX9NEnyhUIl59ednGK9Ov/gVqY8OfarBxLeI2XRjtBUkAYP1P6V5Jr+j3ugaxdaZqkJhvLZykiHnn2PcVU4OHQS1LB0uMqANZ0/BPKl5Bg9B/DVqG1uLHMcHiKwjUjBEc8hXHXstQ+HPC2r+IriKLS7OSbzJBEH6KGPTJ6CvXbb9mXxVJBun1DTIZf+eRdjj8cYqbS3tb+vUNNjg9G1K9tVMb+K7BYiFwreawXGCMDZx0roZfGV8NGjt4PE2mrcofvqZFBBznonoefWu40T9ly7bDazrsKLtOVtkLEH6mus0n9mfwxasG1K9vboA/dBCAjH+NaKbStdfiLl1PJPB/imNheQeLfFdq9oyDyAnmuVbeGIyF4B5H41Q1q409L6NdI8exPZKcIskMq+UuegG3tk17bf8A7M3hWe5doL7ULWNtu1QQ2ODnr68VxWu/svaiuoyjRNctmsMfI10pD54ypCg+5zR7R2smn94+U8ah0uwkiuBJ4rsYlaRmMYimIfj5TjZ1OSPasybS0B/5DOnSHJ5Dyf1SovEekS6Jr+paXI4layuJIDIowG2sVyKzMVk2+35/5jsao0qM8tq2nAe7v/8AEVfg0cQqJI/EOlJIeMCZ/u9D/DxXNgVNa20ty5SFCzAFiPYUJvt+f+YM9o8E+GtMMsF8/jezS6xKVaEkMOAoAyB79a7z4V+AfG+i+OtIvNT1a0udLtJJS8a3QZmUq38P1Oa8s+E/w3fxHqlt/aEUkdnNvRHPRn2FscdsY596+m/Avw8fw/rv9oSXEk6qVCB3OR8rAnH1at5fBeVkQtXoXfjUgf4U+JlaVIgbQjzHyAOR1xXw1No0Pmtt1vTJASSGLyDI55+5x0719w/HNN/wj8UjB/49CePZga+KPDXgnxB4kupLfSdPklkjQSNuIQBSCQcn2BNYQUpKyVzSVk7spxacI/ua1p6HIbh5Oo6H7nua17WS+iuQ3/CUafkyCcs0kjgv/eOU68mu68Ifs++JNbRJr6a20+3kG5HZt5YZYHgdOVrqpP2XrwQ/Jr8DSBjkmJgCOP8A69Uotdv6+ZN0zz+HWnTTltT4rsHLY3MfNURDg4X5OcEfjmr323RLe0leHxfbSXMgTEbQy+XkMWbPy9+Oa9R0z9mPRo4UGpaxdSy4+YxKFGcds1tn9nfwebDyvLuzcAf61ZsE8+nStFP+8vxFy+TPlj4hT2NzrqS6Zex3kLQgs8asoDlmLDDAHqc/jXMV9UeJ/wBnG3t3SfwvqDKjMFkivIkkwCw5XIPb8a8v+JnhNfB/iLRtJV7WWG6Akku2tI1YhnCFSCuAFwTn/a5rOUHK8roq9tDyeiu18bXukKmmSeHUswDE6TgWijLK5AYhs4JGOnHFcv8A2hPgHy7XGcZ+yxf/ABNZNNDKVFXft8+M+XbY9fssf/xNX7M3swWX7PbGI9xaxe/+z7H8qajJ6JBdIw6K+rx8LrCy8DXFzd2OnyzxabNN50dpGz+aEZgzZXGOVAA/u5r5b+3zf3Lb/wABo/8A4mqnBxEnc97/AGL42HxN1J9rBTo0vJBx/r4O9FXf2Ote1TUfiLf2V7ezS2cOjOY4ScIm2WBRgDpgEiipbuCVj5sooopDCiiigAr7E/ZGiSX4a324BsahIGB/3Fx/WvjwV9h/sg7/APhXWoEuvlfb2wu3BB2r37jFNO2wWu0exaPp0cWkW9tMFlxGFY+vOa87+K/wz03xFLf6zHp6Saotuqq5Jwcd8DuOa9YUALgccVHOSiSE5K7eg61UajUrjaVrHnvw08KwaR4WSC2tYIVkeGQjH3n2jcx9Oc16RkFiT3PX8ar2cSRwIiqAoOcDtVsAkd8ehqas3JglyoQLyM//AK+afgZHHPtTV6c9qcx6HBIzmsWA2VXdVVWwSeSBkYzTSyeYqY5bkfh1qT+IDOP60jEgpjAI4z16/wD6hRcVz40+P+i29h4r1lEsERpJTdLc5wrbsFhj6sK8aFp50hMCsseSVLnAIB//AFV9Q/Hx9Ks/E/lX4mma4s5pZVTGFXB2/T5sV4pLpKJpWnRiR4YGkZ1aXpsZj83HI/h+tejKPMkzNuzORtbWO31XyrrYYs7WOcgA/wBa9B+HHg+O/wBQWW4RxbwzDzUZcBlWPcwP1yB+dWvCkOmL4ihvLjTIrmBUIEavgOAoALZ6Hqfevb/hxpGoyvJH5kUULSC8gjMfMaMxyp9c4/IGqjBR95ieuh2Hw70hrO0tbiFoorVoFYW8S4QE7jle/Rh+td0ihVySCfr0qCzhW2t44gMCNQMgf0qwOFbkY9MflXDVm5yubJcqscx8RdOXVfAmuWMmdlxashwcd6474VeDptLuNcu5/Mjhu3jW3jk+8IliZR+Hz/8AjteieIVVtDvhhGBjPyv0696NGScx3ElxgM8mVAOfl7fzrSE7U2DV5FyCFIYljiXaqjgfn/ial7jjkelAxwD078U9QSOcYI69hWD1d2Vew3HqAB796QbQ2DzSknsSMdBSkHGSMjr9KAGHg181ftY27rqWkzJ5gLWskUChQVILZlPPQ7dvNfS5GR0985ryH9omzlbw/aX8URdE328zBEIRWU4Yk89TwB361rR1lYmW1z4wntlVJXY8rgYXkZJ45+gNRC3JU8g4G7jkYrsILJGsra6k04tYqqBhkKZGbcFyfqKfo+n22owwiQBE8g5ZeoKA9u+7sPWt/Z3ZlzFTw/b3Os/ZtM8zfCziWBJGxHDzg5+vAr3X4aeCxc6bJ58cJTzj9lRUVmdRlicnjksRyeK888EeG9M1TZK/2+3RW3TBY18tiegHOR+Xavpr4faLFY6ULVJbpJYjG7OqhOOuzPII7HHrWt3ThzEpczsa95pVpYeEtXtbO3jjjltbgsqLjJMbdf8AGvzrr9Kdd40LUien2WXv/smvhfUvH9jfN4fK+GdP0/8Asy3aGVrDbG1ySc7iWVh+BBOSee1cKd73NmrHf/sU/wDJU9V/7Asv/o+Cipf2NZRP8XtbmAKiTSZ3wSDjNxAewH8hRQB89UUUUAFFFFAC19i/sgL/AMW31AnvqLY9vkWvjoV9ifsfuP8AhXWpKcnGong+mxf8KAW57qcAHjoPxoYAjocEd6coOBngHpx1pdu7AJOOai5V7DYgBnjPc+9SIAG+vSmr93kjHXGKVvlGeTgE49SP/wBVDYmOUHbkN+lOB+YDg854OOKr2cjzwwzFHiLqGKSDkfhUhyGJbBAHWpCwwb2O5nKnPPygj8P0qUY+XqSOMnvUUEIjeSXfKfNYvtdshfYDt6/Wp2yckYPGMU2Jnzv+0taIvibQpX8tI722kt5X/ibDDgfTI/OvGNTdJkjhkkX/AEOExEHgsEwqj6jI/AGvq34yeF7bxNoVvDKuJ45CEZRkqCMn8Plr5S8NQudbvkunJS13q8jRbm2Yc5x3JOB7V30neCM57mp4ZtdQ1W9xYvCiW0cKSxADO0FFJI9AwyfrX17o+mG0CMsgG7+HAyBngZ9P8a8P+EHhK7Hie6nl3wxRSJJgrjcQGBX6Z2n8K+hh8oG0KzEqME7cDIyf5/X261FeVlylU11GzXEdvFvmPyb0XgEklmCqOPcgVOR0J/ECkK+mQpOPf6/59KcW4xjnpmuNlledVkiZJFDI3BU9MUqrtTaOABxxTmUlWA7/AONKDjOcccZIqr9B+Y3GR8pIP508AHp3PWkUkEbf/rU8DIOQDxmpYMY3QnPPtQ3BAIGc8UvTqTgjHHbsaQ859QM0AMOVBB5zx71wHxz06fU/h1fxQTeSUdJGIydwU52/Q16ASAe34VR1q2W70q8tXUsksDAnt06f59K0pu0k2D2Ph55pdSlVZMru8xODgL5a5GR75OKs6Sr3l1Z20XCyykxxKvzOVVRkn35/KnajoN1baitohldpZwBMUID/AD4H5k11vhzTbi4udPbTEzcvsLS7fljiI4XP17+1d6jK9mc9z0j4XeGJLZpL/U5Da21wqxW2FwwLAqMgZw+O/QYr2mKJIkxGNo6/jVDw8rDSrYzSRyTGMbmjIKk+oI4Nafr1rkq1HORvCCSKGukDRNSJ6C1l4/4Aa/Nav0o18hdD1Ek4xazE59NjV+a9ZIJbn0B+xT/yVPVf+wLL/wCj4KKP2Kf+Sp6r/wBgWX/0fBRTEfP9FFFABRRRQAo619i/sgAD4bage51Fv/QF/wAa+OhX2F+x+xPw81MHoNQOPxQZ/kKAW57yOTjHHoeKdk8ZI4pi8/nxTkyQM9CefSoZTHKcemc8UuMnA4x3pBjGByKXPuQRx061JI5OOOMdqZNGJHQc8HJIbA47f59KUHC9OvXmnY6Acj3oDqKQMDHFKCGAJxz0poGep7dDQECklR985OPX1pAVdTtEv7Ga1lLKsq7S6HBH0Pavnq78KSweIp5bDSbu23KUEnQO21kY4xyACDk9TzX0hwQcjJ70wx+Y4LDhTxn+npXRRr+zVrCkrmRoNitvboTGqkgFuv3u/wCtadwHURiNQwY/N6gev/1qnjUL/Fnn8qCPp9aylNydxrQhbcEYooLY4GcDOM8/pT0GVyMnI4z9aU5LADPy889KRQFAC8Zwee1TcLjOfz9e1Lt+Y88Y/SjoMjkj3/z2oJPPoeP8/pT1GMPzYUdPX3pSSAeozzQB8456GnMf4iBjAx60MYx8jAXBY8emPehR8vT0HvTjyAC2MdfalJ+vHvxQBFOnmRSIGZNylQyHBHbI9KV8MG2krkelKc/kcDJ6UZ6genU9aY0eR+PfBW66tltoppLWS7inkkjUbhK3yluOABjOBXT+FfCFtpNvawokRa1RInkcEs4CnkYOBnPcEcV2TAYFNSNEd2jRVZyCxxy2OBmuh4iTjYj2auEaKiqiAKijAAGABTqPpR61zmhQ19tmhamwG7baynHrhDX5rV+letDOj36ngG3kB+m05r81KpEy3PoD9in/AJKnqv8A2BZf/R8FFH7FP/JU9V/7Asv/AKPgopknz/Wx4UbTF122/tyBZ7FjtdXmeFATwCzIrMAOvAJ4rHooQGlqz2Et1fSaZAILVrjNvFJIzyJH83G7ABHTkjPT3rW+HWoWOmeIlutTi0+aFIyyxX8W+GQhlO1vkcjIBGQM9sjORy9FO/UVi7q9xDd6ve3NrAlvbzTvJHDGNqxqWJCgdgBxX1l+x1/yIOs8n/kIDg/9c6+QK+u/2Oif+EH1vJJAv1wP+AUm7jW59Ar909h9KD+A9c80zgDH9KeGGRnPHoKgqwq4wdue1PA4zwMewpisMg4wBQGAwRkUmhMkHynIAAI69qU89ev0xmmhztwfx5xS+gA4NIVtRwx04Boz6AD68Uwc8k/qf5UF1bABBb068jsaVhWHOSSCDwP1oHcgAH+dNYAgqOuOCKaSpJJHJ+lFh2JSc5AH64pGJ28hto9OSfwpARjnAOeeKUclScDtSAQ53AkEHIyQCaQbldumMDjbznJ79P8AP4UE/NnGD/D/APX/AFpGIIJBPPqT1pgIcNnPXr0/z70hO3BBPA6ntxTX+6238getDN0PBPrinYqwozweQc889qQq2SQy7Mc55NGR6A47EUKVCk8e+frTYMd2Azgg5GKacE9APXFOZgrA5OTwMf5+tMzkYC4+lCBCZOMADBpioys7PI7b2yAT90YHA9qdkHJOeTShsDHbvxTtcoBjHPpSenFKSOMU3v8AhTAX8uaSjP0oB/SlcZS1tQ2k3pZQ22GRhkd9h6fy/GvzWr9K9WO3SL4k5It5Dk/7pr806cSJH0B+xT/yVPVf+wLL/wCj4KKl/Ypt5/8AhZOq3PkyfZhpMsZl2nZu86A7c9M45xRVEnS/8Mjf9Tt/5Sf/ALdR/wAMjf8AU7f+Un/7dXjHhHxJ8SvFviG00TQ/FniKbUbrf5UbaxKgO1Gc8l8DhTVjxRrHxP8ADUVncal4t117K8DG2u7TXXuYJtvDBZI5CuQeozmgD1//AIZG/wCp2/8AKT/9uo/4ZG/6nb/yk/8A26vAP+Fj+OP+hy8Sf+DSf/4qj/hY/jf/AKHLxJ/4NJ//AIqgD3//AIZG/wCp2/8AKT/9ur1v4NfCk/DbR9QsDrR1MXc6zB/svk7MLjGN7Z+tfE3/AAsbxx/0OXiX/wAGk/8A8VXcfBvUfGHj7xrFol54+8U2UJgknaWPUZmb5RnGC+KdgvY+4xYAHiT9KPsPOfNOfpXi/wDwqPVjn/i7PjbHb/S5P/iqU/CTVsDHxZ8b597uT/4ql7vcOZns5sc9ZT/3zQbLP/LT/wAdrxkfCPVOCfix43x3xeSf/FUf8Kj1UDB+LPjfd/19yf8AxVFo9wuz2cWODxJ/47QbPPWT/wAdrxj/AIVHqhIx8WfHHHX/AEuT/wCKpR8I9UwSfix45x/19yf/ABVFo9wuz2f7J0zJnBz0oNnn/lp0/wBmvGB8I9UK8fFnxuTjqLuT/wCKpf8AhUmpA7f+Fr+OenP+mSf/ABVFod/zDU9l+x/9NSfqKPsXQmUkj1FeN/8ACo9UPH/C1/HHPA/0yTj/AMerXg+G0cNtHHP4y8fTSqoDTf27Km89Mhc4GT2pe73/ADHdnpgscMCJeR/s0psuD8+M+3/168ab4RatuyvxU8dBc4AN6+Rz/v0x/hJrABP/AAtXxvjOAftb/wDxdO0O/wCf+QantH2Lr+85PfHSj7FhsiU5+leJx/CbWZVVo/ip44I3EMPtT/8Axz8akPwj1oMd/wAVfHATt/pb8fj5lHLD+b8/8hXZ7JJpxdGCzFSR125xThYfLgyEn6da8YHwj1sqf+Lp+OC3Ti7f/wCOUq/CPWD1+Kfjnjr/AKa3P0+fj8arlp/zL8f8guz2f7AD/wAtD+VAsB/z0P5V43/wqPVtpP8AwtLx3n/r9fj/AMfpw+EeqnaP+FpeOv8AwOfkf99UuWH8y/H/ACDmZ7F9gH/PQ/lR9gGMeYfyrxz/AIVJqhAI+KPj3HGR9vbP/oVL/wAKj1MH5vip46Ax3vn/AMaXLD+Zfj/kO7PYvsA/56H8qPsA/wCeh/KvHT8ItV2r/wAXU8c7v+v1zn/x6vJfjxq3ir4b6hoOmaR428QXQe2eV57i7YyOfMBG7kg4xgH0yOmarljvcXMz65/s9t7EyrjHyjZ0/Xmnf2eD/wAtP/Ha/PF/ix4+dpWbxdrQMrB223TDBAI4x90c9BgH8Kqj4leORj/isfEXAx/yEpv/AIqpaQXZ+jA08Af6w/lR/Z4/56H8q/Ob/hZXjnIP/CY+Isj/AKiU3/xVH/CyvHOD/wAVj4i5/wColN/8VRZDuz9Er7SBdWVxb+dt86No92zOMjGcZ5r5+1r9mO+1oWw1DxxA32dSkflaDHDgcddkoz0HXNfN3/CyvHO7d/wmPiLP/YSmx+W6g/ErxyVwfGPiLHtqU3/xVC0EfYvwX+Ci/DPW5tRXXF1FpraS3ZRY+STueNgd3mN08sjAAzu9qK5X9j/xDrWvReKTrur6lqRhFn5ZvLqSbZuE2du4nGcDOOuBRTe4kfNvwZ8V2Pgj4k6P4h1WK5msrPzvMS2VWkO+F0GAxA6sO/TNWPF/ivR5PAuk+EfDMeoSafaXcl/Ld6giRyySsu0KqIzBVA/2iSeeKwvCmhW2rrqE+oXk1pZ2SRs7w2/nOS8ixqAu5c8tnr0Fdzpfww0PU7/VLC38SX8N1plob25+1aX5YEa4zj94eeQRVKF9Qv0PJaK9Rg8A+Hpmt8at4iCzsI492iFd7FN4UEyAZ2/N16c1AfBnhVZQr67rgOXXb/YxzlPv/wAePl4z6U/Zv+ri5kebg4Oa9n/ZNI/4WyvOCdPuMcdflFc9J4U8GQwiW48R61FHvaPe+jkLuHVc7vvDuK7n4TT+CPAfiSLxKmu6zewLA8Gz+yGQNv8AlyHyRScLXDmPrAkKgJIwB1JxTfMBOUR3BOCV5Ga4G6+LfhaGeztrqx8RwzXLAQRPY/NMfRR1Pan3Hxc8MWumy6jPp/iWHTlZle7NhiIMG2EE9vm+X68VlZrdP7i01fc71y5lKhBjOQSevvimqsxzu8sqcA+o9s+leXP8e/AhIKT6uCOT/o3v0z+daZ+JGkSW9rcx2fjDyZ42MUg04sso8tm3AAZOFy30WnGL/pMm9j0GOULuDqQw6gcj2+lODRBwWZA3QY6en/1q8ys/jR4Pil+yP/b0t4kKOyNYnzGTYG3kY6FSGyexFXr74u+F9Oit5tQsfEFqswJheaxK7wBnjPsQalxfZ/iO67noHmRDadwGeB+dIJY+QrgHIHzHBPbvWN4P8T6V4s0uXUdEExtklMLNPFsLN149q3HiV33NGpfaF57D0pOy3ABNENxDDA4xn/PFSg8ZzjvxzTWgj8wPtG4DAYjoP8inA4IHJYDOOv8AnmobXQdtCITRnDblBB2gMeh/pSTEOhRXXzD8h5zjPXP+NOitooyzCMFm6seSakxtVFVcLnHy8bR1zVaLYLdxkQAllQdAR15xxTy6qCxYKF6k9qiY7JTKF3LjYxXsadjdKrKAVxktjhsdPf1NFr6gIkpOT5blcfLwOfw7evajdK/CRED1bke2MVOMlu5z+tcvNfSjWYUFyXjaEM0IPU+dt3Z9xxVQhzPQHodAvnqcfu8Hnv17/WlWVxxJGwPquMAVDpwf94ZGZhwY9+CyjnPP+elXBxjFS9HYOgwSoW27xn09aQTR/wDPRfzzTmVXUqwDD0PNAVQvCDgfdx1paD1GrNCTtDjI9R1+n/1q+Sf2x5I5fFmgPEwYGybkf7+P8a+uMAsrFfmA4PpntXyb+2ciJ4n8OBQoP2JxgDGBv4q4NPYTPnWiiirEFFFFABRRRQB9Z/sRkeX4wAbJ22OeenE9FdP+yTrFlqPhO5tLWKGK5sYLeO4CW+xmJMpDNJ/y0zzx/DjHeiqnuTHbU+X/AIZ6imnxau+61a4X7LNDBc3KQLMUnViu5yF6Z/DNek+BLqfU9b1+51SPRbSV/DVxZiKyvrZxO4cSfLFGxI+UHoMce9fPld78FFDeOVVtwzY3gGOpP2d+KuEnpETVrs76XWfiFeaJp6T+GJ7m0itnXSxKqPGIfs+ThcfvcIMg89Mda4bU/E0t9bXltLowWe72ySyIxXZI0aCIoB8qDjJHfOD0rX0fU/Gl8+mabpV5bzXr2BurDyrlg9rCEIMaZICsQp+XnJ+tN1O68YXPh7W/O1rTrSyupozfaSr7ZWlZVCjZt4ZtucAgZB6VprbQnqYPjS71a9S2e/s5bS3ikkjlDOCJLzj7Q+B0JOOOg7dauJq2vL8OvsY0uYaKsgYX+6TYGEoYcZ2j5uOlVvH2natarpUmrTWDq0JhiFmzspdMLI7EjBckYYqeopqXmvL4Ee3Szsf7EDZa4Ozzh84OMbs9eMben50Pd7gtkekXPiHxhH4w8Oanofhr/iY3VvIYXZ4rl72NiPNIKfKqcffxxzzWX4n1vWrrwDqlvc6A9jaXNzI0s0d0jJ5S3JJDRctuRztDDAOcnPWqWl+KfEn9seGoNKv9L0VobPzLI+YxR0kf5oc/MV3MD8g4FTeII/FCeEPEc17Jo8tvd3kk1/8AZpmeTAmUMEXlUG8L6Nj8abbd9QW6R5xqEtvJd3JslmitCxMazSB3Vf8AaI6nrzXqug3fiG01DR7/AMP6NfP4le1YRkalFKM/ZyEaO2zkDywGIYc4x3ryW4eGV5ZIYFtoHOVhjYsEX0DHk9+vrXpejWOsTalpn9hHw7F4nubbYGjvXF0P3BKMQTtjITHA6tjNRa4XsjM8Tar4pvtW8RQX+n/ZdWuoYZtWkaPbMEEaH5m6RoflO0YPQdsVe8eXepz6fo0epaWtk4QsZ3uVleV9oBA2scLjB+YZyawvGWoeJbW+1TRfEcipdzNBLqABDvNIIhsMj8kkA8rnG7NLqvim813TtO0+a2tbaCz5BiGWkfbjOeoXH8PrT6B1Ppn9mZmHw9vQSP8AkINj2OwV68nH3gc56cdK8e/ZjJPw9vQAN39osMnv8tevgSAEZTjAFctZe8aQ2H+p/Sl74H50m18/fX8jQQ+eHT8QaxLDoMDOcZ9aB23YB/PFIA+Mkp7DmlAIPJGAKYC5PUUhH4e1BzyVxuA4z0oXOBuxuxzjpRa4Dh1B5HPauVaxVfEMZa3Uwrb4Egznd9o3gegAzmuqXGayZYSNRhJDsQBgjj+PNaUnZikaFqCIQSeSTx2HJqWkHCj8f50uKzbuxiE56dffmlP6UnA64FFMQtfJf7Z+P+Es8PEEE/YmyP8AgVfWg9/yFfJn7aAf/hKfDpbbtNk+Mdfv1cNwPnSiiirEFFFFABRRRQB9a/sSD9x4tIP8Nl/Keim/sR48nxfg87bHI/CeinLcS2Pk2ut+FusafoXjK2vNZlmhsDDPDLJDH5jJ5kToCFyM8sO9cjS0J21QNXVj04P4Wlit1PjP7O0VmLHdFoLglN27JIk5bP8AF1qa/n8N3ZuHn+IE8kl1JDLI66E6vviXajZ3+nXHU815XSVftGLlR6zrU/hjW4raC/8AHhEVuXdRFoUioXb7zn58lmPJP1rpfBmgWPjCxHgrQPiCJopVab7NJoxjGFO5j5h5HqBmvAh1HNezfsm/8lhtiSeLK4P/AI7Q6kt2LlR7Fpnwd13Tb3Tbuz13w2tzp9q1lbltJY5jPUv83L8n5uvJ9aoH4FasNJ1DTY/E+l29nqEglulgspFLchtgO44TIBx19693BBXkfhnr7VkeKtatNE0v7ReyKsTMUbnbtO0sOfcjAHvSjVnJ2HyJanhFz+zubrUrlJfE+nRTNtdoYLJkRc9AozgD8a30+CetfZFt18SaLH+6MT3MWnMJ5lKbBvfPJVThcYxRpvxbjurWe5uNOka6jtVMpYbRDJv4VwO2CMGvWvDmpx6rp8cylBI6DKg5w2BuTr2PFbSc4K6IST0Z4jc/s4Xl3Ms8/iq3kkESRljatnai4X6nA5PrTrf9myZDz4mtzz8pW2bP0r6KjGUwVOR/DS4UDceBj8hXP9YltZF8iOO+FvgmTwNoNzpsl6l6JrjzxIkZTb8uMYPeu0+nQUgxnHFBzn1brWE5czuWlYAPf2pitJ58qMg8oAFXz1PcEe1Sc5znj0o7f54pDD8aO/ekUBRheAKU0AJ29qP85paTvQIbO5it5XWMyMqkiMEAuf7oJ4596qeZ5y27ywrDMyqfLLhmjPdSRxx0zmqXiy/NppE4immgnwCrxjBJ64UsCDwOQMnHauM8O/EK31O4htpngTUo5EWVcFRIMndgHlQOCSfyrohRlJcyJlJLQ9NGAvGOpx270VV0+7triMJBcRSOF37VkDMVJ+9gds8ZxVr/AD1rn6lCjHH1pO3agjJ64NH8qBhXyh+2nn/hJvDXAA+xSfnvr6vHFfJ/7aRP/CUeG8gD/QXI9fv1cNxdD5yooorQQUUUUAFFFFAH1n+xH/qvF/rtsf5T0V0H7HmkabaeEL/UrHUzd3t8IVu7fZgWzRmQKue5IbP5etFVLcS2Pi2iikqRhS0lFAC17J+yexHxhsxjKtZ3APsNmf6V41Xsv7J5x8YLPGP+PK46/wC52piZ9lM6xRb5XCKF5YjpXiH7ROu2k/gy5sorg+f9rEL2wHzh1XKMPbAz+Nep+N7x7DQ4rmNlVY5Szs3T7pC59Rk5Ir5C+LPiY6jNFCHkE6TSmTAysmD8rKeuOua0pQSg5sU5a2OWstZv2SWCNz5k5QyshyXYEYyO/QV9B/BvxLehLqTUyVhtIJZmcDI8xnH3sfxAnp3FfLEU8sb7lcq69MccnrXTeDfFd1oFyVVnlsZZFlnhB5bbnB/DOeauM1tLYhrqfoFZSxz20EqsCHjBDfUZ5q4CfUcHn61wfwr8baf4y0JJLISRz2qqkyOO+Oqnv7n1rvQc898YrjqR5XY1iHb8c8+tHp69KTHG0Hp60vSs2WBAPUZo6mg0EDGG6H1p2EFJgbw+BuAIB7gHrS96SgAplxKsEJkcqM4ChjjcxOAPqakFcV8SfECaVFaWaxRNdSnzo5Z4lkjjZeQdpOcjnBAwKunDnkorqK9lc4T9orxJLpXhSCGKcJfS3wmiVuGURqcnj0OB714Za+JDPcJrPnl9RC+XLHt2nJTLEY/2hnmtn446m8kuimVDNIgYoXk3iSI/MC2eQ2Sc46ivH5buRrySYEiZyXyvbPpXa/3ehi/e1PtD4S+J7C4sNFJMBvtQiEC+WAWQJk5djyRkYAGeTXrLZA4HI9T/AFr4N+Hvjq78P6jY+Z5U9pE5ZlcfNGpOW2EEYx1HuK+3vC+qx61olrfROZElUnfnP0z6Ejk1hWXN76Lg7aM1O+Of6Up6UUVz2LETLbd5CnHOOQK53xJ4M8O+K5Ip/Eei217NGhhQzjLIm7PBB4zjPHriujoFNNxejA4I/CDwAFP/ABSlgQfQNn8OaP8AhT3w/wBoH/CLWGBx/F/jXeY5JPcUvUVXtJ9w5V2OCX4P+ARz/wAIrp/47v8AGhfg/wCAFAC+F9P69SGJ/U13o60o7Yo9pPuHKuxwL/CDwC/lF/CunZjUoMBlGCepweT7nmsnxN8KPA1h4d1a7tfDGmi5trWWeMvv2hlXIyN3T2r1Tt7Vz/xAB/4QfxGFJXOmznOcfwHvVRqSursXIjyH9jfWm1dPFy/2fp1isP2MhbOExhiRMMtyf7oorK/Ybzjxr/24/wDteiqbu9QR8p0UUUgCiiigAr2L9lFsfGKy7/6Jccf8Arx6vXf2Vjj4w2Bz/wAutx7f8szTQnsez/H7Ur/UL6z0XRbtYJLK2a7u45G2xtGwyWYnjAH4182ePpIH1uMW4PkxwRqjL0JKg9+o96779pee5h+KGrIkxRGsYBjf8rx7V+XGfXtXlHiPUDf34ZHZ7eOGOKEOACqBRgcenrW3MlCxLTcjMBAYEgN65705Gw2MdRzmo/5mk69KzTHY9s/Zy8VDR/G2nWdxKy2d27QsWPCAqcfrivsqLIyCe/y4r829Mup7WdZrZmicfddeCD6j3FfoH8OdUbW/Anh/VJjiS7tEZ8dCwG3P14qKuq1COh0q4BIySc46Uo7flSM2Fzxt70dTwOKwsaXFIPNBO3nn0pOD9DS/jigAwAMAYA4x6UdqY674ipZlJ/iRtpH0NPJzTADxz+VeGfF/xHYab46S3u4rq6u/IWNIy6qsaPGcsh7DIyS34cV7mM9q+OvjdJJqnxX8QRLqNskPmpaHzW8vYFTOxiwBABB5GV561vhnyyuiKmx534210axrM7PvNjCNlrb7gfLXHXcOvPPvmuckjCq251ZgQNqHdgEZznp+FXbuGW31Z7XUPLt2UFMt91BjPGM5GOn1rK8wb32/NHgjnjI7VrJtt3IXkTwbC4LbmUttIxzj/GvfP2avF1/beKNO0ATCS21CaTeswJaPbGSCpzhR8vI718+RuFIOCuTj/PFdV4IktP8AhJtNOqSBdNNwEnJAYbD14PHp149anR6BsfoUfY/jR3qhodzBc6TYy2gxayQqYSNuCgXH8JKj6A/Sr2RkD2zXKzUd/jmkBO7tjtRgZPvwaSgdxQOwzg++aPSkPIIPSg0AL29sUUUDqPagBG3jHloHOeVzgn6VieND5vgnXvLXdnT7jhuDjyzkfWtsqDk4BbpmsfxuC3grxD3J0+44J/6ZmqjuhHmP7Ka+Dhaaz/whr6o1z9lsRqX2xQF87E33OT/tZHThcd6K5X9hzP8AxWmfSxx/5MUVq/MlHynR2opKQwoopaAEr1v9lzH/AAt/T897a4A/79mvJe1ep/s0SpH8X9HWVtokWSIH3ZSKqO4pbGp+1DJ/xc6/tyINp8pzIB+8B8sDB9q8bkdWbKqAMAYruvjnqI1L4s+KpkkMkX2541brwnyce3FcDQ30BIdn3OaAe5zTaXBzUjLNrKVkUZBBPfpX27+zXq0d/wDCPSoFnWWWwklgcDqg3kqD+B618NCvSfg18S7r4f6vK7Bp9OuiiXEHXC55dR/eApvVWJ21PvEENtPUDmlGBgdPSvNrT4veF9Sv9GtNEv47ifUXHySAxmKPpliRw2eMV0mr+NfDek2n2u/1i1S2SVYTKTuCs67lzjOMgZ/CsXBoq50w4we9GO3JPvXk/hL4z6Fr/i7XbOOYxaTZwJNBdygqJFBCuT3A3EYz1zXqcEqTxRyRnMbgMPcEcGiUWlqO5ICCR6Hv60VznibxtoPhm9trPWb37Pd3TKsEWxi0ue4wMYHc54rctL22vLSK6tpkkt5RuSRTkMPY0vMCygy646kgV8Q/H7UYrr4h6+9jbCCIyGGYs252aMlHfGPlVj/nmvqq68e6DZ+PLnQLzU447m2tBcyoQSFUAsy8fxbcEjr/ACr4o+JfiaXxN4w1bVDc+fHdSusRUtsWEN8iLuwQuADggfSt6S5dSZanKXdxLdTtLcStLIQBuc5JAAA5PsBUZ5PJJPTNA7Y6UnPTHP5VV7BcF45ABxVq3l6KWOO4JwKq545pVJDDGR2xTvcTVz7o/Z51y2v/AIb6PaTalHPqSCYi3YqrxQpIVHyj+EcfN3z1Neomvgv4V/EW88C3N/cwtJMJYVjjhIUoG8wEsc8gBd3A6sQT0r6X0n4+eDtTuNOiW7urMSnFwLqAnYSPlGVyMbj1rKcNbocXpY9do9up/lWDL4w8OxSiN9asd5jaUKJc5VepFZV/8T/BthJKl1rcSiMKxdY3ZTu6AEDk1nZlXR2ecdqKwdH8YeHtYWA2GrWjNMgkWNn2uAemQeh7YrXivbOaSSOG8t5JEYqyrKpKkdj70vUCdSCAw5HWgfhSBlYDDA5GRj09aq6vqllo2m3Wo6ncJb2drGZZZGPCgfSgaLg9jWJ43Ct4M8Qq+dv9n3HQ/wDTNqy/A/xB0HxrJqK6Fc+YlnIIyzgoZQVzuAPYdKh+LXiXT9A8Eagb67iilvYZbWBS4yzNGxPHpgYz7iqSd9RX0PIf2Gjx41/7cv8A2vRSfsNdPGv/AG5f+3FFasR8rdun402lqewtZb69t7S3CmeeRYkDMFBZjgZJ4HJ6mkBBRXQeLfCt34Xu4Le/u9OnaaHzkazuVnX7xUqSvRgQevHHWsvRtPl1XU7eytwTLM21QBuJ4zgDuTjAHc4FO2tgbtqUxXUfDafTbfxZbvrUM8tl5cm8QFt4+QkFdvOeKzvFGkRaLqS2sF6t4phjlLiMoUZlyUYZPzKcg4JGRXa/s7WqXfxQso5I1k/0edlDDOD5Zwf1q4e7NXJlsaOsa/8ADjT9Rntx4Ju7gKwHmTXbo7DGckbuDntWcPFnw+3HPw+O30/tGX/GvQfj58Kzbrc+JNNDu9zOqvAvO3EQyx9y1eB/2ZMsNy0yujRQiYLt6r5gTJ9smtJ828dvREpI7r/hLPh9glfh8xb0OpS4/nUg8WfDrPPw+fB9NSk/xrzaKB5AxRSwHXFKkDPt2qSSMn6f5BqOab/4Zf5Byo9NHi74cFB/xbx93tqMmP51O/i34Zrt2/D2UnaC4N/Jw3dfvdPeuc0L4f6pqGsafbyIkVtcwxXb3DN8sULgHc3fOGAHqa928Nfs86bPd2c2sO62q2+ZEiY7pX3HGfTirtJK8nb5f8AWl7I8ztvG/wAOYCzwfDoo2Plb+0HJB7d+K0JvHPgnVUnS4+HdxLsAZo4710XCLhSwB6gZ7dK95k+CHglbmy8nSo1tI4JIZlZjumJdWDE+owRn0OK6/T/CHh7TN0mn6PZ28sjBjJ5QZmbBXLZznhiPxrP2i7j5WfPfh7xJ4HttMu5bH4bX0djPH/pzBjMBEMMMFm7HBwMetfTumNFJp9s8KsImiQoGGCFKjAIqO30vT4I5Y4rG2RJyWkRYlAc4AOR9MCrqoFCqi7QBgADgD0rOpUUkkrlRhbc4nxV4D0XXr97/AF7SE1KeOMIkoZg2zsoCkY69aw9d1pfBmlT2UGi3I0bT0LqIVDBAEDAAHJHzEL9a9TBBGaZJEsqeXIAy+jKCD+HSqhWtpLYHDsfLeleNvB/jHxK7SeF1g8Q3ccqrczqzo8sgwBIIyCwLMBng/QVy2oX3gjTNTv8ASx8PZ7+7tEP2toLqZVwgBlYKSxQK2eewHXBNfTs/g3SR4se9stHsoHeyUG4jUIfME29cAemOo57GvN/HdvqPgjx5rPiqHQv7TsL6W1l3JOYRGIQzSZZSG3MAx28oeSwPArdS5kknqQ4tHh0niv4b7vl+Hs23/sKyD8ab/wAJX8Ocn/i3swwflX+1pMY9zXNeL9Luo78ajLYG0i1IPfwxKc7Y2bIGO2MgVzwtZGJKqWUDJK+mcfz4qG5p/wDARS5T0keLPhsvT4ezt7f2pIPrzVmbxT8MEkYQeArmZCoILahIpz3BAJ4H68Vxug+ENS1x79bCEMbKLzpdzgED0Ge9dR4Y+FOuavf/AGeS0aJGtvOLsw/d8rjPvtbOPeqtUeq/Ql8pt6J8Qvh9pVy8tl4BeN5Ymt5d167oY3G1gVYkEEHv3A+tPh8SfCmK+Vf+EGujbkgCb7W5O0gc7S2MgnpmvXfA37P+haalpdeIVF9dJHiaHJMTucYbHXsePf2rqrr4M+Crm6uppNHiSOfZmONioQqByuOmcZOOtRzKOnMPlvrY8BvvG/w9jP8AZc3gJ2sraZ/Kf7U6SknqWIbOD6ZwM1p6DqHgK+hWWP4a6iLWZvJd4pJJh8vzHALdRtGa+i7bwB4Tt0kVPD2m/vE8ty0IYsvHBJ57A10FtaW9pF5dpbwwoGLAKgUZPBPHcjjNHtop3u393/BDlfY8HgbQrKxkksPhrfsZNkjxIvz5DBlyd3HIQ/5NdRZvp6z2WpxeEdSi1O4RbttqYSNnO07ju5YeacjHc16uvyncpHrkUu485J9etN4lef3/APAGqZz0tzqNts+z2k0jNJIkmNgKBej9fusOlcl41a91nwzcw6h4Wu9Tt5HXzLCSVYgWByCzA5wBz9a9LCdefvcEdqbOgZXyNxYbT3JHpWcaqvsNxfc+fdHvdP8ADFyLvw38PL621a5V4Xiicn5EU46nGCB19687+J/xMtvEUFzZa54PKagluVSWeQhrVyeCo7jJ/UV9fxwAndsLONyhzxkHt6+n5Vx3xK8KaDfeDdfvNR0u1kuk06ZzP5fzZVd68j/aUH8K2dWMnpdMlRaPKf2G/wDmdf8Aty/9uKKP2GuR41/7cv8A24orne5ofKlFL6UlAE0l3PIxZ5WZjGsRJ7ooAA+gCj8qZDLJBNHNBI8csbB0dCQysOQQR0IplFFwLF/e3OoXb3V7M89w+N0jnJOAAM/gBXqf7MClvi5pq4yDBcZ/79nNeSV63+y6xHxe04DGWt7gc85/dmqT6iex9oXFvDcQCKaNJozztkGQcV5b4w+FGkvos7WduskqWLWwRvl3DzvOAB/3vWvVwwxnnmq2qq0mlXqxtslMD+Ww/hO04P50qdVx0BxTPnXRfhpYxa3NElpG8sl+UWPGIoECDMeT94neTnp8prL8KfDkT+HdUtYrSKbUY7YXjQOQp3SWrhFV+6hi54PVRXuf2cS32m2uFVLm3USbRj95uxvHvhjn3NQadbRWNzPBAuZo7Io0jdSVinIOf+2mP+Aiu6Ul0RlGOpP4J8N2VlpNneT2ii+k020tZ3I3eYI0XAx0GD2ruokBZcbhwRjpgVi+HFKaNZqzF2WCEFm6n5Fyfqa21YEK43YbHGa4Ksm3ZmiVkP4x1I7cU75WyuMg/nTBgAjAPfmnBvm+blTjHPvWI4sdtHTtRnkg9KacjryR+tAILKKVy7jgc59aPypMnAPUe5/OlPen5AIcB+nz4z05xWR4s0OHxHok2m3JxDP8r8c7SMMAe2QdufQmtUviVlPZd2PxPen/AI89c04ycXdCaueNfGD4d/2ppMt5pP2OGa0shFHDKPl2qykjf128DI9q8l1f4V3lrf2qWUlj9nvbWGWJ0kKtJh84CkcZODnj0r68mgjuF2TKCrrsI65U9Qc9q83ltRdG2tpILdDa28R3KM5QTNhcegwMV30antF7xjKNtjnvh98PrW3u3NzDGWW3hN0Y8/vpSNxBHTAHGO5Ga9Z0rTFsbaNDskmGQ0gUKX7c/h/KszwgkgsS7ymVm2Zkcct+7GCR7Afr+NdKCTx+tY4irK/L0KhFLUjihETyMJZn3tuw7ZCeyjsOOlS9+KUc9KQDNc3oaCgZ7UnXgUFQwIYZU8EUZ68cDI60hh06dumKBSZAA4oDc+45oAXIGM9D70Y7E5wKbuGOBRvGO9MBRkj5wAxHY5rD8dAHwP4jBUsBptz8o9fKatvzBk43fjWD47Zh4F8SFGZXGmXOGB5H7pulOO+hLPDP2G+P+E1/7cf/AG4orov2S/DX/COSeKEN39pNzDZS58vZt5uBjqc9KK1ejEnfY//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left ventricular outflow tract (LVOT) diameter (red line), measured just under the aortic valve, is obtained from the long axis parasternal view (panel A); the diameter is 1.5 cm and the area 1.8 cm2. Using the apical four chamber view, the Doppler sample volume in the LVOT is obtained from a position that approximates the locus from which the diameter of the LVOT had been measured (panel B). Another approach uses the continuous wave Doppler, sampling the jet across the stenotic aortic valve in the apical four chamber view (panel C); the peak velocity is 4.7 meter/s, yielding a peak gradient of 88 mmHg, a mean gradient of 45 mmHg, a flow velocity integral (VTI) of 100cm, and a valve area of 0.27 cm2. With the Doppler probe over the right parasternal window, the stenotic jet shows a peak velocity of 5.4 m/s, a peak gradient of 117 mmHg, a VTI of 129 cm and a valve area of 0.21 cm2.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31395=[""].join("\n");
var outline_f30_42_31395=null;
var title_f30_42_31396="Carisoprodol, aspirin, and codeine: Patient drug information";
var content_f30_42_31396=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Carisoprodol, aspirin, and codeine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/21/11607?source=see_link\">",
"     see \"Carisoprodol, aspirin, and codeine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021835\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701724",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to carisoprodol, aspirin, codeine, meprobamate, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ringing in ears.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used with rest, PT (physical therapy), pain drugs, and other therapies.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11782 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-7C479FB97E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31396=[""].join("\n");
var outline_f30_42_31396=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021835\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021837\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021836\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021841\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021842\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021844\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021839\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021840\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021845\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021846\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?11/21/11607?source=related_link\">",
"      Carisoprodol, aspirin, and codeine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_42_31397="Prost CA extraprost extension";
var content_f30_42_31397=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prostate adenocarcinoma with extraprostatic extension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph of an hematoxylin and eosin stained section from a prostate core needle biopsy. Evidence of extraprostatic extension of the tumor is suggested by the presence of tumor cells infiltrating fat (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ximing Yang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31397=[""].join("\n");
var outline_f30_42_31397=null;
var title_f30_42_31398="Marfan syndrome skeletal";
var content_f30_42_31398=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F86852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F86852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Example of skeletal features in Marfan syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Marfan syndrome in a 14-year-old boy. Note arachnodactyly, relatively long limbs (dolichostenomelia), pectus carinatum, sparse subcutaneous fat, unilateral genu valgum, and pes planus. Ectopia lentis and scoliosis also were present. This patient died of aortic rupture at age 15 years.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Koopman WJ, Moreland LW, Arthritis and Allied Conditions A Textbook of Rheumatology, Lippincott Williams &amp; Wilkins, Philadelphia 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31398=[""].join("\n");
var outline_f30_42_31398=null;
var title_f30_42_31399="Pulmonary histiocytosis X Low";
var content_f30_42_31399=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary Langerhans cell histiocytosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 411px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows both nodular (long arrow) and stellate (short arrow) lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Colby, TV, Koss, MN, Travis, WD. Tumors of the Lower Respiratory Tract. Armed Forces Institute of Pathology, Washington, DC.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31399=[""].join("\n");
var outline_f30_42_31399=null;
var title_f30_42_31400="Keratoacanthoma - face";
var content_f30_42_31400=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55042%7EPC%2F59550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55042%7EPC%2F59550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratoacanthoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratoacanthoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A central keratin plug is present in this rapidly growing lower lid nodule.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission from Slomovits, TL (Ed), Basic and clinical science courses section, American Academy of Ophthalmology, San Francisco 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31400=[""].join("\n");
var outline_f30_42_31400=null;
var title_f30_42_31401="Zoonoses from cats";
var content_f30_42_31401=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Zoonoses from cats",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/42/31401/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31401/contributors\">",
"     Camille N Kotton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/42/31401/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31401/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/42/31401/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31401/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/42/31401/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pets serve valuable social roles in society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Pets may lower blood pressure, reduce cholesterol and triglyceride levels, and improve feelings of loneliness, while increasing opportunities for exercise, outdoor activities, and socialization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a small, randomized, controlled study of 28 patients with chronic age-related disabilities living in a nursing home, patients were randomly assigned to animal interaction (\"pet therapy\") compared with usual activities (control group) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/3\">",
"     3",
"    </a>",
"    ]. The \"pet therapy\" group patients had improved symptoms of depression and a significant decrease in blood pressure values as compared with the control patients.",
"   </p>",
"   <p>",
"    Despite these benefits, pets present zoonotic risks, especially for immunocompromised hosts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The epidemiology of cat-related zoonoses will be reviewed here. The epidemiology of pet-related zoonoses other than cats is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/24/29065?source=see_link\">",
"     \"Zoonoses from dogs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/22/26986?source=see_link\">",
"     \"Zoonoses from pets other than dogs and cats\"",
"    </a>",
"    .) The clinical management of specific zoonotic diseases is discussed under the appropriate topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A zoonosis is an animal disease that is transmissible to humans. Humans are usually an accidental host that acquire disease through close contact with an infected animal, who may or may not be symptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Pet Association estimates that there are 77 million cats in the United States (",
"    <a class=\"external\" href=\"file://www.apapets.org/\">",
"     www.apapets.org",
"    </a>",
"    ). The most common route of infection related to cat contact is through bites and scratches, especially in children. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28038?source=see_link\">",
"     \"Soft tissue infections due to dog and cat bites\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cats can harbor many of the same infections as dogs. In addition, cats may transmit zoonoses specific to felines, such as cat-scratch disease, toxoplasmosis, and Sporothrix schenckii infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should ask about pets when taking a medical history and formulating a differential diagnosis. Many of the risks posed by pet ownership can be reduced by good hygiene after handling pets, careful pet selection, and proper pet care. New pets can pose more of a health risk because health history and vaccination records may not be known. Adult pets are generally safer than younger animals, since they are less likely to be involved in playful activities that include scratching and biting. Children are at highest risk for infection because they are more likely to have close contact with pets.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cats are responsible for transmission of an extensive array of bacterial and parasitic zoonotic pathogens (",
"    <a class=\"graphic graphic_table graphicRef57235 graphicRef70031 \" href=\"mobipreview.htm?39/29/40413\">",
"     table 1A-B",
"    </a>",
"    ). Many different routes of transmission can cause infections related to pets including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infectious saliva that contaminate bite wounds, skin abrasions, or mucous membranes",
"     </li>",
"     <li>",
"      Hand-to-mouth transfer of microorganisms, cysts, or oocysts (eggs) from feces of an infected animal",
"     </li>",
"     <li>",
"      Aerosol from body fluids (eg, respiratory secretions, placenta)",
"     </li>",
"     <li>",
"      Tick or flea bites when these vectors are carried into the home by pets",
"     </li>",
"     <li>",
"      Direct contact with an infected cat",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Infectious saliva",
"    </span>",
"    &nbsp;&mdash;&nbsp;Saliva can transmit and contaminate bite wounds, skin abrasions, or mucous membranes. Cat bites are particularly problematic in that the cat's teeth are slender and sharp and can produce deep puncture wounds. Because of the penetrating capabilities of the teeth, contamination of bone and joint can occur and result in osteomyelitis or septic arthritis; infection complicates cat bites in about 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28038?source=see_link\">",
"     \"Soft tissue infections due to dog and cat bites\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Bartonella henselae",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonella henselae, the etiologic agent of cat scratch disease (CSD) can cause disease in both normal and immunocompromised hosts. However, 80 percent of cases occur in children, with a peak in the incidence of cases between ages 2 and 14 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/8\">",
"     8",
"    </a>",
"    ]. In the United States, approximately 40 percent of cats have serologic evidence of past or current B. henselae infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/9\">",
"     9",
"    </a>",
"    ]. However, incidence in cats varies geographically, in one study of 255 cats in Northern California, B. henselae bacteremia was documented in 56 and 34 percent of cats less than one year and at least one year of age, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/10\">",
"     10",
"    </a>",
"    ]. Individual reports from numerous countries suggest a worldwide distribution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/8\">",
"     8",
"    </a>",
"    ]. Infection in cats, including bacteremia, is asymptomatic. Although preliminary data suggests that asymptomatic bacteremia in cats can be successfully treated with antibiotics, this practice is not recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CSD can result from a cat scratch or bite, as well as possibly from a fleabite. CSD is more likely to be transmitted by kittens than adult cats, as kittens are more likely to be bacteremic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/10\">",
"     10",
"    </a>",
"    ]. Human CSD most often presents as a localized cutaneous and lymph node disorder near the site of organism inoculation. In some individuals, the organisms disseminate and infect the liver, spleen, eye, or central nervous system. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/47/23289?source=see_link\">",
"     \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Pasteurella multocida",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cats are the source of infection in 60 to 80 percent of human P. multocida infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/12\">",
"     12",
"    </a>",
"    ]. P. multocida are commensals in the upper respiratory tracts of &gt;90 percent of felines and are the major pathogen causing infection as a result of a cat bite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/13\">",
"     13",
"    </a>",
"    ]. Pasteurella are found worldwide. Both healthy (eg, cats and dogs) and diseased (eg, rabbits) wild and domestic animals are the main reservoirs for the organism.",
"   </p>",
"   <p>",
"    Pasteurella infection is most often secondary to a bite or scratch from a cat, although a lick has also caused infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Pasteurella can cause serious soft-tissue infections and less commonly septic arthritis, osteomyelitis, sepsis, and meningitis particularly in infants and other immunocompromised hosts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/0/13321?source=see_link\">",
"     \"Pasteurella infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Rabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies is a fatal disease in cats. In the United States in 2004, of 7170 cases in nonhuman animals, 281 (4.1 percent) cases occurred in cats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/17\">",
"     17",
"    </a>",
"    ]. However, cats rarely are implicated in rabies transmission to humans. In developing countries, dogs account for 90 percent or more of reported cases, while in the United States, bat bites account for the majority of cases. Human rabies is rare in the United States, with only 47 cases reported between 1990 and 2005 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, rabies should be considered in the differential diagnosis of patients presenting with acute progressive encephalitis regardless of a history of an animal bite. Because of the nonspecific early symptoms, other more common infectious and noninfectious disorders (eg, encephalitis caused by arboviruses or enterovirus and Guillain-Barr&eacute; syndrome or vasculitis) should be ruled out (",
"    <a class=\"graphic graphic_algorithm graphicRef79957 \" href=\"mobipreview.htm?30/11/30896\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Capnocytophaga",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capnocytophaga was first isolated in 1976 from the blood and CSF of a patient who had received a dog bite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/19\">",
"     19",
"    </a>",
"    ]. Although more commonly associated with dog bites, Capnocytophaga canimorsus (formerly CDC group DF-2) is a fastidious, gram-negative rod that forms part of the normal oral flora of dogs and cats.",
"   </p>",
"   <p>",
"    Human infection with two species, C. canimorsus and C. cynodegmi, can follow a cat bite or scratch [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. C. canimorsus can cause fulminant sepsis and meningitis, particularly in asplenic patients or alcoholics. Human corneal infection with C. canimorsus has occurred following eye trauma due to a cat bite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9895?source=see_link\">",
"     \"Clinical features and management of sepsis in the asplenic patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Tularemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tularemia is a zoonosis caused by the gram-negative bacterium, Francisella tularensis. Cats may develop potentially fatal infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/24\">",
"     24",
"    </a>",
"    ]. Humans are accidental hosts following contact with infected animals or vectors. In the United States, tularemia has been reported from all 49 continental states, but the majority of cases occur in the south central states, mainly Arkansas, Missouri, and Oklahoma. Vector-borne disease, especially by ticks, is the most common way the disease is transmitted in the United States. The rare transmission of tularemia from a cat bite has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/53/14166?source=see_link\">",
"     \"Epidemiology, microbiology, and pathogenesis of tularemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients infected with Francisella spp present with the abrupt onset of fever, chills, headache, and malaise, after an incubation period of 2 to 10 days. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30888?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of tularemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Cowpox",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite its name, domestic cats, not cattle, are the most commonly reported source of human cowpox infection; wild rodents are thought to be the principal reservoir of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/27\">",
"     27",
"    </a>",
"    ]. In cats, ulcerated, crusted focal skin lesions can occur, sometimes with mild systemic illness and concurrent oral lesions; young or immunosuppressed animals may develop severe systemic illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transmission of cowpox from a domestic cat to a human was first reported in 1985, but cases are still observed, mainly in European countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. In humans, cowpox is an uncommon and probably underdiagnosed infection that may mimic anthrax with its painful, hemorrhagic pustules or black eschars (",
"    <a class=\"graphic graphic_picture graphicRef53156 \" href=\"mobipreview.htm?20/0/20483\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Fecal transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common zoonotic pathogens causing feline gastroenteritis include Salmonella, Campylobacter, Cryptosporidium and Giardia; cats with diarrhea should have a stool specimen examined for these pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/21\">",
"     21",
"    </a>",
"    ]. In addition, numerous parasitic diseases can be transmitted from cats to humans through feces, including toxocariasis, cutaneous larva migrans (eg, Ancylostoma braziliense), echinococcosis, and toxoplasmosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Salmonella",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most cases of salmonellosis in humans are due to foodborne illness, salmonellosis may also be transmitted from contact with animals, such as turtles and lizards. Contact with cats is an uncommon way that humans get salmonellosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/19/14649?source=see_link\">",
"     \"Microbiology and epidemiology of salmonellosis\"",
"    </a>",
"    .) An S. typhimurium outbreak associated with a veterinary clinic in New York State identified seven human cases and a case in a diabetic cat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/33\">",
"     33",
"    </a>",
"    ]. The cat had chronic intermittent diarrhea attributed to diabetes-related dietary changes and, in retrospect, may have contaminated the clinic.",
"   </p>",
"   <p>",
"    Salmonella spp infections transmitted to humans usually result in a mild, self-limiting gastroenteritis. However, severe invasive illness, such as septicemia or meningitis, can occur especially in infants and immunocompromised persons. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/8/26761?source=see_link\">",
"     \"Approach to the patient with nontyphoidal Salmonella in a stool culture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Campylobacter",
"    </span>",
"    &nbsp;&mdash;&nbsp;Like salmonellosis, the mode of transmission of Campylobacter infection is most often foodborne. However, in a substantial proportion of Campylobacter cases the source of infection is unknown. In a survey of 218 human cases of infection that identified the source, 6 percent were due to exposure to an animal with diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/60/5065?source=see_link\">",
"     \"Microbiology, pathogenesis, and epidemiology of Campylobacter infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Direct zoonotic transmission of Campylobacter from contact with infected cats and kittens has been documented [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/35\">",
"     35",
"    </a>",
"    ]. A microbiologic survey of 152 cats found 37 (24 percent) positive for Campylobacter organisms in three private veterinary clinics and an animal shelter in Minnesota; carriage was higher in cats &le;1 year old compared with those &gt;1 year (30 versus 3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/36\">",
"     36",
"    </a>",
"    ]. There was no correlation between positive cultures and clinical disease. The median duration of carriage was 44 days for nine cats surveyed.",
"   </p>",
"   <p>",
"    Campylobacter enteritis in humans presents after an incubation period of one to seven days as a syndrome most commonly characterized by prominent abdominal pain and profuse diarrhea that is often bloody. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/19/19769?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of Campylobacter infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Cryptosporidium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryptosporidium is an intracellular protozoan parasite that is associated with gastrointestinal diseases in all classes of vertebrates including mammals, reptiles, birds, and fish. Infected cats are asymptomatic or have a mild gastroenteritis. Fecal shedding of Cryptosporidium spp in cats ranges from 1 to 8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cryptosporidium infection in immunocompetent individuals has a variable presentation, it can be asymptomatic, cause a self-limited gastroenteritis (usually resolving in 10 to 14 days without treatment), or can cause more severe diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/39\">",
"     39",
"    </a>",
"    ]. In immunocompromised hosts, the illness is more frequently protracted and severe, and can lead to significant malabsorption and weight loss. Cryptosporidium parvum and C. hominis are the usual pathogens in humans; immunocompromised hosts can also be infected by other Cryptosporidium spp [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/40/13961?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Giardia lamblia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giardia lamblia (also known as G. duodenalis or G. intestinalis) is a flagellated protozoan parasite and one of the most common gastrointestinal parasites in the United States. Water is the major source for the endemic or epidemic spread of giardiasis. However, there is some evidence supporting the zoonotic transmission of Giardia, with the greatest risk from pets, especially dogs and cats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/39-41\">",
"     39-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The spectrum of clinical disease includes asymptomatic infection, self-limited acute giardiasis, and chronic infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33224?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of giardiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Toxocara cati",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxocara cati (cat roundworm) cause visceral larva migrans and ocular larva migrans in humans. These roundworms live in the small intestine of the cat in the adult stage, where eggs are passed in the feces. A seroprevalence study in North Carolina found that of 100 feral and 76 domestic cats examined, 21 and 18 percent, respectively, were positive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Human infections are caused by ingestion of eggs from contaminated hands, soil, or fomites and are usually asymptomatic to mild and accompanied by a persistent eosinophilia. The larvae penetrate the intestinal wall but are unable to complete their life cycle and produce eosinophilic granulomas in host tissues. Infection produces a syndrome in humans termed visceral larva migrans or toxocariasis. This disorder may be subclinical; or may present primarily as an ocular form. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16935?source=see_link\">",
"     \"Toxocariasis: visceral and ocular larva migrans\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systemic toxocariasis most often affects children aged one to four. Clinical manifestations include eosinophilia, rash, fever, cough, weight loss, hepatosplenomegaly, pulmonary infiltrates, seizures, and behavior disorders. Ocular larva migrans often presents in older children with a unilateral reduction in vision or strabismus and often with retinal involvement but without the systemic symptoms or eosinophilia seen in visceral disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Echinococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dogs and other carnivorous mammals are the definitive hosts for the tapeworm echinococcus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/59/20407?source=see_link\">",
"     \"Epidemiology and control of echinococcosis\"",
"    </a>",
"    .) Cats appear to have only a minor role in the maintenance of E. multilocularis in endemic areas, and infections in cats are of minimal public health significance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Toxoplasma gondii",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxoplasma gondii is an intracellular parasite with a worldwide distribution. In the United States, T. gondii infects 30 to 40 percent of domestic cats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/43\">",
"     43",
"    </a>",
"    ]. Felines of all types are the only host animals in which the sexual form of T. gondii can develop [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/44\">",
"     44",
"    </a>",
"    ]. Following feline ingestion of any form of T. gondii, the parasite infects the gut epithelial cells and reproduces. The feline then excretes infectious oocysts in feces.",
"   </p>",
"   <p>",
"    Despite the high prevalence of T. gondii infection in cats, most cats are asymptomatic. Clinical disease is rare, but more common in young cats (&le;2 years of age) and in older cats where it may be associated with co-infection with feline leukemia virus or feline immunodeficiency virus.",
"   </p>",
"   <p>",
"    Human infection is caused by ingestion of cysts from raw or undercooked meat of infected animals, ingestion of sporulated oocysts from cat feces (primarily through environmental exposure), and through transplacental transmission. If non-felines, including humans and other mammals, ingest T. gondii oocysts, the organisms invade intestinal epithelium and disseminate throughout the body. They then encyst and can lie dormant (but viable) in any nucleated cells within tissues for the life of the host.",
"   </p>",
"   <p>",
"    Approximately one-third of the United States population is seropositive (indicating latent infection) for T. gondii [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Rates differ by population, being higher with increasing age and in those persons born outside the United States.",
"   </p>",
"   <p>",
"    The proportions of infection in the United States related to different forms of transmission have been difficult to determine. The Centers for Disease Control and Prevention (CDC) estimates that about 50 percent of human infection is related to ingestion of contaminated meat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/47\">",
"     47",
"    </a>",
"    ]. The proportion associated with exposure to cats or cat feces is not known. However, a study in HIV-positive, T. gondii-seronegative patients, found that only 13 of 650 (2 percent) patients followed for a mean duration of 2.1 years, seroconverted during the study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/48\">",
"     48",
"    </a>",
"    ]. A pet history was available on 12 of the 13 patients and only one had owned or lived in a household with a cat during the period of seroconversion.",
"   </p>",
"   <p>",
"    Infection in immunocompetent persons is asymptomatic in 80 to 90 percent of cases; when symptomatic infection occurs, the most common manifestation is bilateral, symmetrical, non-tender cervical adenopathy. Clinical disease is much more likely in immunocompromised patients (eg, HIV-infected or solid organ transplant recipients) and in infants of mothers infected during pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/22/33129?source=see_link\">",
"     \"Toxoplasmosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=see_link\">",
"     \"Toxoplasmosis in immunocompetent hosts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/39/22137?source=see_link\">",
"     \"Toxoplasmosis and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    People who are seronegative for T. gondii and who are immunocompromised or pregnant should be counseled to eat only well-cooked meats, wash fruits and vegetables before eating, wash their hands after outdoor activities involving soil contact, and avoid changing the cat litter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Ancylostoma braziliense",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hookworm, A. braziliense, is an agent of cutaneous larva migrans. The eggs are shed in the feces of infected dogs or cats. Although adult animals are usually asymptomatic, puppies and kittens develop diarrhea, weight loss, and anemia. A. braziliense is found in temperate climates, including southern and Eastern Europe, the Mediterranean, North Africa, the Middle East, Pakistan and northern India, northern Australia, and parts of South America.",
"   </p>",
"   <p>",
"    Humans (and pets) are infected when bare skin comes in contact with soil contaminated with the larvae. The second-stage larvae are able to penetrate the intact skin of humans and the footpads of dogs and cats. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36229?source=see_link\">",
"     \"Cutaneous larva migrans (creeping eruption)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A pruritic erythematous papule develops initially at the site of each larval entry. Two to three days later, and at times weeks later, severely pruritic, elevated, serpiginous, reddish-brown lesions appear as the larvae migrate at a rate of several millimeters per day (",
"    <a class=\"graphic graphic_picture graphicRef60144 \" href=\"mobipreview.htm?39/63/40944\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Dipylidium caninum",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dog and cat tapeworm, Dipylidium caninum, commonly infects domestic cats and dogs and may also accidentally infect humans. Fleas usually serve as the intermediate hosts and contain cysticercoids. If a human (usually a child) ingests cysticercoids (larva), an adult tapeworm can develop in the intestine.",
"   </p>",
"   <p>",
"    This infection is usually asymptomatic. However, abdominal pain, diarrhea, pruritus ani, and urticaria can develop. In addition, parents may notice the passage of proglottids (eg, body segments of the adult tapeworm, which have a complete set of reproductive organs) that resemble cucumber seeds in their children's stool. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/26/4519?source=see_link\">",
"     \"Intestinal tapeworms\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Aerosol",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Bordetella bronchiseptica",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bordetella bronchiseptica causes a mild respiratory infection in cats, although life-threatening pneumonia may occur in kittens. The disease occurs worldwide in rodents, swine, dogs, cats and non-human primates.",
"   </p>",
"   <p>",
"    Although rare, human infection with B. bronchiseptica has been documented in both healthy and immunocompromised individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. Of nine HIV patients from whom B. bronchiseptica was isolated, respiratory illnesses ranged from mild upper respiratory tract infections to pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/53\">",
"     53",
"    </a>",
"    ]. Two of these persons had household contact with dogs prior to their illnesses, and one had household contact with cats.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Coxiella burnetii",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coxiella burnetii, the etiologic agent of Q fever, is a worldwide zoonosis. The most common animal reservoirs are goats, cattle, sheep, cats, and occasionally dogs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/54\">",
"     54",
"    </a>",
"    ]. Infected mammals shed C. burnetii in urine, feces, milk, and birth products.",
"   </p>",
"   <p>",
"    In humans, exposure results from inhalation of contaminated aerosols from parturient fluids of infected mammals, which can be present in the environment, on the coats of newborn animals, or from the placenta. A case report describes 15 members of a family who attended a reunion in Maine where they were exposed to a parturient cat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/55\">",
"     55",
"    </a>",
"    ]. Two weeks later, all 11 adults and older children developed symptoms consistent with acute Q fever. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/53/22357?source=see_link\">",
"     \"Microbiology and epidemiology of Q fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical signs of Q fever are often extremely mild or absent. Patients may be asymptomatic or can present acutely with one of three clinical presentations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A self-limited flu-like illness",
"     </li>",
"     <li>",
"      Pneumonia",
"     </li>",
"     <li>",
"      Hepatitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Chronic infection most commonly involves the heart as endocarditis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/13/12502?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Q fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Tick or fleabites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cats can transport ticks and fleas, which subsequently can bite a human host and transmit infectious diseases.",
"   </p>",
"   <p>",
"    Ticks can carry many disease-producing pathogens, including Borrelia burgdorferi (Lyme disease), Ehrlichia (ehrlichiosis), Babesia microti (babesiosis), and Francisella tularensis (tularemia). Fleas carried by cats can bite a human host and transmit plague.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Lyme disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lyme disease is caused by B. burgdorferi, which is spread by the bite of infected Ixodes ticks. Approximately 95 percent of cases of Lyme disease in the United State are reported from twelve states: Massachusetts, Connecticut, Maine, New Hampshire, Rhode Island, New York, New Jersey, Pennsylvania, Delaware, Maryland, Michigan, and Wisconsin. In highly endemic areas, owners of cats who go outdoors should inspect their cats regularly for ticks, as tick collars have a variable efficacy. Owners should inspect their cats for ticks for two reasons. First, cats can develop symptomatic Lyme disease with painful or stiff muscles and joints, fatigue, fever, and loss of appetite. Second, cat may carry ticks indoors, and if these ticks carry B. burgdorferi and attach to a human, they may then transmit Lyme disease to the pet's human family.",
"   </p>",
"   <p>",
"    Human Lyme disease is a multisystem inflammatory disease. One of the first clinical manifestations is the classic erythema migrans (EM) skin lesion (",
"    <a class=\"graphic graphic_picture graphicRef81270 \" href=\"mobipreview.htm?10/10/10400\">",
"     picture 3",
"    </a>",
"    ) that occurs in up to 90 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35225?source=see_link\">",
"     \"Clinical manifestations of Lyme disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Ehrlichiosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two most important human ehrlichial diseases are human monocytic ehrlichiosis (HME), which is caused by E. chaffeensis, and human granulocytic anaplasmosis (HGA), which is caused by Anaplasma phagocytophilum. The principle vector of E. chaffeensis is thought to be the Lone Star tick (Amblyomma americanum) (",
"    <a class=\"graphic graphic_picture graphicRef71086 \" href=\"mobipreview.htm?23/1/23582\">",
"     picture 4",
"    </a>",
"    ). A. phagocytophilum, in contrast, may be transmitted by Ixodes scapularis (",
"    <a class=\"graphic graphic_picture graphicRef73802 \" href=\"mobipreview.htm?14/13/14558\">",
"     picture 5",
"    </a>",
"    ), the tick that is also the vector of Lyme disease and babesiosis (see",
"    <a class=\"local\" href=\"#H29\">",
"     'Babesiosis'",
"    </a>",
"    below). Most cases of HME have occurred in the southeastern, south-central, and mid-Atlantic regions of the United States. States with the highest incidence of HGA during 2001 to 2002 were Rhode Island, Minnesota, Connecticut, New York, and Maryland. HGA is also reported in Western Europe.",
"   </p>",
"   <p>",
"    A cat that goes outdoors should be inspected for ticks, as a tick carrying HME or HGA may infect the animal or the tick may attach to a human once brought indoors by the cat. Infection with A. phagocytophilum is associated with clinical illness in some cats. A report describes five cats with fever, anorexia, and lethargy from Massachusetts and Connecticut who had positive antibody titers to A. phagocytophilum and responded to treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of HME and HGA in humans are variable. Most patients are febrile with nonspecific symptoms including malaise, myalgia, headache, and chills. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/5/6234?source=see_link\">",
"     \"Human ehrlichiosis and anaplasmosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Babesiosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Babesiosis is a tick borne illness caused by malaria-like parasites that infect red blood cells and result in hemolysis. Human disease is most commonly due to Babesia microti (United States) or Babesia divergens (Europe). The vector for babesiosis is the Ixodid tick, the same vector as Lyme disease and anaplasmosis. Babesiosis occurs predominantly on the Northeast coast of the United States. A cat that goes outdoors should be inspected for ticks, as a tick carrying babesiosis may attach to a human once brought indoors by the cat.",
"   </p>",
"   <p>",
"    The clinical manifestations of disease can range from asymptomatic infection to severe hemolytic anemia associated with jaundice, hemoglobinuria, renal failure, and death. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/16/42248?source=see_link\">",
"     \"Epidemiology and pathogenesis of babesiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Yersinia pestis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Yersinia pestis is the etiologic agent of plague. Cats can become severely ill from Yersinia pestis (plague) after been bitten by rodents' fleas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/5,57\">",
"     5,57",
"    </a>",
"    ]. They can carry the infected fleas, which can spread disease to humans through a fleabite. Rarely, ill cats have spread pneumonic disease to man by aerosol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/58\">",
"     58",
"    </a>",
"    ]; or bubonic disease by a bite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Foci of plague are present on most continents other than Australia. In the United States, plague is endemic in all of the western states and has extended north and east over the years. Ninety percent of human cases in the United States have occurred in four states: Arizona, California, Colorado, and New Mexico. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/12/24774?source=see_link\">",
"     \"Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Three generally recognized clinical syndromes are associated with human plague: bubonic, septicemic, and pneumonic. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/15/11512?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Contaminated urine",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Leptospirosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leptospira interrogans, the etiologic agent of human leptospirosis, infects a variety of both wild and domestic mammals, including cats. Animals can be asymptomatic or develop clinical infection, which can be fatal. Transmission to humans occurs by contact with water or soil contaminated with the urine of infected animals (predominantly rats). One study in Baltimore found that cat ownership may be protective against leptospirosis, perhaps because cats reduce human contact with rodents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Leptospirosis in humans may manifest as a subclinical illness followed by seroconversion, a self-limited systemic infection, or a severe, potentially fatal illness accompanied by multiorgan failure. Leptospirosis usually presents with the abrupt onset of fever, rigors, myalgias, and headache, after an incubation period of 2 to 26 days (average 10 days). Many patients have an associated nonproductive cough, nausea, vomiting, and diarrhea. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43879?source=see_link\">",
"     \"Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Direct contact",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Sporothrix schenckii",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sporotrichosis is a subacute to chronic infection caused by the dimorphic fungus Sporothrix schenckii. The fungus is found worldwide in climates ranging from temperate to tropical. Most cases are reported from the Americas and Japan. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/60/8134?source=see_link\">",
"     \"Basic biology and epidemiology of sporotrichosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Disease in humans is usually localized to cutaneous and lymphatic structures and runs a subacute to chronic course. Infected cats develop disease similar to that seen in humans. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12469?source=see_link\">",
"     \"Clinical features and diagnosis of sporotrichosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clusters of cases have been reported in veterinarians, family members, and groomers who have handled cats with chronic ulcerated skin lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/60-64\">",
"     60-64",
"    </a>",
"    ]. Transmission of infection to humans can occur even without an associated penetrating injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Microsporum canis",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. canis is a fungus (eg, dermatophyte) that causes skin and nail infections in animals and humans. M. canis is the cause of from three to 13 percent of human ringworm (tinea capitis) infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/65\">",
"     65",
"    </a>",
"    ]. The disease in cats is similar to that seen in humans and occurs with a variable prevalence of four to 47 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7082?source=see_link\">",
"     \"Dermatophyte (tinea) infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although cats have been implicated in transmission of zoonoses to their owners, risk of transmission from contact with cats is low and may be further reduced by simple precautions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cats should be seen by a veterinarian on a regular basis, treated promptly for diarrhea and dermatoses and should be vaccinated for rabies.",
"     </li>",
"     <li>",
"      Cats who are confined indoors present a lower risk than those who roam outdoors",
"     </li>",
"     <li>",
"      Effective flea control requires treatment of affected cats, their environment, and other animals they contact.",
"     </li>",
"     <li>",
"      Cats should be fed high quality commercial food and should not eat raw meat or eggs. They should not be allowed to eat garbage, feces, or hunt [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/6\">",
"       6",
"      </a>",
"      ]. They should not be allowed to drink non-potable water (eg, surface water or toilet water).",
"     </li>",
"     <li>",
"      Cats claws should be clipped to reduce the risk of cat scratches to owners",
"     </li>",
"     <li>",
"      Outdoor cats should be inspected for ticks regularly",
"     </li>",
"     <li>",
"      Young cats present a greater risk for disease (eg, cat scratch disease) than older cats",
"     </li>",
"     <li>",
"      Owners should wash their hands following contact with or cleaning of litter boxes",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Immunocompromised hosts and pets",
"    </span>",
"    &nbsp;&mdash;&nbsp;Groups at high risk for serious infection from pets include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persons with waning immunity (eg, older adults)",
"     </li>",
"     <li>",
"      Children less than five years old",
"     </li>",
"     <li>",
"      Pregnant women",
"     </li>",
"     <li>",
"      Immunocompromised patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The last group may include patients with AIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/66\">",
"     66",
"    </a>",
"    ] and those taking immunosuppression or without a functioning spleen. Numerous reports exist of the transmission of zoonoses to humans during and after solid organ and hematopoietic stem cell transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/67\">",
"     67",
"    </a>",
"    ]. Most zoonoses present as a primary infection in the post-transplant period; immunocompromised patients are more likely to experience significant morbidity and mortality from these infections.",
"   </p>",
"   <p>",
"    To avoid infections, people at higher risk should take particular precautions with any animal contact. In addition to thorough and frequent hand washing, these precautions might include avoiding contact with animals and their environment (eg, pens, bedding, and manure). For children, risk for exposure might be reduced if they are closely supervised by adults, carried by adults in animal areas, or have animal contact only over a barrier. These measures discourage animals from jumping on or nuzzling children and minimize contact with feces and soiled bedding.",
"   </p>",
"   <p>",
"    The United States Public Health Service and the Infectious Diseases Society of America have issued formal recommendation for HIV positive people who desire pet contact [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/68\">",
"     68",
"    </a>",
"    ]. The guidelines specify:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When obtaining a new pet, HIV-infected persons should avoid animals aged &lt;6 months (or &lt;1 year for cats) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31401/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      HIV-infected persons should be cautious when obtaining a pet from pet-breeding facilities, pet stores, and animal shelters, because of highly variable hygienic and sanitary conditions. Stray animals should be avoided.",
"     </li>",
"     <li>",
"      HIV-infected persons should avoid contact with any animal that has diarrhea. HIV-infected pet owners should seek veterinary care for animals with diarrheal illness, and a fecal sample from such animals should be examined for Cryptosporidium, Salmonella, and Campylobacter.",
"     </li>",
"     <li>",
"      HIV-infected persons should wash their hands after handling pets, including before eating, and should avoid contact with pets' feces.",
"     </li>",
"     <li>",
"      HIV-infected persons should avoid contact with reptiles (eg, snakes, lizards, iguanas, and turtles) as well as chicks and ducklings because of the risk for salmonellosis.",
"     </li>",
"     <li>",
"      Gloves should be used during aquarium cleaning to reduce the risk for infection with Mycobacterium marinum.",
"     </li>",
"     <li>",
"      Contact with exotic pets (eg, nonhuman primates) should be avoided.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Centers for Disease Control offer a \"Pet-Scription\" at",
"    <a class=\"external\" href=\"file://www.cdc.gov/healthypets/health_prof.htm\">",
"     file://www.cdc.gov/healthypets/health_prof.htm#petscription",
"    </a>",
"    , which provides patients with more information about pet and infection risks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=see_link\">",
"       \"Patient information: Animal bites (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A zoonosis is an animal disease that is transmissible to humans. Humans are usually an accidental host that acquires disease through close contact with an infected animal, who may or may not be symptomatic. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children are at highest risk for infection because they are more likely to have close contact with pets. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cats are responsible for transmission of an extensive array of bacterial, fungal, and parasitic zoonotic pathogens. The route of transmission can be through the saliva (eg, bites or contaminated scratches), feces, respiratory secretions, direct contact, or by the cat acting as a vehicle and source of tick or flea exposure. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although cats have been implicated in transmission of zoonoses to their owners, risk of transmission from contact with cats is low and may be further reduced by simple precautions. (See",
"      <a class=\"local\" href=\"#H36\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/1\">",
"      Anderson WP, Reid CM, Jennings GL. Pet ownership and risk factors for cardiovascular disease. Med J Aust 1992; 157:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/2\">",
"      Parslow RA, Jorm AF. Pet ownership and risk factors for cardiovascular disease: another look. Med J Aust 2003; 179:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/3\">",
"      Stasi MF, Amati D, Costa C, et al. Pet-therapy: a trial for institutionalized frail elderly patients. Arch Gerontol Geriatr Suppl 2004; :407.",
"     </a>",
"    </li>",
"    <li>",
"     Bisseru B. Disease of Man Acquired from His Pets, J. B. Lippincott Company, Philadelphia 1967.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/5\">",
"      Elliot DL, Tolle SW, Goldberg L, Miller JB. Pet-associated illness. N Engl J Med 1985; 313:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/6\">",
"      Trevejo RT, Barr MC, Robinson RA. Important emerging bacterial zoonotic infections affecting the immunocompromised. Vet Res 2005; 36:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/7\">",
"      Goldstein EJ. Bite wounds and infection. Clin Infect Dis 1992; 14:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/8\">",
"      Anderson BE, Neuman MA. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 1997; 10:203.",
"     </a>",
"    </li>",
"    <li>",
"     Control C. Cat Scratch Disease (Bartonella henselae Infection). file://www.cdc.gov/healthypets/diseases/catscratch.htm (Accessed on November 07, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/10\">",
"      Chomel BB, Abbott RC, Kasten RW, et al. Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol 1995; 33:2445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/11\">",
"      Koehler JE, Glaser CA, Tappero JW. Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir. JAMA 1994; 271:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/12\">",
"      Weber DJ, Wolfson JS, Swartz MN, Hooper DC. Pasteurella multocida infections. Report of 34 cases and review of the literature. Medicine (Baltimore) 1984; 63:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/13\">",
"      Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med 1999; 340:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/14\">",
"      Hirsh D, Farrell K, Reilly C, Dobson S. Pasteurella multocida meningitis and cervical spine osteomyelitis in a neonate. Pediatr Infect Dis J 2004; 23:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/15\">",
"      Wade T, Booy R, Teare EL, Kroll S. Pasteurella multocida meningitis in infancy - (a lick may be as bad as a bite). Eur J Pediatr 1999; 158:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/16\">",
"      Ashley BD, Noone M, Dwarakanath AD, Malnick H. Fatal Pasteurella dagmatis peritonitis and septicaemia in a patient with cirrhosis: a case report and review of the literature. J Clin Pathol 2004; 57:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/17\">",
"      Krebs JW, Mandel EJ, Swerdlow DL, Rupprecht CE. Rabies surveillance in the United States during 2004. J Am Vet Med Assoc 2005; 227:1912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/18\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Florida, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/19\">",
"      Bobo RA, Newton EJ. A previously undescribed gram-negative bacillus causing septicemia and meningitis. Am J Clin Pathol 1976; 65:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/20\">",
"      Mahrer S, Raik E. Capnocytophaga canimorsus septicemia associated with cat scratch. Pathology 1992; 24:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/21\">",
"      Valtonen M, Lauhio A, Carlson P, et al. Capnocytophaga canimorsus septicemia: fifth report of a cat-associated infection and five other cases. Eur J Clin Microbiol Infect Dis 1995; 14:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/22\">",
"      McLean CR, Hargrove R, Behn E. The first fatal case of capnocytophaga canimorsus sepsis caused by a cat scratch. J R Nav Med Serv 2004; 90:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/23\">",
"      Chodosh J. Cat's tooth keratitis: human corneal infection with Capnocytophaga canimorsus. Cornea 2001; 20:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/24\">",
"      Woods JP, Crystal MA, Morton RJ, Panciera RJ. Tularemia in two cats. J Am Vet Med Assoc 1998; 212:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/25\">",
"      Capellan J, Fong IW. Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis 1993; 16:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/26\">",
"      Arav-Boger R. Cat-bite tularemia in a seventeen-year-old girl treated with ciprofloxacin. Pediatr Infect Dis J 2000; 19:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/27\">",
"      Baxby D, Bennett M, Getty B. Human cowpox 1969-93: a review based on 54 cases. Br J Dermatol 1994; 131:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/28\">",
"      Godfrey DR, Blundell CJ, Essbauer S, et al. Unusual presentations of cowpox infection in cats. J Small Anim Pract 2004; 45:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/29\">",
"      Willemse A, Egberink HF. Transmission of cowpox virus infection from domestic cat to man. Lancet 1985; 1:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/30\">",
"      Haenssle HA, Kiessling J, Kempf VA, et al. Orthopoxvirus infection transmitted by a domestic cat. J Am Acad Dermatol 2006; 54:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/31\">",
"      Hawranek T, Tritscher M, Muss WH, et al. Feline orthopoxvirus infection transmitted from cat to human. J Am Acad Dermatol 2003; 49:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/32\">",
"      Lawn SD, Planche T, Riley P, et al. A black necrotic ulcer. Lancet 2003; 361:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/33\">",
"      Friedman CR, Torigian C, Shillam PJ, et al. An outbreak of salmonellosis among children attending a reptile exhibit at a zoo. J Pediatr 1998; 132:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/34\">",
"      Saeed AM, Harris NV, DiGiacomo RF. The role of exposure to animals in the etiology of Campylobacter jejuni/coli enteritis. Am J Epidemiol 1993; 137:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/35\">",
"      Deming MS, Tauxe RV, Blake PA, et al. Campylobacter enteritis at a university: transmission from eating chicken and from cats. Am J Epidemiol 1987; 126:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/36\">",
"      Bender JB, Shulman SA, Averbeck GA, et al. Epidemiologic features of Campylobacter infection among cats in the upper midwestern United States. J Am Vet Med Assoc 2005; 226:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/37\">",
"      Nutter FB, Dubey JP, Levine JF, et al. Seroprevalences of antibodies against Bartonella henselae and Toxoplasma gondii and fecal shedding of Cryptosporidium spp, Giardia spp, and Toxocara cati in feral and pet domestic cats. J Am Vet Med Assoc 2004; 225:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/38\">",
"      Glaser C, Lewis P, Wong S. Pet-, animal-, and vector-borne infections. Pediatr Rev 2000; 21:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/39\">",
"      Eligio-Garc&iacute;a L, Cortes-Campos A, Jim&eacute;nez-Cardoso E. Genotype of Giardia intestinalis isolates from children and dogs and its relationship to host origin. Parasitol Res 2005; 97:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/40\">",
"      Traub RJ, Monis PT, Robertson I, et al. Epidemiological and molecular evidence supports the zoonotic transmission of Giardia among humans and dogs living in the same community. Parasitology 2004; 128:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/41\">",
"      Thompson RC. The zoonotic significance and molecular epidemiology of Giardia and giardiasis. Vet Parasitol 2004; 126:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/42\">",
"      Thompson RC, Kapel CM, Hobbs RP, Deplazes P. Comparative development of Echinococcus multilocularis in its definitive hosts. Parasitology 2006; 132:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/43\">",
"      Ladiges WC, DiGiacomo RF, Yamaguchi RA. Prevalence of Toxoplasma gondii antibodies and oocysts in pound-source cats. J Am Vet Med Assoc 1982; 180:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/44\">",
"      Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/45\">",
"      Remington JS. Toxoplasmosis in the adult. Bull N Y Acad Med 1974; 50:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/46\">",
"      Falusi O, French AL, Seaberg EC, et al. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis 2002; 35:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/47\">",
"      Lopez A, Dietz VJ, Wilson M, et al. Preventing congenital toxoplasmosis. MMWR Recomm Rep 2000; 49:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/48\">",
"      Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA 1993; 269:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/49\">",
"      Richards FO Jr, Kovacs JA, Luft BJ. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21 Suppl 1:S49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/50\">",
"      Lo Re V 3rd, Brennan PJ, Wadlin J, et al. Infected branchial cleft cyst due to Bordetella bronchiseptica in an immunocompetent patient. J Clin Microbiol 2001; 39:4210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/51\">",
"      Stefanelli P, Mastrantonio P, Hausman SZ, et al. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J Clin Microbiol 1997; 35:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/52\">",
"      Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/53\">",
"      Dworkin MS, Sullivan PS, Buskin SE, et al. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1999; 28:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/54\">",
"      Marrie TJ. Coxiella burnetii pneumonia. Eur Respir J 2003; 21:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/55\">",
"      Pinsky RL, Fishbein DB, Greene CR, Gensheimer KF. An outbreak of cat-associated Q fever in the United States. J Infect Dis 1991; 164:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/56\">",
"      Lappin MR, Breitschwerdt EB, Jensen WA, et al. Molecular and serologic evidence of Anaplasma phagocytophilum infection in cats in North America. J Am Vet Med Assoc 2004; 225:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/57\">",
"      Lowell JL, Wagner DM, Atshabar B, et al. Identifying sources of human exposure to plague. J Clin Microbiol 2005; 43:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/58\">",
"      Doll JM, Zeitz PS, Ettestad P, et al. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am J Trop Med Hyg 1994; 51:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/59\">",
"      Childs JE, Schwartz BS, Ksiazek TG, et al. Risk factors associated with antibodies to leptospires in inner-city residents of Baltimore: a protective role for cats. Am J Public Health 1992; 82:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/60\">",
"      de Lima Barros MB, de Oliveira Schubach A, Galhardo MC, et al. Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol 2003; 42:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/61\">",
"      Fleury RN, Taborda PR, Gupta AK, et al. Zoonotic sporotrichosis. Transmission to humans by infected domestic cat scratching: report of four cases in S&atilde;o Paulo, Brazil. Int J Dermatol 2001; 40:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/62\">",
"      Schubach A, de Lima Barros MB, Schubach TM, et al. Primary conjunctival sporotrichosis: two cases from a zoonotic epidemic in Rio de Janeiro, Brazil. Cornea 2005; 24:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/63\">",
"      Naqvi SH, Becherer P, Gudipati S. Ketoconazole treatment of a family with zoonotic sporotrichosis. Scand J Infect Dis 1993; 25:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/64\">",
"      Reed KD, Moore FM, Geiger GE, Stemper ME. Zoonotic transmission of sporotrichosis: case report and review. Clin Infect Dis 1993; 16:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/65\">",
"      Weitzman I, Chin NX, Kunjukunju N, Della-Latta P. A survey of dermatophytes isolated from human patients in the United States from 1993 to 1995. J Am Acad Dermatol 1998; 39:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/66\">",
"      Glaser CA, Angulo FJ, Rooney JA. Animal-associated opportunistic infections among persons infected with the human immunodeficiency virus. Clin Infect Dis 1994; 18:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/67\">",
"      Kotton CN. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007; 44:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/68\">",
"      Kaplan JE, Masur H, Holmes KK, et al. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31401/abstract/69\">",
"      Robinson RA, Pugh RN. Dogs, zoonoses and immunosuppression. J R Soc Promot Health 2002; 122:95.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5518 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-188.40.116.55-6D8648E745-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31401=[""].join("\n");
var outline_f30_42_31401=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H39\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Infectious saliva",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Bartonella henselae",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Pasteurella multocida",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Rabies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Capnocytophaga",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Tularemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Cowpox",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Fecal transmission",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Salmonella",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Campylobacter",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Cryptosporidium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Giardia lamblia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Toxocara cati",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Echinococcus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Toxoplasma gondii",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Ancylostoma braziliense",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Dipylidium caninum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Aerosol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Bordetella bronchiseptica",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Coxiella burnetii",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Tick or fleabites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Ehrlichiosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Babesiosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Yersinia pestis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Contaminated urine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Leptospirosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Direct contact",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Sporothrix schenckii",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Microsporum canis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Immunocompromised hosts and pets",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5518\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5518|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?30/11/30896\" title=\"algorithm 1\">",
"      Differential dx rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5518|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/0/20483\" title=\"picture 1\">",
"      Cowpox lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/63/40944\" title=\"picture 2\">",
"      Cutaneous larva migrans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?10/10/10400\" title=\"picture 3\">",
"      Erythema migrans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/1/23582\" title=\"picture 4\">",
"      Lone star tick",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/13/14558\" title=\"picture 5\">",
"      Ixodes scapularis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5518|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/60/31692\" title=\"table 1A\">",
"      Zoonoses from Cats A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/28/30156\" title=\"table 1B\">",
"      Zoonoses from Cats B",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/8/26761?source=related_link\">",
"      Approach to the patient with nontyphoidal Salmonella in a stool culture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/60/8134?source=related_link\">",
"      Basic biology and epidemiology of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12469?source=related_link\">",
"      Clinical features and diagnosis of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9895?source=related_link\">",
"      Clinical features and management of sepsis in the asplenic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/13/12502?source=related_link\">",
"      Clinical manifestations and diagnosis of Q fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=related_link\">",
"      Clinical manifestations and diagnosis of rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35225?source=related_link\">",
"      Clinical manifestations of Lyme disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/19/19769?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of Campylobacter infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/15/11512?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30888?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of tularemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36229?source=related_link\">",
"      Cutaneous larva migrans (creeping eruption)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7082?source=related_link\">",
"      Dermatophyte (tinea) infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/59/20407?source=related_link\">",
"      Epidemiology and control of echinococcosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/16/42248?source=related_link\">",
"      Epidemiology and pathogenesis of babesiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/40/13961?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33224?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of giardiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/12/24774?source=related_link\">",
"      Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/53/14166?source=related_link\">",
"      Epidemiology, microbiology, and pathogenesis of tularemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/5/6234?source=related_link\">",
"      Human ehrlichiosis and anaplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/26/4519?source=related_link\">",
"      Intestinal tapeworms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/53/22357?source=related_link\">",
"      Microbiology and epidemiology of Q fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/19/14649?source=related_link\">",
"      Microbiology and epidemiology of salmonellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/47/23289?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43879?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/60/5065?source=related_link\">",
"      Microbiology, pathogenesis, and epidemiology of Campylobacter infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/0/13321?source=related_link\">",
"      Pasteurella infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=related_link\">",
"      Patient information: Animal bites (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28038?source=related_link\">",
"      Soft tissue infections due to dog and cat bites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16935?source=related_link\">",
"      Toxocariasis: visceral and ocular larva migrans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/39/22137?source=related_link\">",
"      Toxoplasmosis and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/22/33129?source=related_link\">",
"      Toxoplasmosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=related_link\">",
"      Toxoplasmosis in immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/24/29065?source=related_link\">",
"      Zoonoses from dogs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/22/26986?source=related_link\">",
"      Zoonoses from pets other than dogs and cats",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_42_31402="Breast conserving therapy";
var content_f30_42_31402=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Breast conserving therapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Michael S Sabel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Lori J Pierce, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/42/31402/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/42/31402/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast conserving therapy (BCT) refers to breast conserving surgery (BCS), followed by moderate-dose radiation therapy (RT) to eradicate any microscopic residual disease. The goals of BCT are to provide the survival equivalent of mastectomy, a cosmetically acceptable breast, and a low rate of recurrence in the treated breast.",
"   </p>",
"   <p>",
"    While modern techniques are less morbid than radical mastectomy, a mastectomy still requires the loss of the breast. For this reason, the question arose as to whether the breast could be preserved without compromising survival. Six modern, prospective, randomized clinical trials directly comparing BCT with mastectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/1-9\">",
"     1-9",
"    </a>",
"    ] and an overview of all completed trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/10\">",
"     10",
"    </a>",
"    ] have shown equivalent survival between the two treatment approaches. The success of BCT is contingent upon moderate-dose RT in eliminating subclinical foci of disease in the ipsilateral breast. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11385?source=see_link&amp;anchor=H2#H2\">",
"     \"Role of radiation therapy in breast conservation therapy\", section on 'Rationale'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major issues related to breast conservation techniques for surgical treatment of breast cancer will be reviewed here. The diagnosis and management of breast cancer is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/46/19177?source=see_link\">",
"     \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION FOR BCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selection of appropriate patients is crucial to the success of BCT. Although BCT provides an acceptable alternative to mastectomy for the treatment of invasive breast cancer, it is not applicable to all patients. Mastectomy is mandatory for tumor control for some subgroups of patients with breast cancer, and it may provide more satisfactory outcomes in others. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/18/12586?source=see_link\">",
"     \"Mastectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American College of Surgeons, the American College of Radiology, the College of American Pathologists, and the Society of Surgical Oncology have developed consensus standards of care for BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/11\">",
"     11",
"    </a>",
"    ]. Similar recommendations have been made by the Canadian Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/12\">",
"     12",
"    </a>",
"    ]. The following issues are emphasized in the appropriate selection of patients for BCT:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A complete history and physical examination prior to treatment.",
"     </li>",
"     <li>",
"      Tissue biopsy with core needle sampling to provide conclusive proof of malignancy. Needle biopsy is preferred over surgical biopsy to reduce unnecessary surgery and avoid scars that may complicate the placement of the subsequent lumpectomy incision. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24504?source=see_link\">",
"       \"Breast biopsy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Accurate histologic assessment of the primary tumor, including histologic subtype, hormone receptor status, and HER2 status. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=see_link\">",
"       \"Pathology of breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/28/43465?source=see_link&amp;anchor=H29980905#H29980905\">",
"       \"Measurement of prognostic factors in breast cancer\", section on 'tests done on breast tissue'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/22/30058?source=see_link&amp;anchor=H6#H6\">",
"       \"HER2 and predicting response to therapy in breast cancer\", section on 'Assays for HER2 expression'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19194?source=see_link&amp;anchor=H4#H4\">",
"       \"Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy\", section on 'Assays for ER and PR'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Once the diagnosis of cancer is made, multidisciplinary coordination among breast and reconstructive surgeons, radiation and medical oncologists, and radiologists and pathologists facilitates treatment planning and streamlines patient care [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/13\">",
"       13",
"      </a>",
"      ]. In some cases, neoadjuvant chemotherapy is warranted to decrease the tumor size and improve the success rate of breast conservation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=see_link\">",
"       \"Diagnostic evaluation of women with suspected breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35466?source=see_link\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Preoperative breast imaging, to define the extent of disease and identify multifocal or multicentric cancer that could preclude breast conservation or potential difficulty in achieving clear surgical margins. Imaging typically includes a combination of bilateral mammographic evaluation, with appropriate magnification views, and ultrasound, if appropriate. The tumor size should be included in the mammographic report, as well as documentation of associated microcalcifications, and the extent of the calcifications within and outside the mass. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=see_link&amp;anchor=H8#H8\">",
"       \"Diagnostic evaluation of women with suspected breast cancer\", section on 'Assessing the extent of disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some surgeons incorporate breast magnetic resonance imaging (MRI) in the work-up of patients considering BCT, however the use of routine MRI in this setting is not indicated. The indications for breast MRI for the preoperative assessment of disease in newly diagnosed breast cancer are listed here and discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=see_link&amp;anchor=H11#H11\">",
"       \"Diagnostic evaluation of women with suspected breast cancer\", section on 'Breast MRI'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For a clinical presentation of disease that is larger than what is appreciated by mammography (particularly in the setting of dense breasts which lower the sensitivity of mammography)",
"     </li>",
"     <li>",
"      For invasive cancers that are contiguous to the chest wall and not completely included on mammographic projections,",
"     </li>",
"     <li>",
"      For patients with axillary nodal metastases and a clinically occult primary tumor",
"     </li>",
"     <li>",
"      For women with Paget&rsquo;s disease of the breast who have a negative physical examination and mammogram",
"     </li>",
"     <li>",
"      In women with locally advanced breast cancer who are being considered for neoadjuvant systemic therapy",
"     </li>",
"     <li>",
"      For women with very high risk for contralateral disease because of an inherited predisposing condition, or prior chest wall irradiation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women should be informed of the risks and benefits of preoperative breast MRI. The limits of the accuracy of MRI should be discussed with patients, so that they understand the need for biopsy of MRI detected lesions before definitive surgery. Breast MRI should be performed with a dedicated breast coil by expert breast imaging radiologists in institutions that have the capability to perform MRI guided needle biopsy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      wire localization of the findings.",
"     </li>",
"     <li>",
"      Surgical decisions should",
"      <strong>",
"       not",
"      </strong>",
"      be based on MRI findings alone. MRI findings alone should not be used to change surgical planning and conversion from breast conservation to mastectomy. All suspicious findings on",
"      <strong>",
"      </strong>",
"      MRI require pathologic confirmation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Selection criteria for BCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The individual patient's needs and expectations should be accurately assessed. This requires that the patient and physician discuss the benefits and risks of mastectomy compared to BCT in regards to long-term survival, the possibility and consequence of local recurrence, and the impact on cosmetic outcome and psychosocial adjustment. There are many issues to consider regarding this decision:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age is not a contraindication to BCT; physiologic age and the presence of comorbid conditions should be the primary determinants of local therapy in older women.",
"     </li>",
"     <li>",
"      Retraction of the skin, nipple, or breast parenchyma is not necessarily a sign of locally advanced breast cancer and does not contraindicate BCT. However, if a portion of skin or the nipple areolar complex will need to be resected to achieve negative margins, the cosmetic implications of this should be factored into the decision to proceed with BCT.",
"     </li>",
"     <li>",
"      Histologic subtypes other than invasive ductal carcinoma (eg, invasive lobular cancer) are not associated with an increased risk of breast cancer recurrence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]; these women are candidates for BCT if the tumor distribution is not diffuse and it can be excised with negative margins [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/16\">",
"       16",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=see_link\">",
"       \"Pathology of breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The presence of an extensive intraductal component (EIC) is an indicator that disease extent may be greater than clinically suspected but is not a contraindication to BCT by itself. Patients with negative margins are still acceptable candidates for BCT. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Extensive intraductal component (EIC)'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Lymph node positivity is a marker of worse prognosis, but positive lymph nodes are not a contraindication for BCT, as BCT and mastectomy have equivalent outcomes independent of nodal metastases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/3/41017?source=see_link\">",
"       \"Postmastectomy chest wall irradiation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tumor location should not influence the choice of treatment. Tumors in a superficial subareolar location may require resection of the nipple-areolar complex to achieve negative margins; oncologic outcomes will not be affected, but the cosmetic result may be. Although oncoplastic techniques improve cosmesis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/17\">",
"       17",
"      </a>",
"      ], the patient and her clinician need to assess whether such a resection is preferable to mastectomy.",
"     </li>",
"     <li>",
"      A family history of breast cancer is not a contraindication to BCT (see",
"      <a class=\"local\" href=\"#H27\">",
"       'Inherited susceptibility'",
"      </a>",
"      below); however, women with a strong family history suggestive of a genetic predisposition should be informed about their increased risk of a second primary cancer. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44025?source=see_link\">",
"       \"Characteristics of hereditary breast and ovarian cancer syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A high risk of systemic relapse is not a contraindication for BCT but instead indicates the need for adjuvant systemic therapy.",
"     </li>",
"     <li>",
"      Breast density should not be used as the sole selection criteria for not performing breast conserving surgery (BCS). However, a prospective study of 1052 patients undergoing attempted BCS found that patients with dense breast tissue were significantly more likely to be treated with an initial mastectomy compared with women with less dense breast tissue (74 versus 52 percent, odds ratio [OR] 1.94, 95% CI 1.44-2.62, p &lt; 0.0001) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/18\">",
"       18",
"      </a>",
"      ]. In addition, MRI was performed more often in patients with dense breast tissue (65 versus 33 percent). Breast density was not associated with positive margins for BCS or conversion to a mastectomy, and preoperative MRI did not decrease the risk of positive margins.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Special considerations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Connective tissue disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with a history of connective tissue disease tolerate irradiation poorly, and so the use of RT as a component of BCT must be weighed against the possible complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/19-24\">",
"     19-24",
"    </a>",
"    ]. However, despite numerous case reports describing radiation-induced toxicities, none of the three published retrospective matched-control studies have shown a statistically significant increase in acute toxicities in this patient population as a whole [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/20,22,23\">",
"     20,22,23",
"    </a>",
"    ]. Only one was able to show a statistically significant increase in the risk of late complications in patients with connective tissue disease, and this effect disappeared in subset analysis by disease in all patients but those with scleroderma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/22\">",
"     22",
"    </a>",
"    ]. In contrast, the largest of the three studies noted that patients with scleroderma and systemic lupus erythematosus (SLE), but",
"    <strong>",
"     not",
"    </strong>",
"    rheumatoid arthritis, were at a significantly increased risk of late toxicities. As a result, many radiation oncologists consider scleroderma and active SLE to be relative contraindications to BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/11,24\">",
"     11,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/34/29224?source=see_link\">",
"     \"Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Tumor size",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tumor size relative to breast size is an important consideration in selecting patients for BCT. A large tumor in a small breast is a relative contraindication, since an adequate resection would result in significant cosmetic alteration. However, tumor size in itself is not an absolute contraindication to BCT. Breast size is also not in itself a contraindication to BCT. Women with large or pendulous breasts can undergo breast irradiation successfully as long as reproducibility of patient setup can be ensured, and it is technically possible to obtain adequate dose homogeneity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Role of neoadjuvant treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neoadjuvant treatment with chemotherapy or hormonal therapy can reduce tumor size significantly and allow for breast conservation with acceptable rates of local recurrence (",
"    <a class=\"graphic graphic_table graphicRef62394 \" href=\"mobipreview.htm?7/51/7997\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clip placement in the tumor bed under ultrasound guidance should be accomplished before or soon after neoadjuvant treatment begins if at all possible. The metallic clip ensures that the surgeon can accurately localize the tumor bed in case there is a complete response to chemotherapy.",
"   </p>",
"   <p>",
"    The presence of multicentric disease, extensive micro-calcifications, extensive skin changes, a clinical diagnosis of inflammatory breast cancer, and dermal lymphatic involvement are considered contraindications for this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few absolute contraindications to BCT. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multicentric disease with two or more primary tumors in separate quadrants of the breast such that they cannot be encompassed in a single excision.",
"     </li>",
"     <li>",
"      Diffuse malignant microcalcifications on mammography.",
"     </li>",
"     <li>",
"      A history of prior therapeutic RT that included a portion of the affected breast, which when combined with the proposed treatment, would result in an excessively high total radiation dose to the chest wall.",
"     </li>",
"     <li>",
"      Pregnancy is an absolute contraindication to the use of breast irradiation; however, it may be possible to perform breast-conserving surgery in the third trimester, deferring breast irradiation until after delivery. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17207?source=see_link\">",
"       \"Breast cancer during pregnancy and lactation: Epidemiology and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Persistently positive resection margins after multiple attempts at reexcision [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H595441743\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3173893\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;A preoperative antibiotic, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    , should be administered after arriving in the operating room and before the incision is made [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. The efficacy of antibiotic prophylaxis decreases if administered more than one hour before surgery (",
"    <a class=\"graphic graphic_table graphicRef79097 \" href=\"mobipreview.htm?22/46/23275\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. A meta-analysis of the randomized controlled trials of preoperative antibiotics versus placebo in patients undergoing breast surgery found that the use of preoperative antibiotics was associated with a significant reduction in infection (relative risk = 0.60; CI = 0.45 to 0.81) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3173900\">",
"    <span class=\"h2\">",
"     Deep venous thrombosis prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients undergoing general anesthesia, primary prophylaxis for prevention of deep venous thrombosis, such as sequential compression devices, should be employed (",
"    <a class=\"graphic graphic_table graphicRef50947 \" href=\"mobipreview.htm?34/54/35693\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SURGICAL TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The type and location of the incision is important for several reasons. It is imperative to remember that any patient who undergoes lumpectomy may ultimately require a mastectomy, and incisions should be planned with possible mastectomy incisions in mind. The incision should be placed close to the tumor to avoid extensive tunneling. In the upper part of the breast, incisions should be curvilinear or transverse and follow the natural skin creases (Langer's lines). In the lower part of the breast, the choice of a curvilinear or radial incision is dependent upon the contour of the breast, the distance from the skin to the tumor, and the amount of breast tissue to be resected. At the completion of the procedure, the incision should be closed with a subcuticular suture to avoid cross-hatching of the skin.",
"   </p>",
"   <p>",
"    In deeper lesions, it is not necessary to remove skin, and preservation of the subcutaneous fat and avoidance of thin skin flaps are important in maintaining a normal post-treatment breast contour. If the tumor is superficial, it may be necessary to remove the overlying skin. Skin removal with a curvilinear incision in the inferior breast distorts the breast contour and should be avoided. It is also not necessary to remove needle tracks from core-needle biopsies or fine-needle aspirations.",
"   </p>",
"   <p>",
"    Meticulous hemostasis is important, because a large hematoma distorts the appearance of the breast and makes re-excision and follow-up evaluation more difficult. The presence of a postbiopsy hematoma is not a contraindication to BCT. Reapproximation of the breast tissue without tissue advancement is best avoided, since it can result in distortion of the breast contour, which may not be apparent with the patient supine on the operating table [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/11\">",
"     11",
"    </a>",
"    ]. Cosmetic outcomes can be improved with oncoplastic techniques. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/30/1512?source=see_link\">",
"     \"Oncoplastic techniques in breast conserving surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Long-term complications of both BCT and mastectomy are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39386?source=see_link\">",
"     \"Breast reconstruction in women with breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8202?source=see_link&amp;anchor=H6#H6\">",
"     \"Patterns of relapse and long-term complications of therapy in breast cancer survivors\", section on 'Long-term adverse effects of primary therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H595441601\">",
"    <span class=\"h2\">",
"     Evaluation of the axilla",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the axilla provides information for treatment decisions in patients with invasive breast cancer. Sentinel node biopsy is the standard initial approach. The management of the regional lymph nodes in breast cancer, sentinel node biopsy, and axillary dissection, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/52/42825?source=see_link\">",
"     \"Management of the regional lymph nodes in breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36602?source=see_link\">",
"     \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/23/20856?source=see_link\">",
"     \"Technique of axillary lymph node dissection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Margins of resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microscopic resection margins are the major selection factor for breast conserving therapy (BCT), because of their marked influence on local recurrence. Women with negative excision margins have low rates of local recurrence following BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/1,34-46\">",
"     1,34-46",
"    </a>",
"    ], while positive resection margins (ie, carcinoma at the inked margin) are associated with a higher risk of local recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/36,38-41,43-45,47\">",
"     36,38-41,43-45,47",
"    </a>",
"    ]. The appropriate macroscopic margin of normal breast tissue to resect around the tumor for women undergoing BCT should be 0.5 to 1.0 cm of grossly normal breast tissue, which will usually result in histologically negative margins (ie, &gt;1 mm distance between tumor and ink) in the majority of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/48\">",
"     48",
"    </a>",
"    ]. Larger resections may be necessary for invasive carcinomas with an EIC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/49-51\">",
"     49-51",
"    </a>",
"    ] or for infiltrating lobular carcinomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/1,52-54\">",
"     1,52-54",
"    </a>",
"    ]. Preoperative wire localization, specimen orientation, and specimen radiography are all helpful for obtaining negative excision margins, as discussed below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Wire localization",
"      </strong>",
"      ��� For resection of nonpalpable lesions, preoperative wire localization by the radiologist allows accurate identification of the area requiring resection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/55\">",
"       55",
"      </a>",
"      ]. Multiple bracketing wires may be helpful for delineation of the boundaries of the resection, but do not ensure clear histologic margins of resection. As an example, in one study of wire bracketing for preoperative localization of 75 cancers, clear histologic margins of resection were obtained in 33 patients (44 percent).",
"     </li>",
"     <li>",
"      <strong>",
"       Specimen orientation",
"      </strong>",
"      ��� The specimen should be removed as a single piece of tissue. Gross inspection of the specimen in the operating room, with or without frozen section analysis, permits identification of positive or close margins and immediate reexcision, if appropriate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/56\">",
"       56",
"      </a>",
"      ]. This will decrease the need to return to the operating room for re-excision. Sutures, clips,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      multicolored inks are used to orient the specimen by the operating surgeon. Inking kits are available with six colors for labeling all of the surgical margins (superior, inferior, medial, lateral, superficial, and deep). Clear uniformity between surgeon and pathologist in terms of what suture or color corresponds to each margin is required. This facilitates reporting of the status of individual margins and if re-excision is required, the surgeon can limit the re-excision to the involved margin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Specimen radiography",
"      </strong>",
"      ��� Specimen radiography should be performed during the surgical procedure to confirm excision of the targeted lesion when the lesion was not palpable. Additional oriented margins can be resected prior to closure when the radiograph suggests inadequate resection, which may eliminate the need for a delayed re-excision. In a retrospective study of 123 patients undergoing BCS, specimen radiography identified 19 patients with a margin &le;2 mm who underwent additional intraoperative excision [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/58\">",
"       58",
"      </a>",
"      ]. In 63 percent of cases",
"      <span class=\"nowrap\">",
"       (12/19)",
"      </span>",
"      histological assessment confirmed that the margins of the first surgical specimen were positive and intraoperative re-excision eliminated the need for a second operation. In another study of 264 patients undergoing BCS, specimen radiography identified 54 patients with close margins (6 with DCIS and 48 with invasive cancer), who underwent additional intraoperative excision [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/56\">",
"       56",
"      </a>",
"      ]. Of these, 25 percent of patients with DCIS and 63 percent of patients with invasive cancer were rendered margin negative with intraoperative reexcision.",
"     </li>",
"     <li>",
"      <strong>",
"       Intraoperative margin assessment",
"      </strong>",
"      ��� Several approaches can be used for intraoperative margin assessment, including frozen section [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/56,59-61\">",
"       56,59-61",
"      </a>",
"      ], cytologic touch prep analysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/62-67\">",
"       62-67",
"      </a>",
"      ], shaved margin analysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/68\">",
"       68",
"      </a>",
"      ], and intraoperative ultrasound [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/69\">",
"       69",
"      </a>",
"      ]. There is no prevailing standard of care for intraoperative margin assessment and practices vary widely [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/70\">",
"       70",
"      </a>",
"      ]. The use of these techniques may assist in obtaining negative margins, but does not guarantee the absence of microscopic tumor on permanent sections. Patients should be advised that additional surgery to obtain clean margins may be necessary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H898881\">",
"    <span class=\"h3\">",
"     Indications for re-excision",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positive or unknown histologic margins should prompt re-excision, since such patients are generally at higher risk for local recurrence even when radiation therapy is administered. Residual carcinoma is present in about one-half of such reexcision specimens, with the incidence being dependent upon specimen histology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/48,50,71\">",
"     48,50,71",
"    </a>",
"    ]. In one series, residual cancer was detected in 67 percent of invasive tumors with associated ductal carcinoma in situ (DCIS), 50 percent of infiltrating lobular carcinomas, and 35 percent of infiltrating ductal carcinomas without associated DCIS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/72\">",
"     72",
"    </a>",
"    ]. Tumors that contain an extensive intraductal component (EIC) have a greater likelihood of residual tumor in the reexcision specimen than EIC-negative cancers (88 versus 48 percent in one report) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Extensive intraductal component (EIC)'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    While there is no standard definition of a close margin, most recommend re-excision for margins less than 2 mm if possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/70,73-75\">",
"     70,73-75",
"    </a>",
"    ]. Guidelines from the National Comprehensive Cancer Network (NCCN) state that margins less than 1 mm are considered inadequate, but do not mandate surgical re-excision if at the fibroglandular boundary of the breast (chest wall or skin) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/76\">",
"     76",
"    </a>",
"    ]. Some studies suggest a higher rate of local recurrence at 10 years in women with \"close\" margins, [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/37,41,77\">",
"     37,41,77",
"    </a>",
"    ], while others do not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/36,39,44,78\">",
"     36,39,44,78",
"    </a>",
"    ]. For cases of a close margin where re-excision is not possible, there is value for a radiation boost in addition to the usual postoperative radiation treatment. A randomized trial of 1616 patients with clinical stage I or II breast cancer demonstrated a significant reduction in the risk of local relapse with a radiation boost (16 Gy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39657?source=see_link&amp;anchor=H15#H15\">",
"     \"Techniques of breast and chest wall irradiation for early stage breast cancer\", section on 'RT boost'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cosmetic outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many surgical factors will play a role in the ultimate cosmetic appearance of the breast. These include the size and placement of the incision, management of the lumpectomy cavity, and the extent of axillary dissection if necessary. The surgeon has control over several of these issues, and careful attention to detail will improve the aesthetic results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/80,81\">",
"     80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to local recurrence, a major goal of BCT is the preservation of a cosmetically acceptable breast. With modern treatment techniques, an acceptable cosmetic outcome can be achieved in almost all patients without compromise of local tumor control. In a series of women treated with a whole breast dose of 45 to 46 Gy (daily dose &le;2 Gy), a boost dose of 18 Gy, and precise field matching techniques, excellent or",
"    <span class=\"nowrap\">",
"     excellent/good",
"    </span>",
"    cosmetic results were noted at three years in 73 and 96 percent of women, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/82\">",
"     82",
"    </a>",
"    ]. Although treatment-related changes in the breast stabilize at approximately three years, other factors that impact the untreated breast, such as change in size because of weight gain or the normal ptosis seen with aging, continue to affect breast symmetry.",
"   </p>",
"   <p>",
"    To help assess the cosmetic outcome after BCT, a scoring system to standardize the grading of cosmetic outcome has been recommended by a joint committee of the ACS, the ACR, the College of American Pathologists, and the Society of Surgical Oncology (SSO) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/83\">",
"     83",
"    </a>",
"    ], and used at the Joint Center for Radiation Therapy (JCRT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/84\">",
"     84",
"    </a>",
"    ]. The following scores are assigned:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Excellent: The treated and untreated breast are almost identical",
"     </li>",
"     <li>",
"      Good: Minimal differences between the treated and untreated breasts",
"     </li>",
"     <li>",
"      Fair: Obvious differences between the treated and untreated breasts",
"     </li>",
"     <li>",
"      Poor: Major aesthetic sequelae in the treated breast",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The amount of resected breast tissue is the major determinant of appearance following BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/49,84-86\">",
"     49,84-86",
"    </a>",
"    ], as illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a trial from the National Cancer Institute of Milan that compared quadrantectomy to gross tumor excision (lumpectomy), both combined with RT, cosmetic evaluations were performed 18 to 24 months post-treatment in 148 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/49\">",
"       49",
"      </a>",
"      ]. Women undergoing quadrantectomy had significantly greater discrepancies in the inferior profile of the breasts, greater distance from the midline to the nipple, and were more likely to have more than a 3 cm difference in height between the nipples (21 versus 7 percent) than those treated with lumpectomy.",
"     </li>",
"     <li>",
"      Similar data were noted by the JCRT in a series that correlated cosmetic outcome to the volume of breast tissue resected (estimated by multiplying the dimensions of the resected breast specimens) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/84\">",
"       84",
"      </a>",
"      ]. For women with &lt;35 cm3 resected tissue, excellent and excellent or good scores were reported by 85 and 96 percent, respectively. In contrast, when the volume of resected tissue was &gt;85 cm3, excellent, and excellent or good scores were reported by 51 and 94 percent of women, respectively. In a later series, cosmetic results declined over the first three years and then stabilized; they were still judged by clinicians to be excellent in 77 percent, and good, fair, or poor in 9, 9, and 5 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications after breast conserving surgery include seroma formation, infection, and arm morbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Seroma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seroma formation occurs in virtually all patients after breast and axillary surgery, and should be considered a transient side effect rather than a major long-lasting complication of these procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/88\">",
"     88",
"    </a>",
"    ]. Although all patients will have some serous fluid collect at the surgical site, seromas are not clinically significant in most cases. A clinically significant seroma can be defined as a postoperative fluid collection that requires one or more aspirations or subsequent drain placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rates of clinically significant seromas of the breast or axilla vary with the surgical procedure performed. In a retrospective review of 324 patients who underwent 561 breast or axillary surgeries, 8.4 percent developed a seroma that required intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/89\">",
"     89",
"    </a>",
"    ]. Seroma rates were significantly lower after breast conserving surgery than after mastectomy (6 versus 14 to 16 percent). The presence of a seroma significantly increased the risk of a concurrent or subsequent surgical site infection (8.5 versus 4 percent in the absence of a seroma). In addition to infection, prolonged seroma formation may also be associated with delayed wound healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/90-92\">",
"     90-92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Breast cellulitis and abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast cellulitis is an emerging problem in women undergoing BCT and represents a shift from the ipsilateral arm cellulitis observed in the past following mastectomy and axillary lymph node dissection (ALND) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/93-95\">",
"     93-95",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/61/43991?source=see_link\">",
"     \"Breast cellulitis: Clinical manifestations, diagnosis, and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    BCT may also be associated with the relatively late occurrence of a postoperative breast abscess (median 5 months, range 1.5 to 8.0 months). In one report, the only factor that correlated with abscess formation was size of the lumpectomy specimen; necrosis of marginally viable fat in the lumpectomy cavity may contribute to this problem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/96\">",
"     96",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9495?source=see_link\">",
"     \"Breast abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H595443738\">",
"    <span class=\"h2\">",
"     Arm morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arm morbidity is common after breast cancer treatment and can include arm swelling, arm pain, arm numbness, arm stiffness, shoulder stiffness, shoulder pain, or nerve injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/97\">",
"     97",
"    </a>",
"    ]. Arm problems are less common after BCT as compared to mastectomy; they are also less frequent with sentinel lymph node (SLN) biopsy than after axillary lymph node dissection (ALND) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After breast cancer treatment, patients should be informed about methods to improve shoulder function and reduce the risk of lymphedema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/99,100\">",
"     99,100",
"    </a>",
"    ]. Prevention and treatment of arm edema are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/52/1866?source=see_link\">",
"     \"Clinical manifestations and diagnosis of lymphedema\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/1/33817?source=see_link\">",
"     \"Prevention and treatment of lymphedema\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     LOCAL RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The local recurrence (LR) rate following breast conserving surgery increases with young age, node positivity, estrogen receptor negativity, and absence of radiation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/101\">",
"     101",
"    </a>",
"    ]. In comparing the results of BCT with mastectomy and assessing the probability and impact of local recurrence, it is important to identify factors that may increase the risk of local recurrence. While not contraindications to BCT, these factors may influence the choice of treatment.",
"   </p>",
"   <p>",
"    Mastectomy does not guarantee freedom from local recurrence. In randomized studies using variable surgical and RT techniques, long-term recurrence rates in the treated breast following BCT (with radiation) range from 5 to 22 percent, compared to 4 to 14 percent with mastectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/2-6,8,9\">",
"     2-6,8,9",
"    </a>",
"    ]. The time course of local recurrence differs with BCT versus mastectomy. Although most postmastectomy local failures occur in the first three postoperative years, they tend to occur later in women treated by BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/84,102-104\">",
"     84,102-104",
"    </a>",
"    ]. In one report, as an example, the actuarial incidence of local recurrence was 7, 14, and 20 percent at 5, 10, and 20 years following BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/103\">",
"     103",
"    </a>",
"    ]. This, in part, may reflect the inclusion of new primaries rather than only true recurrences in the definition of in-breast tumor recurrence.",
"   </p>",
"   <p>",
"    Interpretation of data on local recurrence following BCT is hampered by methodologic problems. Many reports differ with regard to patient selection, surgical and radiation techniques, and the use of adjuvant systemic therapy. Furthermore, the competing risks of distant recurrence and second primary cancers also complicate the estimation of true local recurrence risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/105,106\">",
"     105,106",
"    </a>",
"    ]. Nevertheless, despite these issues, several predictive factors for local recurrence following BCT have been identified. These include tumor factors, treatment factors, and patient-related factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Young age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young age (usually defined as &le;40 years) has consistently been associated with an increased risk of local recurrence after BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/101,104,106-113\">",
"     101,104,106-113",
"    </a>",
"    ]. In a retrospective review of 3131 breast conserving surgical procedures for 3064 women, multivariable analysis showed that age &lt;40 years old (n = 175 procedures) and node positivity were significantly associated with an increased LR rate (hazard ratio [HR] 1.86, 95% CI 1.05-3.30 and 1.59,1.01-2.50) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/101\">",
"     101",
"    </a>",
"    ]. Estrogen receptor positivity and radiation therapy were associated with a decreased risk of LR (HR 0.47, 0.27-0.80 and 0.39, 0.21-0.73) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse pathologic features and attempts to perform a less extensive breast resection in younger patients may explain the higher rate of local recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/109,110\">",
"     109,110",
"    </a>",
"    ]. In multiple series, younger women had a higher frequency of adverse pathologic features, such as larger tumor size, lymphatic vessel invasion, poorly differentiated histologic grade, absence of estrogen receptors (ER), and the presence of an EIC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/104,107,108\">",
"     104,107,108",
"    </a>",
"    ]. However, even when adjusted for these findings, younger age has still been associated with shorter survival and an increased likelihood of local recurrence after BCT.",
"   </p>",
"   <p>",
"    In comparison, young age has also been associated with an increase in local failure following mastectomy in most [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/112,114,115\">",
"     112,114,115",
"    </a>",
"    ], but not all studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/111\">",
"     111",
"    </a>",
"    ]. Data from two randomized trials with long-term follow-up do not show an advantage for either form of local treatment (BCT or mastectomy) in younger compared with older women; however, they do not specifically address the issue of patients under 35 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This issue was addressed in a retrospective review of women aged 20 to 49 undergoing BCT (n = 1597) or mastectomy (n = 801) for early breast cancer in British Columbia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/116\">",
"     116",
"    </a>",
"    ]. There was a difference in local relapse free survival (RFS) at 10 years that favored mastectomy in women aged 20 to 39 who were \"ideal\" candidates for BCT. However, it was not statistically significant and did not translate into a noticeable difference in distant RFS or breast cancer-specific survival.",
"   </p>",
"   <p>",
"    Thus, the available information suggests that young age is a prognostic, rather than predictive factor, and that young age by itself is not a contraindication to BCT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Extensive intraductal component (EIC)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term EIC applies to an invasive ductal carcinoma in which intraductal cancer is prominently present within the tumor or in sections of grossly normal adjacent breast tissue. Although EIC had previously been considered a contraindication to BCT, it is only a risk factor for local recurrence when the margins of resection are not evaluated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/117\">",
"     117",
"    </a>",
"    ]. Compared with EIC-negative cancers, those with EIC-positive margins have a higher rate of true local recurrence, but not new ipsilateral primaries, contralateral breast tumors, or an increased likelihood of distant relapse. These data reflect the higher incidence of multifocality and residual cancer following excision of tumors with an EIC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/50,118\">",
"     50,118",
"    </a>",
"    ]. As an example, in one study of 214 women who underwent mastectomy with detailed histologic evaluation of the specimen, EIC-positive tumors were more likely to have prominent residual intraductal carcinoma at least 2 cm beyond the edge of the primary tumor (30 versus 2 percent in EIC-negative cancers) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, women with EIC and negative resection margins do not have an increased risk of ipsilateral recurrence following BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/34-38\">",
"     34-38",
"    </a>",
"    ]. Therefore, routine assessment of the margins of resection is an important component of the histologic evaluation in women undergoing BCT, particularly those with an EIC. A larger breast resection in such women might result in a smaller residual tumor burden and a reduced risk of ipsilateral recurrence following RT.",
"   </p>",
"   <p>",
"    Recognition of EIC-positive cancers has been greatly facilitated by mammographic magnification views [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/119\">",
"     119",
"    </a>",
"    ]. The intraductal component in these lesions is frequently suggested by the presence of suspicious microcalcifications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/33/6680?source=see_link\">",
"     \"Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Associated lobular carcinoma in situ",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between lobular carcinoma in situ (LCIS) within the resection specimen and local recurrence is controversial. At least two studies suggest that the presence of LCIS within the specimen is associated with higher rates of local recurrence (",
"    <a class=\"graphic graphic_table graphicRef72607 \" href=\"mobipreview.htm?26/14/26860\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/120,121\">",
"     120,121",
"    </a>",
"    ]. In the larger of the two, 1274 women with stage I or II breast cancer undergoing BCT, the 10-year cumulative rate of ipsilateral breast tumor recurrence was significantly higher in women with associated LCIS (29 versus 6 percent, p = 0.03) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/120\">",
"     120",
"    </a>",
"    ]. A protective effect of systemic adjuvant hormonal therapy was suggested, since among women receiving adjuvant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    , the local recurrence rates with and without LCIS were 8 and 6 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/14/44265?source=see_link\">",
"     \"Atypia and lobular carcinoma in situ: High risk lesions of the breast\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=see_link\">",
"     \"Pathology of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, several other studies support the view that the presence of LCIS within the specimen is not a risk factor for local recurrence (",
"    <a class=\"graphic graphic_table graphicRef72607 \" href=\"mobipreview.htm?26/14/26860\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/122-125\">",
"     122-125",
"    </a>",
"    ]. In at least one of the reports, there were no differences in local recurrence rate in women who either received or did not receive adjuvant therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/122\">",
"     122",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24278?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging classification for breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    LCIS should not be considered a contraindication to BCT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Inherited susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;An inherited susceptibility to breast and other cancers has been linked to germ-line mutations in BRCA1 and BRCA2 in some women. Young women with a strong family history of either breast or ovarian cancer have a significant probability of and should be offered genetic counseling about these mutations (",
"    <a class=\"graphic graphic_table graphicRef53270 \" href=\"mobipreview.htm?5/23/5500\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44025?source=see_link\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32249?source=see_link\">",
"     \"Genetic testing for hereditary breast and ovarian cancer syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following treatment of a primary breast cancer, women with an inherited susceptibility for breast cancer are at increased risk (approximately five-fold) of developing a contralateral breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/126-131\">",
"     126-131",
"    </a>",
"    ]. Some, but not all, studies show that women with an inherited susceptibility for breast cancer treated with BCT are also at higher risk of local failure when compared to women with sporadic breast cancer treated with BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/129-134\">",
"     129-134",
"    </a>",
"    ]. In addition, women with breast cancer and a",
"    <span class=\"nowrap\">",
"     BRCA1/2",
"    </span>",
"    mutation have a higher rate of local failure when treated with BCT as compared with mastectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/134\">",
"     134",
"    </a>",
"    ]. In a multi-institutional analysis of 655 women with",
"    <span class=\"nowrap\">",
"     BRCA1/2",
"    </span>",
"    mutations, local failure was more likely in those treated with BCT (302 women) compared to mastectomy (353 women); the cumulative estimated risk at 15 years was 23.5 and 5.5 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/134\">",
"     134",
"    </a>",
"    ]. Chemotherapy has a protective effect and reduced the risk of local failure at 15 years to 11 percent in the patients treated with BCT. There were no differences seen in regional or systemic recurrences between the BCT and mastectomy groups, and no difference in overall survival.",
"   </p>",
"   <p>",
"    Prophylactic oophorectomy also has a protective effect in mutation carriers. This may reduce the risk of developing subsequent breast cancer in patients treated with breast conservation. A multi-institutional series compared the outcomes of 160",
"    <span class=\"nowrap\">",
"     BRCA1/2",
"    </span>",
"    mutation carriers with stage I or II breast cancer treated with BCT with 445 control women with sporadic breast cancer undergoing BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/131\">",
"     131",
"    </a>",
"    ]. At 15 years, there was no significant difference in the rate of in-breast tumor recurrence (24 versus 17 percent for controls, p = 0.19). However,",
"    <span class=\"nowrap\">",
"     BRCA1/2",
"    </span>",
"    mutation status was a significant risk factor for in-breast tumor recurrence in multivariate analysis when carriers who had undergone prophylactic oophorectomy were removed from the analysis (hazard ratio 2.0). These results indirectly suggest a protective effect of oophorectomy in carriers treated with breast conservation although more study is needed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/25/34202?source=see_link\">",
"     \"Risk-reducing bilateral salpingo-oophorectomy in women at high risk of epithelial ovarian and fallopian tubal cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17418?source=see_link\">",
"     \"Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The decision whether to pursue BCT in known",
"    <span class=\"nowrap\">",
"     BRCA1/2",
"    </span>",
"    carriers should be made following extensive discussion with an experienced genetics counselor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     UNDERUTILIZATION OF BCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;BCT continues to be underutilized in the United States despite consistent evidence that BCT and mastectomy are therapeutically equivalent and the recommendation of a 1991 National Institutes of Health Consensus Conference that BCT is the preferable treatment for early stage breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/135\">",
"     135",
"    </a>",
"    ]. More than one-fourth of American women with stages I and II breast carcinoma are still undergoing mastectomy, with considerable geographic and age variation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/54,81,135-143\">",
"     54,81,135-143",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potential explanations for these observations include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Contraindications to BCT",
"     </li>",
"     <li>",
"      The use of inappropriate selection criteria by clinicians",
"     </li>",
"     <li>",
"      Increasing use of breast magnetic resonance imaging (MRI)",
"     </li>",
"     <li>",
"      Patient preference",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The first explanation, medical contraindications, is not a major cause of underuse of BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/144-146\">",
"     144-146",
"    </a>",
"    ]. In one report that included 432 women with stage I or II invasive breast cancer or ductal carcinoma in situ (DCIS) who were prospectively evaluated by a multidisciplinary team, only 97 (22 percent) had contraindications to BCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/144\">",
"     144",
"    </a>",
"    ]. Contraindications to BCT can be readily identified with a careful history, physical examination and detailed mammography, including magnification views of the primary site. Using these parameters, in a series of 263 consecutive women, patients eligible for BCT could be selected with 97 percent accuracy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/146\">",
"     146",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Patient selection for BCT'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The second explanation, clinician-related inappropriate medical and demographic selection factors, has been thought to be a major cause of high mastectomy rates in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/147,148\">",
"     147,148",
"    </a>",
"    ]. A joint study of the American College of Surgeons (ACS) and the American College of Radiology (ACR) evaluated factors predicting use of mastectomy as local therapy in 17,931 women with stage I or II breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/147\">",
"     147",
"    </a>",
"    ]. Women with larger tumor size, a clinically positive axilla, EIC in association with the invasive cancer, and higher histologic grade were more likely to undergo mastectomy than those with more favorable features. Other patient-related factors (eg, older age, insurance status, and geographic location) also predicted a higher mastectomy rate. Older women are more likely to have mastectomy recommended by their clinicians, and the majority undergo the procedure that is recommended by their clinician [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/148\">",
"     148",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Magnetic resonance imaging identifies additional ipsilateral disease in 16 percent of women with a new diagnosis of breast cancer and may influence surgical planning, leading to an increase in the mastectomy rate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnostic evaluation of women with suspected breast cancer\", section on 'Breast MRI'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/33/6680?source=see_link&amp;anchor=H100033269#H100033269\">",
"     \"Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis\", section on 'Role of magnetic resonance imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are data to suggest that patient rather than surgeon preference for mastectomy is more of a factor than previously appreciated. Several studies have shown that more patient involvement in breast surgery decision making actually leads to a greater probability of mastectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/149,150\">",
"     149,150",
"    </a>",
"    ]. Even well informed patients may choose mastectomy over BCT because concerns about the side effects of radiation therapy and the hope of avoiding a cancer recurrence with the need for another cancer operation.",
"   </p>",
"   <p>",
"    Studies show that only 50 to 70 percent of women with early breast cancer actively participate in the surgical decision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/149,151\">",
"     149,151",
"    </a>",
"    ]. The use of decision aids (paper, visual, audiotape, or computerized audiovisual) can enhance patient knowledge of treatment options [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/42/31402/abstract/152\">",
"     152",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/8/8321?source=see_link\">",
"       \"Patient information: Choosing treatment for early-stage breast cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/56/12167?source=see_link\">",
"       \"Patient information: Breast cancer guide to diagnosis and treatment (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/44/27335?source=see_link\">",
"       \"Patient information: Surgical procedures for breast cancer &mdash; Mastectomy and breast conserving therapy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Breast conserving therapy (BCT) allows women with invasive breast cancer to preserve their breast without sacrificing oncologic outcome. Successful BCT requires complete surgical removal of the tumor (with negative surgical margins) followed by moderate-dose RT to eradicate any residual disease. &nbsp;(See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Contraindications to BCT include multicentric disease, diffuse malignant microcalcifications on mammography, prior radiation therapy to the affected breast, and persistently positive resection margins after multiple attempts at re-excision. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Patient selection for BCT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy is an absolute contraindication to the use of breast irradiation. It may be possible to perform breast-conserving surgery for pregnant women if surgery can be performed in the third trimester and breast irradiation is deferred until after delivery. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Patient selection for BCT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Certain connective tissue disorders are a relative contraindication to BCT as these disorders may lead to delayed toxicity from radiation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Patient selection for BCT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Large tumor size has been considered a relative contraindication to BCT. However, neoadjuvant chemotherapy or hormonal therapy can decrease tumor size significantly and allow BCT for large tumors with acceptable local recurrence rates. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Patient selection for BCT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acceptable cosmetic outcome can be achieved in almost all patients undergoing BCT without compromise of local tumor control. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Surgical technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications after breast conserving surgery include seroma formation, infection, and arm morbidity. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Postoperative Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clear margins of resection and postoperative radiation therapy are important for reducing local recurrence rates after BCT. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Local recurrence'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/1\">",
"      Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/2\">",
"      Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/3\">",
"      Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 1995; 31A:1574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/4\">",
"      Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/5\">",
"      van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/6\">",
"      Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/7\">",
"      Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003; 98:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/8\">",
"      Arriagada R, L&ecirc; MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 14:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/9\">",
"      Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992; :19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/10\">",
"      Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. N Engl J Med 1995; 333:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/11\">",
"      Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002; 52:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/12\">",
"      Scarth H, Cantin J, Levine M, Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update). CMAJ 2002; 167:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/13\">",
"      Roughton MC, Shenaq D, Jaskowiak N, et al. Optimizing delivery of breast conservation therapy: a multidisciplinary approach to oncoplastic surgery. Ann Plast Surg 2012; 69:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/14\">",
"      Halsted WS. I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. Ann Surg 1907; 46:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/15\">",
"      Adair F, Berg J, Joubert L, Robbins GF. Long-term followup of breast cancer patients: the 30-year report. Cancer 1974; 33:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/16\">",
"      TURNER-WARWICK RT. The lymphatics of the breast. Br J Surg 1959; 46:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/17\">",
"      Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981; 47:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/18\">",
"      Kapoor NS, Eaton A, King TA, et al. Should breast density influence patient selection for breast-conserving surgery? Ann Surg Oncol 2013; 20:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/19\">",
"      Fleck R, McNeese MD, Ellerbroek NA, et al. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys 1989; 17:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/20\">",
"      Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 1997; 15:2728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/21\">",
"      Ross JG, Hussey DH, Mayr NA, Davis CS. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 1993; 71:3744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/22\">",
"      Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J 2001; 7:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/23\">",
"      Phan C, Mindrum M, Silverman C, et al. Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J 2003; 9:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/24\">",
"      Wo J, Taghian A. Radiotherapy in setting of collagen vascular disease. Int J Radiat Oncol Biol Phys 2007; 69:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/25\">",
"      Alm El-Din MA, Taghian AG. Breast conservation therapy for patients with locally advanced breast cancer. Semin Radiat Oncol 2009; 19:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/26\">",
"      Coopey S, Smith BL, Hanson S, et al. The safety of multiple re-excisions after lumpectomy for breast cancer. Ann Surg Oncol 2011; 18:3797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/27\">",
"      Leaper DJ, Melling AG. Antibiotic prophylaxis in clean surgery: clean non-implant wounds. J Chemother 2001; 13 Spec No 1:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/28\">",
"      Gagliardi AR, Fenech D, Eskicioglu C, et al. Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature. Can J Surg 2009; 52:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/29\">",
"      Throckmorton AD, Boughey JC, Boostrom SY, et al. Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol 2009; 16:2464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/30\">",
"      Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/31\">",
"      Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/32\">",
"      Braxton CC, Gerstenberger PA, Cox GG. Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting. J Ambul Care Manage 2010; 33:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/33\">",
"      Tejirian T, DiFronzo LA, Haigh PI. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and metaanalysis. J Am Coll Surg 2006; 203:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/34\">",
"      Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996; 78:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/35\">",
"      Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986; 57:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/36\">",
"      Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000; 18:1668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/37\">",
"      Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/38\">",
"      Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993; 218:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/39\">",
"      Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol 1994; 12:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/40\">",
"      Dewar JA, Arriagada R, Benhamou S, et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group. Cancer 1995; 76:2260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/41\">",
"      Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999; 44:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/42\">",
"      Peterson ME, Schultz DJ, Reynolds C, Solin LJ. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 1999; 43:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/43\">",
"      Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 1998; 40:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/44\">",
"      Pittinger TP, Maronian NC, Poulter CA, Peacock JL. Importance of margin status in outcome of breast-conserving surgery for carcinoma. Surgery 1994; 116:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/45\">",
"      Cowen D, Houvenaeghel G, Bardou V, et al. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 2000; 47:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/46\">",
"      van Dongen JA, Bartelink H, Fentiman IS, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992; 28A:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/47\">",
"      Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/48\">",
"      Kearney TJ, Morrow M. Effect of reexcision on the success of breast-conserving surgery. Ann Surg Oncol 1995; 2:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/49\">",
"      Veronesi U, Luini A, Galimberti V, Zurrida S. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 1994; 18:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/50\">",
"      Schnitt SJ, Connolly JL, Khettry U, et al. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 1987; 59:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/51\">",
"      Vicini FA, Eberlein TJ, Connolly JL, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991; 214:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/52\">",
"      Morrow M, Keeney K, Scholtens D, et al. Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 2006; 106:2563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/53\">",
"      Peiro G, Bornstein BA, Connolly JL, et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 2000; 59:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/54\">",
"      Clarke DH, Martinez AA. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists, and radiation and medical oncologists. J Clin Oncol 1992; 10:474.",
"     </a>",
"    </li>",
"    <li>",
"     Silverstein, MJ, Larson, L, Soni, R, et, al. Breast biopsy and oncoplastic surgery for the patient with ductal carcinoma in situ: surgical, pathologic, and radiologic issues. In: Ductal carcinoma in situ of the breast, 2nd edition, Silverstein, MJ (Eds), Lippincott Williams and Wilkins, Philadelphia 2002. p.185.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/56\">",
"      Cabioglu N, Hunt KK, Sahin AA, et al. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 2007; 14:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/57\">",
"      Gibson GR, Lesnikoski BA, Yoo J, et al. A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol 2001; 8:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/58\">",
"      Ciccarelli G, Di Virgilio MR, Menna S, et al. Radiography of the surgical specimen in early stage breast lesions: diagnostic reliability in the analysis of the resection margins. Radiol Med 2007; 112:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/59\">",
"      Riedl O, Fitzal F, Mader N, et al. Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer. Eur J Surg Oncol 2009; 35:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/60\">",
"      Olson TP, Harter J, Mu&ntilde;oz A, et al. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol 2007; 14:2953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/61\">",
"      Fukamachi K, Ishida T, Usami S, et al. Total-circumference intraoperative frozen section analysis reduces margin-positive rate in breast-conservation surgery. Jpn J Clin Oncol 2010; 40:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/62\">",
"      Klimberg VS, Westbrook KC, Korourian S. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 1998; 5:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/63\">",
"      Klimberg VS, Harms S, Korourian S. Assessing margin status. Surg Oncol 1999; 8:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/64\">",
"      Cox CE, Hyacinthe M, Gonzalez RJ, et al. Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome. Ann Surg Oncol 1997; 4:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/65\">",
"      Cox CE, Pendas S, Ku NN, et al. Local recurrence of breast cancer after cytological evaluation of lumpectomy margins. Am Surg 1998; 64:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/66\">",
"      Creager AJ, Shaw JA, Young PR, Geisinger KR. Intraoperative evaluation of lumpectomy margins by imprint cytology with histologic correlation: a community hospital experience. Arch Pathol Lab Med 2002; 126:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/67\">",
"      D'Halluin F, Tas P, Rouquette S, et al. Intra-operative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures. Breast 2009; 18:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/68\">",
"      Camp ER, McAuliffe PF, Gilroy JS, et al. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance. J Am Coll Surg 2005; 201:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/69\">",
"      Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg 2003; 186:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/70\">",
"      Blair SL, Thompson K, Rococco J, et al. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg 2009; 209:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/71\">",
"      Gwin JL, Eisenberg BL, Hoffman JP, et al. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg 1993; 218:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/72\">",
"      Schmidt-Ullrich RK, Wazer DE, DiPetrillo T, et al. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant. Int J Radiat Oncol Biol Phys 1993; 27:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/73\">",
"      Law TT, Kwong A. Surgical margins in breast conservation therapy: how much should we excise? South Med J 2009; 102:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/74\">",
"      Morrow M. Breast conservation and negative margins: how much is enough? Breast 2009; 18 Suppl 3:S84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/75\">",
"      Sabel MS. Surgical considerations in early-stage breast cancer: lessons learned and future directions. Semin Radiat Oncol 2011; 21:10.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/77\">",
"      Kunos C, Latson L, Overmoyer B, et al. Breast conservation surgery achieving&gt;or=2 mm tumor-free margins results in decreased local-regional recurrence rates. Breast J 2006; 12:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/78\">",
"      McIntosh A, Freedman G, Eisenberg D, Anderson P. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am J Clin Oncol 2007; 30:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/79\">",
"      Jones HA, Antonini N, Hart AA, et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol 2009; 27:4939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/80\">",
"      Fitzal F, Mittlboeck M, Trischler H, et al. Breast-conserving therapy for centrally located breast cancer. Ann Surg 2008; 247:470.",
"     </a>",
"    </li>",
"    <li>",
"     Morrow M, Harris JR.. Local management of invasive breast cancer. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/82\">",
"      de la Rochefordi&egrave;re A, Abner AL, Silver B, et al. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys 1992; 23:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/83\">",
"      Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin 1998; 48:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/84\">",
"      Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979; 5:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/85\">",
"      Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992; 10:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/86\">",
"      Mills JM, Schultz DJ, Solin LJ. Preservation of cosmesis with low complication risk after conservative surgery and radiotherapy for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 1997; 39:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/87\">",
"      Beadle GF, Silver B, Botnick L, et al. Cosmetic results following primary radiation therapy for early breast cancer. Cancer 1984; 54:2911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/88\">",
"      van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol 2011; 37:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/89\">",
"      Boostrom SY, Throckmorton AD, Boughey JC, et al. Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg 2009; 208:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/90\">",
"      Say CC, Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet 1974; 138:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/91\">",
"      Aitken DR, Minton JP. Complications associated with mastectomy. Surg Clin North Am 1983; 63:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/92\">",
"      Budd DC, Cochran RC, Sturtz DL, Fouty WJ Jr. Surgical morbidity after mastectomy operations. Am J Surg 1978; 135:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/93\">",
"      Mertz KR, Baddour LM, Bell JL, Gwin JL. Breast cellulitis following breast conservation therapy: a novel complication of medical progress. Clin Infect Dis 1998; 26:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/94\">",
"      Rescigno J, McCormick B, Brown AE, Myskowski PL. Breast cellulitis after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1994; 29:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/95\">",
"      Brewer VH, Hahn KA, Rohrbach BW, et al. Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clin Infect Dis 2000; 31:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/96\">",
"      Keidan RD, Hoffman JP, Weese JL, et al. Delayed breast abscesses after lumpectomy and radiation therapy. Am Surg 1990; 56:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/97\">",
"      Arndt V, Merx H, Stegmaier C, et al. Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 2005; 23:4945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/98\">",
"      Husted Madsen A, Haugaard K, Soerensen J, et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast 2008; 17:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/99\">",
"      Beurskens CH, van Uden CJ, Strobbe LJ, et al. The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer 2007; 7:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/100\">",
"      Torres Lacomba M, Yuste S&aacute;nchez MJ, Zapico Go&ntilde;i A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 2010; 340:b5396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/101\">",
"      Miles RC, Gullerud RE, Lohse CM, et al. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol 2012; 19:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/102\">",
"      Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989; 17:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/103\">",
"      Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 1989; 63:1912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/104\">",
"      Gage I, Recht A, Gelman R, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995; 33:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/105\">",
"      Gelman R, Gelber R, Henderson IC, et al. Improved methodology for analyzing local and distant recurrence. J Clin Oncol 1990; 8:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/106\">",
"      Voogd AC, Peterse JL, Crommelin MA, et al. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST). Eur J Cancer 1999; 35:1828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/107\">",
"      Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/108\">",
"      de la Rochefordiere, Mouret-Fourme E, de Ricke Y, et al. Local and distant relapses in relation to age following breast-conserving surgery and irradiation in premenopausal patients with breast cancer (abstract). Int J Radiat Oncol Biol Phys 1998; 42:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/109\">",
"      Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 1990; 8:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/110\">",
"      Vrieling C, Collette L, Fourquet A, et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 2003; 39:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/111\">",
"      Matthews RH, McNeese MD, Montague ED, Oswald MJ. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Radiat Oncol Biol Phys 1988; 14:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/112\">",
"      Chan A, Pintilie M, Vallis K, et al. Breast cancer in women &lt; or = 35 years: review of 1002 cases from a single institution. Ann Oncol 2000; 11:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/113\">",
"      de Bock GH, van der Hage JA, Putter H, et al. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer 2006; 42:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/114\">",
"      Donegan WL, Perez-Mesa CM, Watson FR. A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 1966; 122:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/115\">",
"      de la Rochefordiere A, Asselain B, Campana F, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993; 341:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/116\">",
"      Coulombe G, Tyldesley S, Speers C, et al. Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 2007; 67:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/117\">",
"      Harris JR. Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int J Radiat Oncol Biol Phys 1996; 35:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/118\">",
"      Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/119\">",
"      Healey EA, Osteen RT, Schnitt SJ, et al. Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer? Int J Radiat Oncol Biol Phys 1989; 17:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/120\">",
"      Sasson AR, Fowble B, Hanlon AL, et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 2001; 91:1862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/121\">",
"      Jolly S, Kestin LL, Goldstein NS, Vicini FA. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2006; 66:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/122\">",
"      Abner AL, Connolly JL, Recht A, et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 2000; 88:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/123\">",
"      Ciocca RM, Li T, Freedman GM, Morrow M. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008; 15:2263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/124\">",
"      Ben-David MA, Kleer CG, Paramagul C, et al. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis. Cancer 2006; 106:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/125\">",
"      Stolier AJ, Barre G, Bolton JS, et al. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status. Am Surg 2004; 70:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/126\">",
"      Chabner E, Nixon A, Gelman R, et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 1998; 16:2045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/127\">",
"      Verhoog LC, Brekelmans CT, Seynaeve C, et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998; 351:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/128\">",
"      Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/129\">",
"      Pierce LJ, Strawderman M, Narod SA, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 2000; 18:3360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/130\">",
"      Haffty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 2002; 359:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/131\">",
"      Pierce LJ, Levin AM, Rebbeck TR, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 2006; 24:2437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/132\">",
"      Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000; 48:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/133\">",
"      Robson M, Levin D, Federici M, et al. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst 1999; 91:2112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/134\">",
"      Pierce LJ, Phillips KA, Griffith KA, et al. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat 2010; 121:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/135\">",
"      NIH Consensus Development Conference statement on the treatment of early-stage breast cancer. Oncology (Williston Park) 1991; 5:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/136\">",
"      Guadagnoli E, Weeks JC, Shapiro CL, et al. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 1998; 16:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/137\">",
"      Nattinger AB, Gottlieb MS, Veum J, et al. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992; 326:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/138\">",
"      Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992; 326:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/139\">",
"      Riley GF, Potosky AL, Klabunde CN, et al. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 1999; 281:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/140\">",
"      Temple WJ, Russell ML, Parsons LL, et al. Conservation surgery for breast cancer as the preferred choice: a prospective analysis. J Clin Oncol 2006; 24:3367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/141\">",
"      Gregorio DI, Kulldorff M, Barry L, et al. Geographical differences in primary therapy for early-stage breast cancer. Ann Surg Oncol 2001; 8:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/142\">",
"      Hiotis K, Ye W, Sposto R, Skinner KA. Predictors of breast conservation therapy: size is not all that matters. Cancer 2005; 103:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/143\">",
"      Chagpar AB, Studts JL, Scoggins CR, et al. Factors associated with surgical options for breast carcinoma. Cancer 2006; 106:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/144\">",
"      Morrow M, Bucci C, Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 1998; 186:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/145\">",
"      Foster RS Jr, Farwell ME, Costanza MC. Breast-conserving surgery for breast cancer: patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol 1995; 2:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/146\">",
"      Morrow M, Schmidt R, Hassett C. Patient selection for breast conservation therapy with magnification mammography. Surgery 1995; 118:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/147\">",
"      Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001; 19:2254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/148\">",
"      Cyran EM, Crane LA, Palmer L. Physician sex and other factors associated with type of breast cancer surgery in older women. Arch Surg 2001; 136:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/149\">",
"      Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005; 23:5526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/150\">",
"      Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009; 302:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/151\">",
"      Keating NL, Guadagnoli E, Landrum MB, et al. Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement? J Clin Oncol 2002; 20:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/42/31402/abstract/152\">",
"      Waljee JF, Rogers MA, Alderman AK. Decision aids and breast cancer: do they influence choice for surgery and knowledge of treatment options? J Clin Oncol 2007; 25:1067.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 807 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.80.101-607E99995B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31402=[""].join("\n");
var outline_f30_42_31402=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATIENT SELECTION FOR BCT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Selection criteria for BCT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Special considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Connective tissue disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Tumor size",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Role of neoadjuvant treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H595441743\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3173893\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3173900\">",
"      Deep venous thrombosis prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SURGICAL TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H595441601\">",
"      Evaluation of the axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Margins of resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H898881\">",
"      - Indications for re-excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cosmetic outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      POSTOPERATIVE COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Seroma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Breast cellulitis and abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H595443738\">",
"      Arm morbidity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      LOCAL RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Young age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Extensive intraductal component (EIC)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Associated lobular carcinoma in situ",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Inherited susceptibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      UNDERUTILIZATION OF BCT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/807\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/807|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/51/7997\" title=\"table 1\">",
"      LR after neoadj tx and BCT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/46/23275\" title=\"table 2\">",
"      Timing of surgical prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/54/35693\" title=\"table 3\">",
"      Perioperative VTE prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/14/26860\" title=\"table 4\">",
"      LCIS risk factor recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/23/5500\" title=\"table 5\">",
"      Risk of BRCA1 mutation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/14/44265?source=related_link\">",
"      Atypia and lobular carcinoma in situ: High risk lesions of the breast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9495?source=related_link\">",
"      Breast abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24504?source=related_link\">",
"      Breast biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17207?source=related_link\">",
"      Breast cancer during pregnancy and lactation: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/61/43991?source=related_link\">",
"      Breast cellulitis: Clinical manifestations, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/33/6680?source=related_link\">",
"      Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39386?source=related_link\">",
"      Breast reconstruction in women with breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44025?source=related_link\">",
"      Characteristics of hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/52/1866?source=related_link\">",
"      Clinical manifestations and diagnosis of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=related_link\">",
"      Diagnostic evaluation of women with suspected breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32249?source=related_link\">",
"      Genetic testing for hereditary breast and ovarian cancer syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/22/30058?source=related_link\">",
"      HER2 and predicting response to therapy in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19194?source=related_link\">",
"      Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17418?source=related_link\">",
"      Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/52/42825?source=related_link\">",
"      Management of the regional lymph nodes in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/18/12586?source=related_link\">",
"      Mastectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/28/43465?source=related_link\">",
"      Measurement of prognostic factors in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35466?source=related_link\">",
"      Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/30/1512?source=related_link\">",
"      Oncoplastic techniques in breast conserving surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/34/29224?source=related_link\">",
"      Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/46/19177?source=related_link\">",
"      Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=related_link\">",
"      Pathology of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/56/12167?source=related_link\">",
"      Patient information: Breast cancer guide to diagnosis and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/8/8321?source=related_link\">",
"      Patient information: Choosing treatment for early-stage breast cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/44/27335?source=related_link\">",
"      Patient information: Surgical procedures for breast cancer &mdash; Mastectomy and breast conserving therapy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8202?source=related_link\">",
"      Patterns of relapse and long-term complications of therapy in breast cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/3/41017?source=related_link\">",
"      Postmastectomy chest wall irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/1/33817?source=related_link\">",
"      Prevention and treatment of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/25/34202?source=related_link\">",
"      Risk-reducing bilateral salpingo-oophorectomy in women at high risk of epithelial ovarian and fallopian tubal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11385?source=related_link\">",
"      Role of radiation therapy in breast conservation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36602?source=related_link\">",
"      Sentinel lymph node dissection for breast cancer: Indications and outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/23/20856?source=related_link\">",
"      Technique of axillary lymph node dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39657?source=related_link\">",
"      Techniques of breast and chest wall irradiation for early stage breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24278?source=related_link\">",
"      Tumor node metastasis (TNM) staging classification for breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_42_31403="H2 receptor antagonists";
var content_f30_42_31403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    H2 receptor antagonists",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Available strengths (mg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Standard daily dose (mg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Maintenance dose (mg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cimetidine",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        200 mg",
"        <br/>",
"        300 mg",
"        <br/>",
"        400 mg",
"        <br/>",
"        800 mg",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        400 mg twice daily",
"        <br/>",
"        800 mg at bedtime",
"       </td>",
"       <td>",
"        400 mg at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ranitidine",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        150 mg",
"        <br/>",
"        300 mg",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        150 mg twice daily",
"        <br/>",
"        300 mg at bedtime",
"       </td>",
"       <td>",
"        150 mg at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Famotidine",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        20 mg",
"        <br/>",
"        40 mg",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        20 mg twice daily",
"        <br/>",
"        40 mg at bedtime",
"       </td>",
"       <td>",
"        20 mg at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nizatidine",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        150 mg",
"        <br/>",
"        300 mg",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        150 mg twice daily",
"        <br/>",
"        300 mg at bedtime",
"       </td>",
"       <td>",
"        150 mg at bedtime",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31403=[""].join("\n");
var outline_f30_42_31403=null;
var title_f30_42_31404="LS nerve muscle function";
var content_f30_42_31404=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Basic lower extremity nerve and muscle function",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Nerve (nerve roots)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Major muscles",
"       </td>",
"       <td class=\"subtitle1\">",
"        Motor function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Femoral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L2-L4)",
"       </td>",
"       <td>",
"        Quadriceps",
"       </td>",
"       <td>",
"        Knee extension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L1-L3)",
"       </td>",
"       <td>",
"        Iliopsoas; sartorius",
"       </td>",
"       <td>",
"        Hip flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Obturator",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L2-L4)",
"       </td>",
"       <td>",
"        Adductor L.",
"       </td>",
"       <td>",
"        Hip adduction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Superior gluteal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L4-S1)",
"       </td>",
"       <td>",
"        Gluteus medius",
"       </td>",
"       <td>",
"        Hip abduction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Inferior gluteal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L5-S2)",
"       </td>",
"       <td>",
"        Gluteus maximus",
"       </td>",
"       <td>",
"        Hip extension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Several nerve branches involved",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L5-S2)",
"       </td>",
"       <td>",
"        Obturator; piriformis; gemelli",
"       </td>",
"       <td>",
"        Hip ext rotation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Common peroneal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L4-S3)",
"       </td>",
"       <td>",
"        Tibialis anterior",
"       </td>",
"       <td>",
"        Foot dorsiflexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (Posterior sciatic)",
"       </td>",
"       <td>",
"        Fibularis L. &amp; B.",
"       </td>",
"       <td>",
"        Foot eversion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L5,S1)",
"       </td>",
"       <td>",
"        Extensor digit. L.",
"       </td>",
"       <td>",
"        Toe extension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Tibial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (L5-S2)",
"       </td>",
"       <td>",
"        Hamstrings",
"       </td>",
"       <td>",
"        Knee flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (Anterior sciatic) (S1, S2)",
"       </td>",
"       <td>",
"        Gastrocnemius; soleus",
"       </td>",
"       <td>",
"        Foot plantar flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (S2, S3)",
"       </td>",
"       <td>",
"        Flexor digit. L.",
"       </td>",
"       <td>",
"        Toe flexion",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     B: brevis; L: longus.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31404=[""].join("\n");
var outline_f30_42_31404=null;
var title_f30_42_31405="Beta blocker in HF after MI";
var content_f30_42_31405=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beta blocker reduces mortality in patients with HF after MI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 274px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The AIRE trial randomized 2006 patients with heart failure after a myocardial infarction to ramipril or placebo. Cumulative mortality in the 22 percent who were also receiving a beta blocker was significantly lower than in those not receiving a beta blocker (12 versus 22 percent, p = 0.008).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Spargias KS, Hall AJ, Greenwood DC, et al. Heart 1999; 81:25.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31405=[""].join("\n");
var outline_f30_42_31405=null;
var title_f30_42_31406="Crohns colitis sacculation BE";
var content_f30_42_31406=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75400&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75400&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic Crohn's colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 259px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Barium enema demonstrates sacculations along the medial border of the ascending colon (arrows) produced by scarring and fibrosis in a patient with Crohn's disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_42_31406=[""].join("\n");
var outline_f30_42_31406=null;
var title_f30_42_31407="Contents: Primary care nephrology urology";
var content_f30_42_31407=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care nephrology urology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care nephrology urology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Fluid and electrolytes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/44/31432\">",
"           Approach to the adult with metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/55/4986\">",
"           Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/36/34375\">",
"           Clinical manifestations and diagnosis of edema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/56/24457\">",
"           Etiology, clinical manifestations, and diagnosis of volume depletion in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/48/11018\">",
"           General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/50/30503\">",
"           General principles of the treatment of edema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/31/20981\">",
"           Idiopathic edema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34935\">",
"           Maintenance and replacement fluid therapy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/34/18986\">",
"           Overview of the treatment of hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/34/36393\">",
"           Pathophysiology and etiology of edema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/48/15114\">",
"           Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/60/7113\">",
"           Ambulatory blood pressure monitoring and white coat hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/57/13206\">",
"           Antihypertensive therapy and progression of chronic kidney disease: Experimental studies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/4/43080\">",
"           Blood pressure measurement in the diagnosis and management of hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/41/18068\">",
"           Can therapy be discontinued in well-controlled hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/51/37685\">",
"           Cardiovascular risks of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/47/20218\">",
"           Choice of therapy in essential hypertension: Clinical trials",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/29/36314\">",
"           Choice of therapy in primary (essential) hypertension: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/55/36728\">",
"           Definition, risk factors, and evaluation of resistant hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/43/42679\">",
"           Diet in the treatment and prevention of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/14/19685\">",
"           Differences between angiotensin converting enzyme inhibitors and receptor blockers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/26/18853\">",
"           Drug treatment of hypertensive emergencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/17/31001\">",
"           Establishing the diagnosis of renovascular hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/4/4169\">",
"           Hypertension: Who should be treated?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/26/422\">",
"           Initial evaluation of the hypertensive adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/27/41398\">",
"           Malignant hypertension and hypertensive encephalopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/17/23828\">",
"           Patient adherence and the treatment of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/40/44677\">",
"           Prehypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/35/24120\">",
"           Salt intake, salt restriction, and essential hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/41/4755\">",
"           The prevalence and control of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/54/8040\">",
"           Treatment of bilateral atherosclerotic renal artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/14/15592\">",
"           Treatment of hypertension in blacks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/45/21210\">",
"           Treatment of hypertension in patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/27/25018\">",
"           Treatment of hypertension in the elderly patient, particularly isolated systolic hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/27/35256\">",
"           Treatment of resistant hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/11/18614\">",
"           Treatment of specific hypertensive emergencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/43/29369\">",
"           Treatment of unilateral atherosclerotic renal artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/40/33417\">",
"           What is goal blood pressure in the treatment of hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/21/27991\">",
"           Who should be evaluated for renovascular or other causes of secondary hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/50/1827\">",
"           Withdrawal syndromes with antihypertensive therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nephrolithiasis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/50/20266\">",
"           Diagnosis and acute management of suspected nephrolithiasis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/22/29033\">",
"           Evaluation of the adult patient with established nephrolithiasis and treatment if stone composition is unknown",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/2/38953\">",
"           Prevention of recurrent calcium stones in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/53/33626\">",
"           Risk factors for calcium stones in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/58/39847\">",
"           The first kidney stone and asymptomatic nephrolithiasis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/62/3047\">",
"           Uric acid nephrolithiasis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/57/13206\">",
"           Antihypertensive therapy and progression of chronic kidney disease: Experimental studies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/45/36570\">",
"           Assessment of kidney function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/37/13914\">",
"           Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/23/35190\">",
"           Calculation of the creatinine clearance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/31/34298\">",
"           Chronic kidney disease and coronary heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35785\">",
"           Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/31/27130\">",
"           Differential diagnosis and evaluation of glomerular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/59/34746\">",
"           Etiology and evaluation of hematuria in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/20/27973\">",
"           Exercise-induced hematuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/49/42777\">",
"           Microalbuminuria in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/33/39449\">",
"           Microalbuminuria in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/15/17655\">",
"           Orthostatic (postural) proteinuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/63/30714\">",
"           Overview of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/18/32041\">",
"           Overview of heavy proteinuria and the nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/32/10759\">",
"           Overview of renal tubular acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/35/37434\">",
"           Overview of the management of chronic kidney disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/34/22058\">",
"           Urinalysis in the diagnosis of kidney disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urinary incontinence",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/14/29929\">",
"           Clinical presentation and diagnosis of urinary incontinence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/1/7192\">",
"           Epidemiology, risk factors, and pathogenesis of urinary incontinence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/1/11290\">",
"           Lower urinary tract symptoms in men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/29/28122\">",
"           Nocturia: Clinical presentation, diagnosis, and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/4/32842\">",
"           Treatment of urinary incontinence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/48/41737\">",
"           Urinary incontinence in men",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urinary tract infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/42/4776\">",
"           Acute bacterial prostatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/15/13561\">",
"           Acute uncomplicated cystitis and pyelonephritis in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/4/35912\">",
"           Acute urinary retention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/19/42295\">",
"           Approach to the adult with asymptomatic bacteriuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/60/23496\">",
"           Chronic bacterial prostatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/24/44422\">",
"           Urinary tract infection associated with urethral catheters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/41/24214\">",
"           Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/33/14872\">",
"           Balanitis and balanoposthitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/19/17720\">",
"           Chronic prostatitis/chronic pelvic pain syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/53/36696\">",
"           Clinical manifestations and diagnostic evaluation of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/19/34104\">",
"           Epidemiology and pathogenesis of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/51/5942\">",
"           Evaluation of nonacute scrotal pathology in adult men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/20/44360\">",
"           Evaluation of the acute scrotum in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/10/22694\">",
"           Hematospermia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/38/19047\">",
"           Male dyspareunia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/2/41001\">",
"           Measurement of prostate specific antigen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/31/8698\">",
"           Medical treatment of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/61/39893\">",
"           Overview of vasectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/55/17273\">",
"           Peyronie's disease: Diagnosis and medical management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/61/7127\">",
"           Priapism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/7/40056\">",
"           Surgical and other invasive therapies of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-74BBCE9953-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f30_42_31407=[""].join("\n");
var outline_f30_42_31407=null;
         